col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

1099 Results       Page 1

Elsevier: Vaccine
  original article Date Title Authors   All Authors
1 [GO] 2024―Feb―26 Socio-demographic determinants of COVID-19 vaccine uptake in Ontario: Exploring differences across the Health Region model Ariel Mundo Ortiz, Bouchra Nasri
2 [GO] 2024―Feb―22 Mortality risk after COVID-19 vaccination: A self-controlled case series study Stanley Xu, Lina S. Sy, Vennis Hong, Paddy Farrington, Sungching C. Glenn, Denison S. Ryan, et al. (+13)
3 [GO] 2024―Feb―22 Audiovestibular adverse events following COVID-19 vaccinations Aishwarya N. Shetty, Hannah J. Morgan, Linny K. Phuong, John Mallard, Diana Vlasenko, Christopher Pearce, et al. (+3)
4 [GO] 2024―Feb―16 Risk of SARS-CoV-2 breakthrough infection following NVX-CoV2373 and BNT162b2 vaccinations in Korean Adults: A population-based observational study Hee Kyoung Kim, Seon Kyeong Park, Seung Ah Choe, Eun Sun Gwak, Benjamin John Cowling, Young-Man Kim, et al. (+7)
5 [GO] 2024―Feb―15 U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 - May 2023 Christopher Duggar, Jeanne M. Santoli, Cameron Noblit, Lori B. Moore, Roua El Kalach, Carolyn B. Bridges
6 [GO] 2024―Feb―15 COVID-19 vaccine perspectives and uptake among university students three years into the pandemic Barbara J. Kuter, Kate Brien, Susannah Anderson, Sarah Bauerle Bass, Linda Gutierrez, Stella Winters, et al. (+3)
7 [GO] 2024―Feb―15 Vaccine effectiveness against COVID-19: A test negative case-control study in Tunisia, August 2021 Emna Mziou, Aicha Hchaichi, Hejer Letaief, Sonia Dhaouadi, Mouna Safer, Khouloud Talmoudi, et al. (+7)
8 [GO] 2024―Feb―15 Immunogenicity and safety of a SARS-CoV-2 mRNA vaccine (SYS6006) in healthy Chinese participants: A randomized, observer-blinded, placebo-controlled phase 2 clinical trial Fei Jin, Yuanzheng Qiu, Zhiwei Wu, Yuan-Hui Wang, Chengye Cai, Liangcai Fu, et al. (+18)
9 [GO] 2024―Feb―14 Did the COVID-19 experience change U.S. parents’ attitudes towards HPV vaccination? Results from a national survey Ann C. Klassen, Giyoung Lee, Shawn Chiang, Regan Murray, Mengfei Guan, Wen-Juo Lo, et al. (+4)
10 [GO] 2024―Feb―14 The impact of time since SARS-Cov-2 vaccination, age, sex and comorbidities on COVID-19 outcome in hospitalized patients with SARS-CoV-2 infection Francesco Donato, Andrea Pilotto, Emanuele Focà, Marco Tresoldi, Alessio Tonoli, Cristiano Perani, et al. (+13)
11 [GO] 2024―Feb―13 Food insecurity and COVID-19 vaccine hesitancy among adults in the United States (US) Elizabeth B. Hearn, Ganiat Kehinde, Usha Sambamoorthi
12 [GO] 2024―Feb―12 Acute disseminated encephalomyelitis and transverse myelitis following COVID-19 vaccination - A self-controlled case series analysis Hannah J. Morgan, Hazel J. Clothier, Gonzalo Sepulveda Kattan, James H. Boyd, Jim P. Buttery
13 [GO] 2024―Feb―12 COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals K. Faksova, D. Walsh, Y. Jiang, J. Griffin, A. Phillips, A. Gentile, et al. (+30)
14 [GO] 2024―Feb―10 SARS-CoV-2 specific antibody response after an mRNA vaccine as the third dose: Homologous versus heterologous boost Olivera Lijeskić, Neda Bauman, Miloš Marković, Jelena Srbljanović, Branko Bobić, Đorđe Zlatković, Tijana Štajner
15 [GO] 2024―Feb―09 COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic Lauri E. Markowitz, Robert H. Hopkins, Karen R. Broder, Grace M. Lee, Kathryn M. Edwards, Matthew F. Daley, et al. (+22)
16 [GO] 2024―Feb―09 Safe in pregnancy: A global living systematic review and meta-analysis of COVID-19 vaccines in pregnancy Pierre Buekens, Mabel Berrueta, Agustín Ciapponi, Ariel Bardach, Agustina Mazzoni, Federico Rodriguez-Cairoli, et al. (+6)
17 [GO] 2024―Feb―09 Leveraging the immunoinformatics approach for designing the SARS-CoV-2 omicron-specific antigenic cassette of mRNA vaccine Rucha Wadapurkar, Sanjay Singh, Ajay Singh
18 [GO] 2024―Feb―06 Public opinion on global COVID-19 vaccine procurement and distribution policies: A nationally representative survey in Aotearoa New Zealand 2022 Komathi Kolandai, Barry Milne, Martin von Randow, Chris Bullen, Samantha Marsh, John A. Crump
19 [GO] 2024―Feb―05 The age-specific impact of COVID-19 vaccination on medical expenditures and hospitalization duration after breakthrough infection: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) Study Megumi Maeda, Fumiko Murata, Haruhisa Fukuda
20 [GO] 2024―Feb―02 The impact of Covid-19 vaccination in Aotearoa New Zealand: A modelling study Samik Datta, Giorgia Vattiato, Oliver J. Maclaren, Ning Hua, Andrew Sporle, Michael J. Plank
21 [GO] 2024―Feb―02 Infection-mediated immune response in SARS-CoV-2 breakthrough infection and implications for next-generation COVID-19 vaccine development Sho Miyamoto, Tadaki Suzuki
22 [GO] 2024―Feb―02 Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort study Patrick Rivers, Cynthia Porter, Lindsay B. LeClair, Zuha Jeddy, Ashley L. Fowlkes, Julie Mayo Lamberte, et al. (+18)
23 [GO] 2024―Feb―01 Strong immunogenicity & protection in mice with PlaCCine: A COVID-19 DNA vaccine formulated with a functional polymer Subeena Sood, Majed M. Matar, Jessica Kim, Meredyth Kinsella, Kempaiah Rayavara, Olivia Signer, et al. (+14)
24 [GO] 2024―Jan―30 Flu-COVID combo recombinant protein vaccines elicited protective immune responses against both influenza and SARS-CoV-2 viruses infection Ying Huang, Hua Shi, David Forgacs, Ted M. Ross
25 [GO] 2024―Jan―30 Immunogenicity of an adenovirus-vectored bivalent vaccine against wild type SARS-CoV-2 and Omicron variants in a murine model Yuanyuan Ji, Xiuwen Sui, Wei Miao, Chang Wang, Qing Wang, Zhuojun Duan, et al. (+6)
26 [GO] 2024―Jan―28 Impact of the 'Health on Wheels' (HoW) strategy on COVID-19 vaccination coverage in hard-to-reach communities in Alta Verapaz, Guatemala, 2022 Evelyn Balsells, Manolo Vicente, Sharon Reyes, Marlon Figueroa, Keyla Sum, Maria Antonieta López Lacán, et al. (+8)
27 [GO] 2024―Jan―27 Are COVID-19 vaccination mandates for healthcare workers effective? A systematic review of the impact of mandates on increasing vaccination, alleviating staff shortages and decreasing staff illness Arnold I. Okpani, Prince Adu, Tyler Paetkau, Karen Lockhart, Annalee Yassi
28 [GO] 2024―Jan―27 Antibodies against SARS-CoV-2 non-structural protein 3 cross-react with human muscle cells and neuroglial cells Xin-Yue Yang, Ting Liu, Si-Cong Jiang, Zhong-Wei Zhang, Yu-Fan Fu, Zi-Lin Li, et al. (+2)
29 [GO] 2024―Jan―27 Short term safety of BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine among children aged 5-11 years, a nationwide parental survey Shirley Shapiro Ben David, Sharon Baruch Gez, Limor Adler, Rada Kovatch, Daniella Rahamim-Cohen, Na'ama Shamir-Stein, et al. (+2)
30 [GO] 2024―Jan―26 The U.S. COVID-19 vaccination program: A look back and future directions Elisha Hall, Barbara E. Mahon, Georgina Peacock
31 [GO] 2024―Jan―25 Determinants of SARS-CoV-2 IgG response and decay in Canadian healthcare workers: A prospective cohort study Nicola Cherry, Anil Adisesh, Igor Burstyn, Carmen Charlton, Yan Chen, Quentin Durand-Moreau, et al. (+5)
32 [GO] 2024―Jan―24 Influence of Community Determinants on Barriers and Facilitators to COVID-19 Vaccine Uptake: Regional Stakeholders’ Perspectives Savanah Russ, Nancy Bennett, Edwin van Wijngaarden, Elaine Hill, Yu Liu
33 [GO] 2024―Jan―23 Strengthening COVID-19 vaccine confidence & demand during the US COVID-19 emergency response Neetu Abad, Kimberly E. Bonner, Jessica Kolis, Kathryn A. Brookmeyer, Chris Voegeli, James T. Lee, et al. (+16)
34 [GO] 2024―Jan―23 Lessons learned: COVID-19 vaccinations and people with disabilities Karyl Rattay, JoAnn M. Thierry, Marshalyn Yeargin-Allsopp, Shannon Griffin-Blake, Catherine E. Rice, Kevin Chatham-Stephens, Karen Remley
35 [GO] 2024―Jan―22 Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort study Mohamad Hamad Saied, Joeri W. van Straalen, Sytze de Roock, Frans M. Verduyn Lunel, Jelle de Wit, Lia G.H. de Rond, et al. (+8)
36 [GO] 2024―Jan―22 Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates Ranajit Pal, Maria Grazia Ferrari, Yoshikazu Honda-Okubo, Lauren Wattay, Jesica Caple, Jennifer Navarrete, et al. (+2)
37 [GO] 2024―Jan―21 Influence of the COVID-19 pandemic on caregiver beliefs and experiences of routine childhood immunisation in Indonesia Madeleine Randell, Meru Sheel, Michelle Dynes, Mu Li, Margie Danchin, Fitriyani Sukesmi, et al. (+8)
38 [GO] 2024―Jan―21 The role of funded partnerships in working towards decreasing COVID-19 vaccination disparities, United States, March 2021-December 2022 Amy Parker Fiebelkorn, Sara Adelsberg, Rishelle Anthony, Samrawit Ashenafi, Amimah F. Asif, Maria Azzarelli, et al. (+50)
39 [GO] 2024―Jan―21 Social network risk factors and COVID-19 vaccination: A cross-sectional survey study Ally Memedovich, Taylor Orr, Aidan Hollis, Charleen Salmon, Jia Hu, Kate Zinszer, et al. (+2)
40 [GO] 2024―Jan―21 SARS-CoV-2 vaccination willingness and humoral vaccination response in radiation oncology patients Hans Geinitz, Elisabeth Silberberger, Kurt Spiegl, Johann Feichtinger, Helga Wagner, Philipp Hermann, et al. (+14)
41 [GO] 2024―Jan―20 Examining changes in sense of purpose before, during, and after COVID-19 vaccination Patrick L. Hill, Talia Morstead, Gabrielle N. Pfund, Anthony L. Burrow, Anita DeLongis, Nancy L. Sin
42 [GO] 2024―Jan―20 Mixed-methods examination of attitudes and behaviors related to COVID-19 vaccines among parents of children with autism and autistic adults Melissa M. Mitchell, Adriana Klott, Jared Scholtes, B. Blair Braden, Christopher J. Smith, Nicole L. Matthews
43 [GO] 2024―Jan―17 Restricted Omicron-specific cross-variant memory B-cell immunity after a 3rd dose/booster of monovalent Wuhan-Hu-1-containing COVID-19 mRNA vaccine Iana H. Haralambieva, Jonathon M. Monroe, Inna G. Ovsyannikova, Nathaniel D. Warner, Diane E. Grill, Gregory A. Poland, Richard B. Kennedy
44 [GO] 2024―Jan―15 How manufacturing won or lost the COVID-19 vaccine race Michael L. King
45 [GO] 2024―Jan―14 COVID-19 vaccination among young people who use drugs in Vancouver, Canada Erica McAdam, Kanna Hayashi, Brittany Barker, Hudson Reddon, JinCheol Choi, Thomas Kerr, Kora DeBeck
46 [GO] 2024―Jan―11 Assessing the relationship between existing childhood, adolescent and adult immunization programmes and national COVID-19 vaccination capacities in 2021 Shoshanna Goldin, Ann Moen, William J. Moss, Jennifer Nuzzo
47 [GO] 2024―Jan―09 Mixed methods approach to understanding COVID-19 vaccine hesitancy among immigrants in the Chicago MaryGrace Sharp, Paula Lozano, Alia Southworth, Aven Peters, Helen Lam, Fornessa T. Randal, et al. (+2)
48 [GO] 2024―Jan―09 The mental health symptoms of individuals with sensory disabilities and the reasons that lead to COVID-19 vaccine refusal and hesitancy Amanda M. Hinson-Enslin, Luis Enrique Espinoza
49 [GO] 2024―Jan―09 Characterizing predictors of COVID-19 vaccine refusal in an urban southern California jail population Nazia S. Qureshi, Loren G. Miller, Stephen P. Judge, Ngoc Dung T. Tran, Sean O. Henderson
50 [GO] 2024―Jan―06 Exploring preventive care practices among unvaccinated individuals in the United States during the COVID-19 pandemic Dejan K. Filipas, Muhieddien Labban, Edoardo Beatrici, Benjamin V. Stone, Zhiyu Qian, Vincent D́Andrea, et al. (+4)
51 [GO] 2024―Jan―06 Parental concerns and vaccine hesitancy against COVID-19 vaccination for children in Greece: A cross-sectional survey E. Steletou, T. Giannouchos, G. Dimitriou, A. Karatza, X. Sinopidis, H.C. Maltezou, et al. (+2)
52 [GO] 2024―Jan―05 Challenges and opportunities during the COVID-19 vaccination efforts in long-term care Nimalie D. Stone, Amy Parker Fiebelkorn, Angela Guo, Elizabeth Mothershed, Lauren Moccia, Jeneita Bell, et al. (+6)
53 [GO] 2024―Jan―05 Racial and ethnic differences in COVID-19 vaccine readiness among adults in the United States, January 2021-April 2023 Elissa C. Kranzler, Timothy O. Ihongbe, Michael C. Marshall, Benjamin Denison, Heather Dahlen, Blake Hoffman, et al. (+3)
54 [GO] 2024―Jan―04 Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions - A cross-sectional study in six EU member states Caroline Buhl, Ramune Jacobsen, Anna Birna Almarsdóttir, Shahab Abtahi, Armin Andersen, Elena Deligianni, et al. (+14)
55 [GO] 2024―Jan―04 Massachusetts companion program bolsters COVID-19 vaccine rates among seniors Marie-Laure Charpignon, Shagun Gupta, Maimuna Shahnaz Majumder
56 [GO] 2023―Dec―29 Development of COVID-19 vaccine policy - United States, 2020-2023 Sara E. Oliver, Megan Wallace, Evelyn Twentyman, Danielle L. Moulia, Monica Godfrey, Ruth Link-Gelles, et al. (+10)
57 [GO] 2023―Dec―28 mRNA vaccines for COVID-19 are safe and clinically effective in patients with cardiac amyloidosis Gina Barzen, Finn Rieber, Karl Stangl, Katrin Hahn, Sebastian Spethmann
58 [GO] 2023―Dec―27 CDC COVID-19 vaccination program: Healthcare provider compliance with COVID-19 vaccine requirements and recommendations Tamara C. Surtees, Charleigh J. Granade, Christopher Wells, Michelle Banks, Paul Lucas, Samuel B. Graitcer
59 [GO] 2023―Dec―27 Long term follow up and outcomes of Covid-19 vaccine associated myocarditis in Victoria, Australia: A clinical surveillance study Priya Shenton, Silja Schrader, Julia Smith, Annette Alafaci, Nicholas Cox, Andrew Taylor, et al. (+5)
60 [GO] 2023―Dec―23 Covid-19 and influenza vaccine effectiveness against associated hospital admission and death among individuals over 65 years in Norway: A population-based cohort study, 3 October 2022 to 20 June 2023 Elina Seppälä, Jesper Dahl, Lamprini Veneti, Kjersti Margrethe Rydland, Birgitte Klüwer, Andreas Rohringer, Hinta Meijerink
61 [GO] 2023―Dec―23 Comparison of adult hesitancy towards COVID-19 vaccines and vaccines in general in the USA Kimberly H. Nguyen, Kelsey C. Coy, Carla L. Black, Paul Scanlon, James A. Singleton
62 [GO] 2023―Dec―23 Vaccine-associated respiratory pathology correlates with viral clearance and protective immunity after immunization with self-amplifying RNA expressing the spike (S) protein of SARS-CoV-2 in mouse models Alla Kachko, Prabhuanand Selvaraj, Shufeng Liu, Jaekwan Kim, David Rotstein, Charles B. Stauft, et al. (+5)
63 [GO] 2023―Dec―22 Neighborhood-level vaccine impact on COVID-19 infection and hospital admission in Q, Canada, during the Delta and early Omicron periods Ernest Lo, Nicholas Brousseau, Fannie Defay, Élise Fortin, Marilou Kiely
64 [GO] 2023―Dec―21 Immunogenicity and safety of a second heterologous booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Interim analysis report of a phase 3 open-label trial Kenji Kuriyama, Kyoko Murakami, Kenkichi Sugiura, Sho Sakui, Ron P. Schuring, Mitsuhiro Mori
65 [GO] 2023―Dec―20 Building the U.S. COVID-19 vaccine effectiveness program: Past successes and future directions Ruth Link-Gelles, Amadea Britton, Katherine E. Fleming-Dutra
66 [GO] 2023―Dec―20 Humoral immune response in people living with HIV after administration of SARS-CoV-2 vaccine CoronaVac or BNT162b2 or CoronaVac/BNT162b2 booster sequence: A cross-sectional study Marcelo Wolff, Paulo Charpentier, Andrea Canals, Cecilia Vial, Juan Hormazábal, Jimena Cortés, Macarena Silva
67 [GO] 2023―Dec―19 COVID-19 vaccine effectiveness against severe COVID-19 requiring oxygen therapy, invasive mechanical ventilation, and death in Japan: A multicenter case-control study (MOTIVATE study) Takeshi Arashiro, Maki Miwa, Hidenori Nakagawa, Junpei Takamatsu, Kunihiro Oba, Satoshi Fujimi, et al. (+55)
68 [GO] 2023―Dec―18 9-Month observational Dia-Vacc study of vaccine type influence on SARS-CoV-2 immunity in dialysis and kidney transplant patients Julian Stumpf, Leona Anders, Torsten Siepmann, Jörg Schwöbel, Claudia Karger, Tom Lindner, et al. (+29)
69 [GO] 2023―Dec―16 A multifaceted approach for identification, validation, and immunogenicity of naturally processed and in silico-predicted highly conserved SARS-CoV-2 peptides Tamar Ratishvili, Huy Quang Quach, Iana H. Haralambieva, Yogesh R. Suryawanshi, Inna G. Ovsyannikova, Richard B. Kennedy, Gregory A. Poland
70 [GO] 2023―Dec―15 Observations of COVID-19 vaccine coverage and vaccine hesitancy on COVID-19 outbreak: An American ecological study Deewan Bajracharya, Rick J. Jansen
71 [GO] 2023―Dec―15 Characterization of SARS-CoV-2-specific humoral immunity and associated factors in the healthy population post-vaccination Xiao-Yong Zhan, Yun Chen, Xiaoying Zhang, Qipeng Shi, Kaiyin Chen, Changchun Zeng, et al. (+20)
72 [GO] 2023―Dec―14 Factors associated with COVID-19 autumn 2022 booster uptake in the Netherlands among older adults aged ≥ 60 years and younger adults with chronic conditions Caren van Roekel, Lisanne Labuschagne, Joyce Pijpers, Annika van Roon, Bente Smagge, José A. Ferreira, et al. (+2)
73 [GO] 2023―Dec―14 Intranasal immunization with the recombinant measles virus encoding the spike protein of SARS-CoV-2 confers protective immunity against COVID-19 in hamsters Sang-In Park, Sohyun Park, Kunse Lee, Hye Won Kwak, Yong Kwan Kim, Hyeong-Jun Park, et al. (+16)
74 [GO] 2023―Dec―14 Impact of the COVID-19 pandemic on routine vaccination coverage under varying prevalence Conditions: A cohort study in Beijing, China Zhiqiang Cao, Rui Yu, Qianli Yuan, Wenyan Ji, Xiaomei Li, Pei Gao, et al. (+3)
75 [GO] 2023―Dec―14 Monitoring and reporting the US COVID-19 vaccination effort Lynn Gibbs Scharf, Kafayat Adeniyi, Emily Augustini, Deborah Boyd, Laura Corvin, Roua El Kalach, et al. (+26)
76 [GO] 2023―Dec―13 Access to SARS-CoV-2 vaccination in immigrants in Italy, by geographical area of origin Eliana Ferroni, Nicola Gennaro, Giovanni Maifredi, Olivia Leoni, Francesco Profili, Cristina Stasi, et al. (+5)
77 [GO] 2023―Dec―12 The importance of community-specific survey data in understanding behavioral and social drivers of COVID-19 vaccination: Lessons learned from urban neighborhoods in four United States cities Sasigant So O'Neil, Emma L. Pendl-Robinson, Elizabeth A. Carosella, Brianna D. Sullivan, Anitha Sivasankaran
78 [GO] 2023―Dec―11 Effectiveness of COVID-19 vaccine mandates in raising vaccination rates among the elderly and general population in Europe: Controlled interrupted time series analysis Theodore Lytras, Abba Adema Alumasa Di Gregorio, Dimitrios Apostolopoulos, Demetris Naziris, Christina Zingerle, Alexandros Heraclides
79 [GO] 2023―Dec―09 Test negative design for vaccine effectiveness estimation in the context of the COVID-19 pandemic: A systematic methodology review Miceline Mésidor, Yan Liu, Denis Talbot, Danuta M. Skowronski, Gaston De Serres, Joanna Merckx, et al. (+5)
80 [GO] 2023―Dec―08 Stronger and durable SARS-CoV-2 immune response to mRNA vaccines in 5-11 years old children with prior COVID-19 Costanza Di Chiara, Anna Cantarutti, Maria Raffaella Petrara, Francesco Bonfante, Elisa Benetti, Riccardo Boracchini, et al. (+15)
81 [GO] 2023―Dec―08 SARS-CoV-2 mucosal vaccine protects against clinical disease with sex bias in efficacy Yongjun Sui, Hanne Andersen, Jianping Li, Tanya Hoang, Mahnaz Minai, Bianca M. Nagata, et al. (+4)
82 [GO] 2023―Dec―07 The intention to get COVID-19 booster vaccination and its association with cognitive and emotional factors: A survey of Chinese COVID-19 infected people in Hong Kong Yanqiu Yu, Xiaoying Zhang, Mason M.C. Lau, Joseph T.F. Lau
83 [GO] 2023―Dec―07 Why did Brazil fail to vaccinate children against COVID-19 during the pandemic? An assessment of attitudinal and behavioral determinants Wladimir Gramacho, Mathieu Turgeon, Pedro Santos Mundim, Isadora Pereira
84 [GO] 2023―Dec―06 CDC COVID-19 Vaccine Pregnancy Registry: Design, data collection, response rates, and cohort description Sabrina A. Madni, Andrea J. Sharma, Lauren Head Zauche, Ansley V. Waters, John F. Nahabedian, Tara Johnson, Christine K. Olson
85 [GO] 2023―Dec―05 The relative effectiveness of three and four doses of COVID-19 vaccine in Victoria, Australia: A data linkage study Jose T. Canevari, Allen C. Cheng, Logan Wu, Stacey L. Rowe, Dennis E. Wollersheim, Daniel West, et al. (+2)
86 [GO] 2023―Dec―01 Production, purification and immunogenicity of Gag virus-like particles carrying SARS-CoV-2 components Anahita Bakhshizadeh Gashti, Gerard Agbayani, Sabahudin Hrapovic, Nasha Nassoury, Nathalie Coulombe, Renu Dudani, et al. (+4)
87 [GO] 2023―Nov―27 RBD class 1 and 2 antibody epitopes elicit around 70% neutralizing capacity against SARS-CoV-2 virus following boosting with inactivated virus vaccine Yuanyuan Wang, Yunqi Hu, Yong Ma, Pengbin Li, Siwei Zhou, Mengxin Xu, et al. (+9)
88 [GO] 2023―Nov―25 Resilience of routine childhood immunization services in two counties in Kenya in the face of the COVID-19 pandemic Harriet Mirieri, Carolyne Nasimiyu, Jeanette Dawa, Caroline Mburu, Rose Jalang'o, Peter Kamau, et al. (+18)
89 [GO] 2023―Nov―25 Modeling COVID-19 vaccine booster-elicited antibody response and impact of infection history Takara Nishiyama, Yuichiro Miyamatsu, Hyeongki Park, Naotoshi Nakamura, Risa Yokokawa Shibata, Shingo Iwami, Yoji Nagasaki
90 [GO] 2023―Nov―25 Evaluation of the humoral response to the third dose of SARS-COV-2 vaccines in liver transplant recipients Nicolás Ducasa, Paula Benencio, Ezequiel Mauro, Margarita Anders, Bianca Mazzitelli, Lucía Bleichmar, et al. (+9)
91 [GO] 2023―Nov―23 Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design Amanda B. Payne, Allison Avrich Ciesla, Elizabeth A.K. Rowley, Zachary A. Weber, Sarah E. Reese, Toan C. Ong, et al. (+9)
92 [GO] 2023―Nov―22 Breakthrough COVID-19 infections and perceived vaccine effectiveness Stephen R. Neely, Feng Hao
93 [GO] 2023―Nov―22 Sociodemographic factors and attitudes associated with Australian parental acceptance of paediatric COVID-19 vaccination Bing Wang, Joshua McDonough, Gang Chen, Jason J. Ong, Helen Marshall
94 [GO] 2023―Nov―22 Excess mortality in Cyprus during the COVID-19 vaccination campaign Eleftheria C. Economidou, Elpidoforos S. Soteriades
95 [GO] 2023―Nov―19 “I’d do it for my baby”: Lessons learned from qualitative research on COVID-19 vaccination among pregnant women in Côte d’Ivoire Danielle Naugle, Natalie Tibbels, Abdul Dosso, William Benie, Marjorie Nana
96 [GO] 2023―Nov―17 Assessing parental intention to vaccinate against COVID-19, influenza, and RSV in the United States in late 2023 Simon F. Haeder
97 [GO] 2023―Nov―17 Influenza vaccination in children with pulmonary disease during the COVID-19 pandemic Nofar Amitai, Reut Wertheimer, Dario Prais, Keren-Or Wertheimer, Gilat Livni
98 [GO] 2023―Nov―16 Who gets COVID-19 booster vaccination? Trust in public health institutions and promotion strategies post-pandemic in the Republic of Korea Yongjin Choi, Soohyun Park, Jinwoo Lee, Youngsung Kim, Byoung Joon Kim, Leesa Lin, Ashley M. Fox
99 [GO] 2023―Nov―14 Impact of a hypothetical COVID-19 vaccine mandate on parental likelihood to vaccinate children: Exploring school-related concerns and vaccination decision-making Joshua T. Sarafian, Stephanie A. Eucker, Michael Gillman, Amy M. DeLaroche, Robert M. Rodriguez, David Rayburn, et al. (+7)
100 [GO] 2023―Nov―14 Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022-May 2023 Ian D. Plumb, Melissa Briggs Hagen, Ryan Wiegand, Ghinwa Dumyati, Christopher Myers, Karisa K. Harland, et al. (+64)
101 [GO] 2023―Nov―11 Impact of the surge of COVID-19 Omicron outbreak on the intention of seasonal influenza vaccination in Hong Kong: A cross-sectional study Xiaoting Jiang, Jingxuan Wang, Conglu Li, Eng Kiong Yeoh, Zihao Guo, Yuchen Wei, Ka Chun Chong
102 [GO] 2023―Nov―11 “Who is Anders Tegnell?” Unanswered questions hamper COVID-19 vaccine uptake: A qualitative study among ethnic minorities in Sweden Sibylle Herzig van Wees, Maria Stålgren, Nina Viberg, Bi Puranen, Anna Mia Ekström, Elin C. Larsson
103 [GO] 2023―Nov―11 Factors associated with uptake of bivalent mRNA COVID-19 vaccines in a large US health care system Katia J. Bruxvoort, Lina S. Sy, Vennis Hong, Bruno Lewin, Lei Qian, Xuan Huang, et al. (+3)
104 [GO] 2023―Nov―10 COVID-19 vaccination attitudes, values, intentions: US parents for their children, September 2021 Matthew Z. Dudley, Benjamin Schwartz, Janesse Brewer, Lilly Kan, Roger Bernier, Jennifer E. Gerber, et al. (+4)
105 [GO] 2023―Nov―10 Inactivated COVID-19 vaccines in peri-pregnancy period: Evaluation of safety for both pregnant women and neonates Caihua Yang, Zengyue Zheng, Ping Zheng, Juan Chen, Qianyun Huang, Yue Chen, et al. (+4)
106 [GO] 2023―Nov―07 The association between antipyretic analgesics use and SARS-CoV-2 antibody titers following the second dose of the BNT162b2 mRNA vaccine: An observational study Yosuke Inoue, Yunfei Li, Shohei Yamamoto, Ami Fukunaga, Hironori Ishiwari, Masamichi Ishii, et al. (+5)
107 [GO] 2023―Nov―04 Dimensions of equality in uptake of COVID-19 vaccination in Wales, UK: A multivariable linked data population analysis Gethin Jones, Malorie Perry, Rowena Bailey, Sudha Arumugam, Adrian Edwards, Alex Lench, et al. (+10)
108 [GO] 2023―Nov―04 Investigation of the SARS-CoV-2 post-vaccination antibody response in Canadian farmed mink Line Gram Hansen, Lars Erik Larsen, Thomas Bruun Rasmussen, Younes Miar, Ria Lassuniére, Charlotte Sværke Jørgensen, Pia Ryt-Hansen
109 [GO] 2023―Nov―03 Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adults Gui-Ling Chen, Xu-Ya Yu, Li-Ping Luo, Fan Zhang, Xia-Hong Dai, Nan Li, et al. (+21)
110 [GO] 2023―Nov―01 Vaccines and global health: COVID-19 vaccine development, strategy, and implementation symposium - Summary of the meeting at Vagelos College of Physicians and Surgeons (February 22-26, 2021, New York) Wilmot G. James, Lawrence R. Stanberry, Phillip S. LaRussa, Marc D. Grodman
111 [GO] 2023―Oct―29 A single blinded, phase IV, adaptive randomised control trial to evaluate the safety of coadministration of seasonal influenza and COVID-19 vaccines (The FluVID study) J.A. Ramsay, M. Jones, A.M. Vande More, S.L. Hunt, P.C.M. Williams, M. Messer, et al. (+6)
112 [GO] 2023―Oct―28 Understanding COVID-19 vaccine hesitancy in Canada Claire Corsten, Zoua M. Vang, Ian Gold, Maya J. Goldenberg, Fernanda Pérez-Gay Juarez, Daniel Weinstock, et al. (+3)
113 [GO] 2023―Oct―28 Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccines Yi Liu, Stephany Sánchez-Ovando, Louise Carolan, Leslie Dowson, Arseniy Khvorov, A. Jessica Hadiprodjo, et al. (+24)
114 [GO] 2023―Oct―26 Adverse events of acute nephrotoxicity reported to EudraVigilance and VAERS after COVID-19 vaccination Cleo Anastassopoulou, Fotini Boufidou, Sophia Hatziantoniou, Konstantinos Vasileiou, Nikolaos Spanakis, Athanasios Tsakris
115 [GO] 2023―Oct―25 The state of COVID-19 vaccine confidence and need in Black individuals in Canada: Understanding the role of sociodemographic factors, health literacy, conspiracy theories, traumatic stressors and racial discrimination Jude Mary Cénat, Seyed Mohammad Mahdi Moshirian Farahi, Cathy Broussard, Rose Darly Dalexis
116 [GO] 2023―Oct―25 Background rates for severe cutaneous reactions in the US: Contextual support for safety assessment of COVID-19 vaccines and novel biologics Diane Gubernot, Mikhail Menis, Barbee Whitaker
117 [GO] 2023―Oct―25 “Fighting the pandemic!” Western Australian pharmacists’ perspectives on COVID-19 vaccines: A qualitative study Taaiba Walliar, Basil Khan, Sophie Newstead, Ghoufran Al-Assadi, Sandra M Salter, Liza Seubert, et al. (+2)
118 [GO] 2023―Oct―24 Antibodies to SARS-CoV2 induced by vaccination and infection correlate with protection against the infection Noelia Flor, María Inés García, Ana Molineri, Oscar Bottasso, Cristina Diez, Carolina Veaute
119 [GO] 2023―Oct―21 Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86 Ninaad Lasrado, Ai-ris Y. Collier, Nicole P. Hachmann, Jessica Miller, Marjorie Rowe, Eleanor D. Schonberg, et al. (+11)
120 [GO] 2023―Oct―20 Innovative method for rapid detection of falsified COVID-19 vaccines through unopened vials using handheld Spatially Offset Raman Spectroscopy (SORS) Sara Mosca, Qianqi Lin, Robert Stokes, Tehmina Bharucha, Bevin Gangadharan, Rebecca Clarke, et al. (+17)
121 [GO] 2023―Oct―19 Corrigendum to “Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants” [Vaccine 41(11) (2023) 1892-1901] Hye Won Kwak, Hyo-Jung Park, Seo-Yeon Jung, Eun Young Oh, Sang-In Park, Yeonhwa Kim, et al. (+21)
122 [GO] 2023―Oct―19 Advax-CpG55.2-adjuvanted monovalent or trivalent SARS-CoV-2 recombinant spike protein vaccine protects hamsters against heterologous infection with Beta or Delta variants Yoshikazu Honda-Okubo, Richard Bowen, Mckinzee Barker, Helle Bielefeldt-Ohmann, Nikolai Petrovsky
123 [GO] 2023―Oct―19 Reactogenicity, pregnancy outcomes, and SARS-CoV-2 infection following COVID-19 vaccination during pregnancy in Canada: A national prospective cohort study E. McClymont, A. Atkinson, A. Albert, G. Av-Gay, J. Andrade, J. Barrett, et al. (+16)
124 [GO] 2023―Oct―17 Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries Fabio Riefolo, Belén Castillo-Cano, Mar Martín-Pérez, Davide Messina, Roel Elbers, Dorieke Brink-Kwakkel, et al. (+15)
125 [GO] 2023―Oct―17 U.S. public support and opposition to vaccination mandates in K-12 education in light of the COVID-19 pandemic Simon F. Haeder
126 [GO] 2023―Oct―17 Effectiveness of inactivated COVID-19 vaccines against SARS-CoV-2 Omicron subvariant BF.7 among outpatients in Beijing, China Hui Yang, Zhaojian Wang, Ying Zhang, Man Xu, Yushu Wang, Yi Zhang, et al. (+2)
127 [GO] 2023―Oct―17 Distinct features of SARS-CoV-2 humoral immunity against Omicron breakthrough infection Takeyuki Goto, Yong Chong, Naoki Tani, Natsumi Susai, Tomoyo Yoshinaga, Tomoki Sasaki, et al. (+5)
128 [GO] 2023―Oct―13 Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1/BA.2 and BA.5 in Japan Takeshi Arashiro, Yuzo Arima, Jin Kuramochi, Hirokazu Muraoka, Akihiro Sato, Kumi Chubachi, et al. (+31)
129 [GO] 2023―Oct―09 Nonclinical safety assessment and immunogenicity of rVSVInd(GML)-mspSGtc vaccine for SARS-CoV-2 in rabbits Heeseon Park, Min Seong Jang, Jung-Ah Choi, Woojin Kim, Yong-Bum Kim, Na Hyung Kim, et al. (+3)
130 [GO] 2023―Oct―09 SARS-CoV-2 mRNA vaccine requires signal peptide to induce antibody responses Chuncong Mo, Xiao Li, Qianying Wu, Ye Fan, Donglan Liu, Yuhui Zhu, et al. (+9)
131 [GO] 2023―Oct―09 Safety, immunogenicity and efficacy of Relcovax®, a dual receptor binding domain (RBD) and nucleocapsid (N) subunit protein vaccine candidate against SARS-CoV-2 virus Nikhil Sathe, Sameer Shaikh, Mahesh Bhavsar, Leena Parte, Anjaneyulu Gadiparthi, Satish Kad, et al. (+16)
132 [GO] 2023―Oct―07 Thrombosis with thrombocytopenia syndrome (TTS) following adenovirus vector COVID-19 vaccination in Canada T.D. Procter, H. Ogasawara, S. Spruin, S. Wijayasri, N. Abraham, C. Blaser, et al. (+3)
133 [GO] 2023―Sep―27 Approaches to evaluate the specific immune responses to SARS-CoV-2 Ana Lopez-Gomez, Hector F. Pelaez-Prestel, Ignacio Juarez
134 [GO] 2023―Sep―27 25-Hydroxyvitamin D concentrations do not affect the humoral or cellular immune response following SARS-CoV-2 mRNA vaccinations A.H.A. Lavell, A.E. Schramade, J.J. Sikkens, K. van der Straten, K.A. van Dort, M.A. Slim, et al. (+31)
135 [GO] 2023―Sep―26 Sequential heterologous immunization with COVID-19 vaccines induces broader neutralizing responses against SARS-CoV-2 variants in comparison with homologous boosters Xiuli Shen, Yanling Hao, Shuhui Wang, Dan Li, Li Ren, Meiling Zhu, et al. (+7)
136 [GO] 2023―Sep―25 Trends in COVID-19 and influenza vaccine ordering and distribution in Massachusetts jails Nicole Cassarino, Kathryn K. Ahnger-Pier, Alysse Wurcel
137 [GO] 2023―Sep―23 Insights to COVID-19 vaccine delivery: Results from a survey of 27 countries Ishani Mathur, Rachael Church, Anika Ruisch, Karina Noyes, Anna McCaffrey, Ulla Griffiths, et al. (+4)
138 [GO] 2023―Sep―22 Acceptance of COVID-19 vaccination and vaccine confidence levels in Thailand: A cross-sectional study P. Ngamchaliew, N. Kaewkuea, N. Nonthasorn, T. Vonnasrichan, N. Rongsawat, L. Rattanachai, et al. (+3)
139 [GO] 2023―Sep―22 Effectiveness of various COVID-19 vaccine regimens among 10.4 million patients from the National COVID Cohort Collaborative during Pre-Delta to Omicron periods - United States, 11 December 2020 to 30 June 2022 Yuanyuan Fu, Kaipeng Wu, Zhanwei Wang, Hua Yang, Yu Chen, Lang Wu, et al. (+4)
140 [GO] 2023―Sep―20 A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Novavax COVID-19 Vaccine (NVX-CoV2373), a recombinant spike protein vaccine with Matrix-M adjuvant to prevent disease caused by SARS-CoV-2 viruses Bethanie Wilkinson, Kinjal S. Patel, Katherine Smith, Robert Walker, Chengbin Wang, Ann M. Greene, et al. (+4)
141 [GO] 2023―Sep―19 Review: Factors influencing parents’ decisions to vaccinate children against COVID-19 Haifa S. Alharbi
142 [GO] 2023―Sep―17 A large survey on COVID-19 vaccination in patients with Parkinson’s disease and healthy population Chao Han, Zhen Zhen Zhao, Piu Chan, Fang Li, Chun Ling Chi, Xin Zhang, et al. (+3)
143 [GO] 2023―Sep―17 Preclinical evaluation of a SARS-CoV-2 variant B.1.351-based candidate DNA vaccine Ria Lassaunière, Charlotta Polacek, Jeanette Linnea Tingstedt, Anders Fomsgaard
144 [GO] 2023―Sep―16 Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectiveness Nicole Shaver, Melanie Katz, Gideon Darko Asamoah, Lori-Ann Linkins, Wael Abdelkader, Andrew Beck, et al. (+38)
145 [GO] 2023―Sep―15 COVID-19 vaccine effectiveness against hospitalizations in Paraguay, May 2021-April 2022: A test-negative design Sandra Irala, Sarah Hamid, Elena Penayo, Fabiana Michel, Paula Couto, Cynthia Vazquez, et al. (+7)
146 [GO] 2023―Sep―15 Evaluation of dynamics of immune responses and protective efficacy in piglets immunized with an inactivated porcine reproductive and respiratory syndrome vaccine candidate Megha Katare Pandey, Katherukamem Rajukumar, Dhanapal Senthilkumar, Subbiah Kombiah, Fateh Singh, Govindarajulu Venkatesh, et al. (+5)
147 [GO] 2023―Sep―12 COVID-19 vaccine booster doses provide increased protection against COVID-19 hospitalization compared with previously vaccinated individuals: Interim findings from the REFORCO-Brazil real-world effectiveness study during Delta and Omicron Wilhelmine Meeraus, Anke L. Stuurman, Ilgaz Durukal, Eduardo Conde-Sousa, Andrew Lee, André Santa Maria, et al. (+6)
148 [GO] 2023―Sep―10 An overview of protein-based SARS-CoV-2 vaccines Yogesh R. Suryawanshi
149 [GO] 2023―Sep―09 When to be vaccinated? What to consider? Modelling decision-making and time preference for COVID-19 vaccine through a conjoint experiment Pak Hong Ricci Yue, Hi Po Bobo Lau, Siu Man Ng, Lai Wan Cecilia Chan, Samson Yuen
150 [GO] 2023―Sep―09 Comparative effectiveness and duration of protection of ChAdOx1, CoronaVac, BNT162b2, mRNA-1273, and Ad26.COV2.S COVID-19 vaccines for symptomatic and hospitalized Mu, Delta, and Omicron: A test-negative case-control study Angel Paternina-Caicedo, David Santiago Quevedo, Diana Sofía Ríos, Diane Moyano, Nelson Alvis-Guzmán, Nelson Rafael Alviz-Zakzuk, et al. (+5)
151 [GO] 2023―Sep―05 Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis A. Phillips, Y. Jiang, D. Walsh, N. Andrews, M. Artama, H. Clothier, et al. (+21)
152 [GO] 2023―Sep―04 Understanding low COVID-19 booster uptake among US adults Elizabeth T. Jacobs, Felina M. Cordova-Marks, Leslie V. Farland, Kacey C. Ernst, Jennifer G. Andrews, Sage Vu, et al. (+4)
153 [GO] 2023―Sep―04 Characteristics of epitope dominance pattern and cross-variant neutralisation in 16 SARS-CoV-2 mRNA vaccine sera Mayo Yasugi, Yu Nakagama, Natsuko Kaku, Yuko Nitahara, Noritoshi Hatanaka, Shinji Yamasaki, Yasutoshi Kido
154 [GO] 2023―Sep―01 Confirmed cases of COVID-19 after vaccination against COVID in health personnel in Bogotá, Colombia Alexandra Porras-Ramírez, Rafael Sánchez-París, Walter López-Devia, Zuly Moreno-Perilla, Roberto Jurado-Zambrano, Carlos Luna-Jaspe Caina, et al. (+4)
155 [GO] 2023―Sep―01 Correlates of COVID-19 vaccine coverage in Arkansas: Results from a weighted random sample survey Don E. Willis, Ramey Moore, Jennifer A. Andersen, Ji Li, James P. Selig, Joshua C. McKinnon, et al. (+3)
156 [GO] 2023―Sep―01 Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster dose Maria da Penha Gomes Gouvea, Ketty Lysie Libardi Lira Machado, Yasmin Gurtler Pinheiro de Oliveira, Isac Ribeiro Moulaz, Allan Gonçalves Henriques, Thayná Martins Gouveia, et al. (+33)
157 [GO] 2023―Aug―31 Developmental and reproductive safety of Advax-CpG55.2™ adjuvanted COVID-19 and influenza vaccines in mice Isaac G. Sakala, Yoshikazu Honda-Okubo, Nikolai Petrovsky
158 [GO] 2023―Aug―31 Rheumatoid arthritis and older age are associated with lower humoral and cellular immune response to primary series COVID-19 mRNA vaccine Holly M. Dudley, Megan O'Mara, Ann Auma, Jenny Gong, Yael Ross, Natalie Gurevich, et al. (+17)
159 [GO] 2023―Aug―31 The impact of the COVID-19 pandemic on parental vaccine hesitancy: A cross-sectional survey Lily A. Grills, Abram L. Wagner
160 [GO] 2023―Aug―31 Challenges & opportunities for the epidemiological evaluation of the effects of COVID-19 vaccination on reproduction and pregnancy Annette K. Regan, Deshayne B. Fell, Lauren A. Wise, Gabriela Vazquez-Benitez, Siri E. Håberg, Comfort Ogar, et al. (+3)
161 [GO] 2023―Aug―30 Canada’s National Advisory Committee on immunization: Adaptations and challenges during the COVID-19 pandemic Matthew Tunis, Shelley Deeks, Robyn Harrison, Caroline Quach, Shainoor Ismail, Marina Salvadori, et al. (+4)
162 [GO] 2023―Aug―29 Social network, political climate, income inequality, and Americans uptake of monovalent COVID-19 booster Feng Hao, Wanyun Shao
163 [GO] 2023―Aug―29 Parental attitudes, beliefs and behaviors toward childhood and COVID-19 vaccines: A countrywide survey conducted in Kazakhstan examining vaccine refusal and hesitancy Alua Yeskendir, Arnur Gusmanov, Baurzhan Zhussupov
164 [GO] 2023―Aug―27 COVID-19 vaccine hesitancy among older adult Thai Muslim people: A case-control study Farooq Phiriyasart, Natnaree Aimyong, Ann Jirapongsuwan, Norisan Roseh
165 [GO] 2023―Aug―27 Vaccine microarray patch self-administration: An innovative approach to improve pandemic and routine vaccination rates E. Hacker, B. Baker, T. Lake, C. Ross, M. Cox, C. Davies, et al. (+3)
166 [GO] 2023―Aug―26 The immunogenicity of Alum+CpG adjuvant SARS-CoV-2 inactivated vaccine in mice Jie Yang, Boran Li, Dongsheng Yang, Jie Wu, Anna Yang, Wenhui Wang, et al. (+12)
167 [GO] 2023―Aug―25 Immune responses and safety of COVID-19 vaccination in atypical hemolytic uremic syndrome patients in Taiwan I.-Ru Chen, Guei-Jane Wang, Po-Ren Hsueh, Chia-Hui Chou, Long-Bin Jeng, Hui-Ju Lin, et al. (+4)
168 [GO] 2023―Aug―25 The prevalence and clinical course of shoulder injury related to vaccine administration (SIRVA) after COVID-19 vaccines in Dutch hospital workers Esther R.C. Janssen, Astrid Z. van Montfoort, Freek Hollman, Frederik O. Lambers Heerspink
169 [GO] 2023―Aug―25 Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2 Shiho Chiba, Peter J. Halfmann, Shun Iida, Yuichiro Hirata, Yuko Sato, Makoto Kuroda, et al. (+4)
170 [GO] 2023―Aug―25 COVID-19 vaccine decision-making among Black women: A qualitative study Inari S. Mohammed, Rachel Widome, Kelly M. Searle
171 [GO] 2023―Aug―24 Use of adrenaline to manage suspected anaphylaxis following COVID-19 vaccination: An Australian retrospective cohort study Lucy Deng, Kathryn Tapper, Deepali Thosar, Emma Goeman, Louise Baker, Stephen Adelstein, et al. (+10)
172 [GO] 2023―Aug―22 Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 spike ferritin nanoparticle vaccine antigen produced from two different cell lines Ozan S. Kumru, Mrinmoy Sanyal, Natalia Friedland, John M. Hickey, Richa Joshi, Payton Weidenbacher, et al. (+5)
173 [GO] 2023―Aug―19 Simultaneous administration of mRNA COVID-19 bivalent booster and influenza vaccines Tat'Yana A. Kenigsberg, Kristin Goddard, Kayla E. Hanson, Ned Lewis, Nicola Klein, Stephanie A. Irving, et al. (+10)
174 [GO] 2023―Aug―18 Neutralizing antibody and T-cell responses against SARS-CoV-2 variants by heterologous CoronaVac/ChAdOx-1 vaccination in elderly subjects with chronic obstructive pulmonary disease Warawut Chaiwong, Nuchjira Takheaw, Supansa Pata, Witida Laopajon, Pilaiporn Duangjit, Juthamas Inchai, et al. (+12)
175 [GO] 2023―Aug―17 Lessons learned from the COVID-19 pandemic for improved influenza control Abraham Palache, John-Kenneth Billingsley, Kristin MacLaren, Lyn Morgan, Steven Rockman, Paula Barbosa
176 [GO] 2023―Aug―17 Predictors of incomplete COVID-19 vaccine schedule among adults in Scotland: Two retrospective cohort analyses of the primary schedule and third dose Kirsty Morrison, Lucy Cullen, Allan B. James, Vera Chua, Christopher Sullivan, Chris Robertson, et al. (+12)
177 [GO] 2023―Aug―15 Are intelligent people more likely to get vaccinated? The association between COVID-19 vaccine adherence and cognitive profiles Meital Zur, Leah Shelef, Elon Glassberg, Noam Fink, Ilan Matok, Limor Friedensohn
178 [GO] 2023―Aug―14 Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5-11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial Orasri Wittawatmongkol, Pornumpa Bunjoungmanee, Pope Kosalaraksa, Kamolwish Laoprasopwattana, Sophida Boonsathorn, Napaporn Chantasrisawad, et al. (+13)
179 [GO] 2023―Aug―14 DS-5670a, a novel mRNA-encapsulated lipid nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2: Results from a phase 2 clinical study Kaoru Toyama, Takashi Eto, Kenji Takazawa, Shinji Shimizu, Tetsuo Nakayama, Kei Furihata, et al. (+7)
180 [GO] 2023―Aug―12 Parental acceptability of vaccinating young children against influenza and COVID-19 Céline Berthélémy, Pascal Bouché, Zohra Lamiral, Jean-Marc Boivin
181 [GO] 2023―Aug―10 Impact of CoronaVac on Covid-19 outcomes of elderly adults in a large and socially unequal Brazilian city: A target trial emulation study Higor S. Monteiro, Antonio S. Lima Neto, Rebecca Kahn, Geziel S. Sousa, Humberto A. Carmona, José S. Andrade, Marcia C. Castro
182 [GO] 2023―Aug―06 COVID-19 vaccine behaviour among citizens of the Métis Nation of Ontario: A qualitative study Abigail J. Simms, Keith D. King, Noel Tsui, Sarah A. Edwards, Graham Mecredy
183 [GO] 2023―Aug―06 Individual and structural determinants of COVID-19 vaccine uptake in a marginalized community in the United States Jeanna Campbell, Amandeep Kaur, Danilo Gamino, Ellen Benoit, Brianna Amos, Liliane Windsor
184 [GO] 2023―Aug―04 Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study L. Moscara, V. Venerito, A. Martinelli, A. Di Lorenzo, F. Toro, F. Violante, et al. (+2)
185 [GO] 2023―Aug―04 Inactivated SARS-CoV-2 vaccination does not disturb the clinical course of Graves’ disease: An observational cohort study Shichen Xu, Huixin Yu, Xian Cheng, Jing Wu, Jiandong Bao, Li Zhang
186 [GO] 2023―Aug―03 Protection against symptomatic SARS-CoV-2 infection conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to the mRNA Original monovalent vaccines - A matched cohort study in France Vincent Auvigne, Cynthia Raissa Tamandjou Tchuem, Justine Schaeffer, Sophie Vaux, Isabelle Parent Du Chatelet
187 [GO] 2023―Jul―30 A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States Megan Wallace, Hannah G. Rosenblum, Danielle L. Moulia, Karen R. Broder, Tom T. Shimabukuro, Christopher A. Taylor, et al. (+6)
188 [GO] 2023―Jul―29 Beyond the numbers: An in-depth look at Cameroon's fifth national COVID-19 vaccination campaign through geographical and gender lenses Adidja Amani, Andreas Ateke Njoh, Phionah Atuhebwe, Shalom Ndoula, Raoul Nembot, Franck Mbossou, et al. (+13)
189 [GO] 2023―Jul―29 Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection Bette Liu, Sandrine Stepien, Jiahui Qian, Heather Gidding, Katrina Nicolopoulos, Janaki Amin, et al. (+2)
190 [GO] 2023―Jul―28 COVID-19 vaccine uptake before and after a vaccine mandate at a major academic hospital: Trends by race/ethnicity and level of patient contact Judith Green-McKenzie, Frances S. Shofer, Gregory Kruse, Florence Momplaisir, Patrick J. Brennan, Barbara J. Kuter
191 [GO] 2023―Jul―27 Robust immunogenicity of a third BNT162b2 vaccination against SARS-CoV-2 Omicron variant in a naïve New Zealand cohort Brittany Lavender, Caitlin Hooker, Chris Frampton, Michael Williams, Simon Carson, Aimee Paterson, et al. (+8)
192 [GO] 2023―Jul―26 BNT162b2 mRNA COVID-19 against symptomatic Omicron infection following a mass vaccination campaign in southern Brazil: A prospective test-negative design study Regis Goulart Rosa, Maicon Falavigna, Josélia Larger Manfio, Cintia Laura Pereira de Araujo, Mírian Cohen, Gynara Rezende Gonzalez do Valle Barbosa, et al. (+23)
193 [GO] 2023―Jul―22 Effectiveness of COVID-19 vaccines against infection in Japan: A test-negative study from the VENUS study Yudai Tamada, Kenji Takeuchi, Taro Kusama, Megumi Maeda, Fumiko Murata, Ken Osaka, Haruhisa Fukuda
194 [GO] 2023―Jul―20 Safety signal identification for COVID-19 bivalent booster vaccination using tree-based scan statistics in the Vaccine Safety Datalink W. Katherine Yih, Matthew F. Daley, Jonathan Duffy, Bruce Fireman, David L. McClure, Jennifer C. Nelson, et al. (+7)
195 [GO] 2023―Jul―20 Impact of a COVID-19 certificate requirement on vaccine uptake pattern and intention for future vaccination. A cross-sectional study among French adults Lucia Araujo-Chaveron, Jonathan Sicsic, Hadrien Moffroid, Carolina Díaz Luévano, Serge Blondel, François Langot, Judith E. Mueller
196 [GO] 2023―Jul―20 COVID-19 vaccine uptake in mental healthcare users: Czech nationwide register study Vojtech Pisl, Jan Vevera
197 [GO] 2023―Jul―16 Vaccine hesitancy comes in waves: Longitudinal evidence on willingness to vaccinate against COVID-19 from seven European countries Iryna Sabat, Sebastian Neumann-Böhme, Pedro Pita Barros, Aleksandra Torbica, Job van Exel, Werner Brouwer, et al. (+2)
198 [GO] 2023―Jul―16 Social inequalities and the early provision and dispersal of COVID-19 vaccinations in the United States: A population trends study Sean A.P. Clouston, Douglas W. Hanes, Bruce G. Link
199 [GO] 2023―Jul―16 Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate Alexandra Moros, Antoni Prenafeta, Antonio Barreiro, Eva Perozo, Alex Fernández, Manuel Cañete, et al. (+11)
200 [GO] 2023―Jul―13 COVID-19 mRNA vaccines as hypothetical epigenetic players: Results from an in silico analysis, considerations and perspectives Rossella Talotta
201 [GO] 2023―Jul―13 Impact of COVID vaccine and comorbidities in patients receiving casirivimab-imdevimab monoclonal antibody during SARS-CoV-2 B.1.617.2 (Delta) surge: A real-world study Pankaj Agrawal, Dushyant Damania, Attila Cseh, John Grab, Laura Strom, Brianna Frank, et al. (+2)
202 [GO] 2023―Jul―07 Social processes, practical issues, and COVID-19 vaccination among hesitant adults Don E. Willis, Sharon Reece, Morgan Gurel-Headley, James P. Selig, Ji Li, Stacy Zimmerman, et al. (+2)
203 [GO] 2023―Jul―05 Let's talk about COVID-19 vaccination: relevance of conversations about COVID-19 vaccination and information sources on vaccination intention in Switzerland Aylin Wagner, Sibylle Juvalta, Camilla Speranza, L. Suzanne Suggs, Julia Drava
204 [GO] 2023―Jul―03 Heavy bleeding and other menstrual disturbances in young women after COVID-19 vaccination Lill Trogstad, Ida Laake, Anna H Robertson, Siri Mjaaland, Ida H Caspersen, Lene K Juvet, et al. (+3)
205 [GO] 2023―Jul―03 Barriers to COVID-19 vaccination of migrant populations: a qualitative interview study of immunisation providers in Victoria, Australia Jane Tuckerman, Jessica Kaufman, Isabella Overmars, Philippa Holland, Margie Danchin
206 [GO] 2023―Jul―03 Between nudges and mandates: The drivers of COVID-19 vaccination intentions and subsequent uptake in Russia Yana Roshchina, Ksenia Rozhkova, Sergey Roshchin
207 [GO] 2023―Jul―03 Veteran influenza vaccination acceptance rates after completion of the COVID-19 vaccination series among historical influenza vaccine refusers Ursula C. Patel, Thomas Schultz, Justin Schmidt
208 [GO] 2023―Jun―30 Immunogenicity and protective effects of recombinant bivalent COVID-19 vaccine in mice and rhesus macaques Yuying Liu, Aijing Zhang, Yan Wang, Jianguo Yang, Fei Yin, Shuming Wu, et al. (+20)
209 [GO] 2023―Jun―30 Effectiveness of inactivated influenza and COVID-19 vaccines in hospitalized children in 2022/23 season in Japan - The first season of co-circulation of influenza and COVID-19 Masayoshi Shinjoh, Munehiro Furuichi, Shinya Tsuzuki, Asef Iqbal, Naoya Fukushima, Sachiko Soen, et al. (+15)
210 [GO] 2023―Jun―28 Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice Katherine S Lee, Nathaniel A Rader, Olivia A Miller, Melissa Cooper, Ting Y Wong, Md. Shahrier Amin, et al. (+4)
211 [GO] 2023―Jun―27 Safety surveillance of the NVX-CoV2373 COVID-19 vaccine among Koreans aged 18 years and over Seontae Kim, Mijeong Ko, Yesul Heo, Yeon-Kyeng Lee, Yunhyung Kwon, Seok-Kyoung Choi, Eunok Bahng
212 [GO] 2023―Jun―24 Characterization of immune responses to two and three doses of the adenoviral vectored vaccine ChAdOx1 nCov-19 and the whole virion inactivated vaccine BBV152 in a mix-and-match study in India Anita Chaudhary, Ramya Madhavan, Sudhir Babji, Reshma Raju, Chanduni Syed, Ajith Kumar, et al. (+8)
213 [GO] 2023―Jun―23 Immediate adverse reactions following COVID-19 vaccination among 16-65-year-old Danish citizens K. Torp Hansen, F. Kusk Povlsen, B. Hammer Bech, S. Nygaard Hansen, C. Ulrikka Rask, P. Fink, et al. (+5)
214 [GO] 2023―Jun―23 Public Perception of COVID-19 Vaccines through Analysis of Twitter Content and Users Sameh N. Saleh, Samuel A. McDonald, Mujeeb A. Basit, Sanat Kumar, Reuben J. Arasaratnam, Trish M. Perl, et al. (+2)
215 [GO] 2023―Jun―23 Modifiers of COVID-19 Vaccine Efficacy: Results from Four COVID-19 Prevention Network Efficacy Trials Christine B. Turley, LaKesha Tables, Trevon Fuller, Lisa J. Sanders, Hyman Scott, Amaran Moodley, et al. (+29)
216 [GO] 2023―Jun―21 A cohort study reveals different dynamics of SARS-CoV-2-specific antibody formation after Comirnaty and Vaxzevria vaccination Adam Augustyniak, Tomasz Szymanski, Filip Porzucek, Adam Aron Mieloch, Julia Anna Semba, Katarzyna Anna Hubert, et al. (+8)
217 [GO] 2023―Jun―20 How to Model the Impact of Vaccines for Policymaking When the Characteristics are Uncertain: A Case Study in Thailand Prior to the Vaccine Rollout During the COVID-19 Pandemic Nantasit Luangasanatip, Chris Painter, Wirichada Pan-ngum, Sompob Saralamba, Tanaphum Wichaita, Lisa White, et al. (+5)
218 [GO] 2023―Jun―20 PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness Xiangyu Chen, Yao Lin, Shuai Yue, Yang Yang, Xiaofan Yang, Junjian He, et al. (+11)
219 [GO] 2023―Jun―19 Impacts of routine varicella vaccination program and COVID-19 pandemic on varicella and herpes zoster incidence and health resource use among children in Japan Kazuhiro Ud, Yusuke Okubo, Mitsuru Tsuge, Hirokazu Tsukahara, Isao Miyairi
220 [GO] 2023―Jun―19 Compliance, procrastination and refusal: American COVID-19 vaccination trust and value orientation Rueyling Tzeng, Fang-Yi Huang, Jaein Lee
221 [GO] 2023―Jun―19 An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects Cynomolgus macaques from a homologous SARS-CoV-2 virus challenge Yoshikazu Honda-Okubo, Lei Li, Greiciely André, King Ho Leong, Elizabeth W. Howerth, Anne G. Bebin-Blackwell, et al. (+2)
222 [GO] 2023―Jun―16 Public opinion on COVID-19 vaccine prioritization in Bangladesh: Who gets the vaccine and whom do you leave out? Raaj Kishore Biswas, Awan Afiaz, Samin Huq, Maysha Farzana, Enamul Kabir
223 [GO] 2023―Jun―16 Licenced doses of approved COVID-19 vaccines may not be optimal: a review of the early-phase, dose-finding trials David T Dunn, Richard Gilson, Sheena McCormack, Laura E McCoy
224 [GO] 2023―Jun―15 Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink Tat'Yana A. Kenigsberg, Kayla E. Hanson, Nicola P. Klein, Ousseny Zerbo, Kristin Goddard, Stanley Xu, et al. (+7)
225 [GO] 2023―Jun―15 Evaluation of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Adults Aged 65 Years and Older: Two Self-Controlled Studies in the U.S Azadeh Shoaibi, Patricia C. Lloyd, Hui-Lee Wong, Tainya C. Clarke, Yoganand Chillarige, Rose Do, et al. (+16)
226 [GO] 2023―Jun―15 Intramuscular administration of recombinant Newcastle disease virus expressing SARS-CoV-2 spike protein protects hACE-2 TG mice against SARS-CoV-2 infection Deok-Hwan Kim, Jiho Lee, Sungsu Youk, Jei-hyun Jeong, Da-ye Lee, Hyo-seon Ju, et al. (+13)
227 [GO] 2023―Jun―15 Single Ad26.COV2.S booster dose following two doses of BBIBP-CorV vaccine against SARS-CoV-2 infection in adults: day 28 results of a phase 1/2 open-label trial Sant Muangnoicharoen, Rakpong Wiangcharoen, Sira Nanthapisal, Supitcha Kamolratakul, Saranath Lawpoolsri, Anan Jongkaewwattana, et al. (+12)
228 [GO] 2023―Jun―13 COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn Flor M. Munoz, Christine M. Posavad, Barbra A. Richardson, Martina L. Badell, Katherine E. Bunge, Mark J. Mulligan, et al. (+18)
229 [GO] 2023―Jun―09 Uptake of COVID-19 vaccines among healthcare workers and the effect of nudging interventions: A mixed methods study Bahar Madran, İlker Kayi, Ayşe Beşer, Önder Ergönül
230 [GO] 2023―Jun―09 Cellular and humoral immune responses after a third dose of SARS-CoV-2 mRNA vaccine in lung transplant recipients in Japan Masahiro Ui, Takashi Hirama, Miki Akiba, Masako Honda, Toshiaki Kikuchi, Yoshinori Okada
231 [GO] 2023―Jun―08 Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021- January 2022 Brechje de Gier, Liselotte van Asten, Tjarda M. Boere, Annika van Roon, Caren van Roekel, Joyce Pijpers, et al. (+6)
232 [GO] 2023―Jun―08 Seasonal influenza vaccination in the Americas: Progress and challenges during the COVID-19 pandemic Francisco Nogareda, Radhika Gharpure, Marcela Contreras, Martha Velandia, Carmelita Lucia Pacis, Ana Elena Chevez, et al. (+2)
233 [GO] 2023―Jun―07 Re-evaluation of the risk of venous thromboembolism after COVID-19 vaccination using haematological criteria Rebecca J Shaw, Andrew J Doyle, Emily A Millen, Julia Stowe, Elise Tessier, Nick Andrews, Elizabeth Miller
234 [GO] 2023―Jun―06 From High Hopes to Disenchantment: A Qualitative Analysis of Editorial Cartoons on COVID-19 Vaccines in Canadian Newspapers Catherine Pelletier, Fabienne Labbé, Julie A. Bettinger, Janet Curran, Janice E. Graham, Devon Greyson, et al. (+5)
235 [GO] 2023―Jun―06 Immune response enhancement with GLS-5310 DNA primary vaccine against SARS-CoV-2 followed by administration of an mRNA vaccine heterologous boost Woo Joo Kim, Christine C. Roberts, Joon Young Song, Jin Gu Yoon, Hye Seong, Hak-Jun Hyun, et al. (+13)
236 [GO] 2023―Jun―06 Protective immunity induced by an inhaled SARS-CoV-2 subunit vaccine Elizabeth Elder, Chandrashekar Bangalore Revanna, Catharina Johansson, Robert P.A. Wallin, Johan Sjödahl, Ola Winqvist, Ali Mirazimi
237 [GO] 2023―Jun―05 COVID-19 vaccination and menstrual cycle characteristics: A prospective cohort study Amelia K. Wesselink, Sharonda M. Lovett, Janice Weinberg, Ruth J. Geller, Tanran R. Wang, Annette K. Regan, et al. (+7)
238 [GO] 2023―Jun―05 Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG Gergely Tibor Kozma, Tamás Mészáros, Petra Berényi, Réka Facskó, Zsófia Patkó, Csaba Zs. Oláh, et al. (+6)
239 [GO] 2023―Jun―05 Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study Jennifer H. Ku, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Julia E. Tubert, et al. (+8)
240 [GO] 2023―Jun―05 Immunological responses and adverse reactions of the heterologous second booster dose of BNT162b2 after two-dose CoronaVac for COVID-19 vaccination in healthcare workers of Faculty of Medicine, Naresuan University Supawadee Makanut, Apirath Wangteeraprasert, Wittawat Jitpewngam, Jatuporn Ngoenkam, Sutatip Pongcharoen
241 [GO] 2023―Jun―02 One year safety and immunogenicity of AZD1222 (ChAdOx1 nCoV-19): Final analysis of a randomized, placebo-controlled phase 1/2 trial in Japan Kensuke Ishikawa, Maria-Claudia Nascimento, Michiko Asano, Hajime Hirata, Yohji Itoh, Elizabeth J. Kelly, et al. (+4)
242 [GO] 2023―May―29 Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: a nationwide cohort study A. Arrospide, MG. Sagardui, I. Larizgoitia, A. Iturralde, A. Moreda, J. Mar J
243 [GO] 2023―May―29 Vaccination, Human Mobility, and COVID-19 Health Outcomes: Empirical Comparison Before and During the Outbreak of SARS-Cov-2 B.1.1.529 (Omicron) Variant Songhua Hu, Chenfeng Xiong, Yingrui Zhao, Xin Yuan, Xuqiu Wang
244 [GO] 2023―May―29 Medical outcomes of children with neurodevelopmental disorders after SARS-CoV-2 vaccination: A six-month follow-up study Liang-Jen Wang, Ching-Shu Tsai, Wen-Jiun Chou, Chia-Jung Lee, Sheng-Yu Lee, Yi-Jun Chen, I-Chun Lin
245 [GO] 2023―May―24 Spontaneously reported adverse events following COVID-19 basic and booster immunizations in The Netherlands Saskia C. van der Boor, Else T.J. Schmitz-de Vries, Dennis Smits, Joep H.G. Scholl, Leàn Rolfes, Florence van Hunsel
246 [GO] 2023―May―24 COVID-19 Vaccine Safety Inquiries to the Centers for Disease Control and Prevention Immunization Safety Office Elaine R. Miller, Pedro L. Moro, Tom T. Shimabukuro, Grace Carlock, Shaeyla Davis, Emma Freeborn, et al. (+6)
247 [GO] 2023―May―22 Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review Anwar I. Joudeh, Abdu Qaid Lutf, Salah Mahdi, Gui Tran
248 [GO] 2023―May―22 Incidence of myopericarditis after mRNA COVID-19 vaccination: a meta-analysis with focus on adolescents aged 12-17 years Bao-Qiang Guo, Hong-Bin Li, Li-Qiang Yang
249 [GO] 2023―May―22 Effectiveness of COVID-19 Vaccines at Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompromised Adults: An Observational Study of Real-World Data Across 10 US States from August-December 2021 Peter J. Embi, Matthew E. Levy, Palak Patel, Malini B. DeSilva, Manjusha Gaglani, Kristin Dascomb, et al. (+33)
250 [GO] 2023―May―22 Estimating global changes in routine childhood vaccination coverage during the COVID-19 pandemic, 2020-2021 Cyrus Ghaznavi, Akifumi Eguchi, Kaung Suu Lwin, Daisuke Yoneoka, Yuta Tanoue, Rauniyar Santosh Kumar, et al. (+3)
251 [GO] 2023―May―22 Title: A qualitative study on COVID-19 pandemic impacts on parental attitudes and intentions for routine adolescent vaccinations: the role of trust Katarzyna T Bolsewicz, Maryke S Steffens, Catherine King, Ikram Abdi, Bianca Bullivant, Frank Beard
252 [GO] 2023―May―22 Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis Alicandro G, Orena BS, Rosazza C, Cariani L, Russo M, Zatelli M, et al. (+4)
253 [GO] 2023―May―17 Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination Zhao-Hua Zhou, Margaret M. Cortese, Jia-Long Fang, Robert Wood, Donna S. Hummell, Kimberly A. Risma, et al. (+20)
254 [GO] 2023―May―17 Uncovering inequities in Covid-19 vaccine coverage for adults and elderly in Brazil: A multilevel study of 2021-2022 data Antonio Fernando Boing, Alexandra Crispim Boing, Lorena Barberia, Marcelo Eduardo Borges, SV Subramanian
255 [GO] 2023―May―15 Comparison of mRNA Vaccine Effectiveness against COVID-19-associated Hospitalization by Vaccination Source: Immunization Information Systems, Electronic Medical Records, and Self-Report - IVY Network, February 1*August 31, 2022 Diya Surie, Levi Bonnell, Jennifer DeCuir, Manjusha Gaglani, Tresa McNeal, Shekhar Ghamande, et al. (+37)
256 [GO] 2023―May―15 COVID-19 Vaccine Decision-making among Pregnant and Lactating Women in Bangladesh Rupali J. Limaye, Prachi Singh, Alicia Paul, Berhaun Fesshaye, Clarice Lee, Eleonor Zavala, et al. (+6)
257 [GO] 2023―May―15 Assessing vaccine safety during a pandemic: Recent experience and lessons learned for the future Steven B. Black, Rebecca E Chandler, Kathryn M. Edwards, Miriam C.J.M. Sturkenboom
258 [GO] 2023―May―11 Factors Associated with Receipt of mRNA-1273 Vaccine at a United States National Retail Pharmacy During the COVID-19 Pandemic Erin Roberts, Philip O. Buck, Renae L. Smith-Ray, Nicolas Van de Velde, Tanya Singh, James Mansi, et al. (+2)
259 [GO] 2023―May―10 Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022 Senna C.J.L. van Iersel, Scott A. McDonald, Brechje de Gier, Mirjam J. Knol, Hester E. de Melker, C.H. Henri van Werkhovena, Susan J.M. Hahné
260 [GO] 2023―May―10 The increasing age of respiratory syncytial virus-related hospitalisation during COVID-19 pandemic in Lyon was associated with reduced hospitalisation costs Álvaro Roy, Stéphanie Polazzi, Dominique Ploin, Yves Gillet, Etienne Javouhey, Bruno Lina, et al. (+5)
261 [GO] 2023―May―10 Safety of the NVX-CoV2373 COVID-19 Vaccine in Randomized Placebo-Controlled Clinical Trials Katherine Smith, Karim Hegazy, Miranda R. Cai, Irene McKnight, Matthew D. Rousculp, Katia Alves
262 [GO] 2023―May―10 Estimated vaccine effectiveness against SARS-CoV-2 Delta and Omicron infections among health care workers and the general adult population in Norway, August 2021 - January 2022 Petter Langlete, Martin Tesli, Lamprini Veneti, Jostein Starrfelt, Petter Elstrøm, Hinta Meijerink
263 [GO] 2023―May―09 Personal risk or societal benefit? Investigating adults’ support for COVID-19 childhood vaccination Chiara Chiavenna, Laura P. Leone, Alessia Melegaro, Tiziano Rotesi, Scott E. Bokemper, Elliott E. Paintsil, et al. (+5)
264 [GO] 2023―May―08 Randomized Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Booster (Third Dose) of BNT162b2 COVID-19 Vaccine Coadministered With 20-Valent Pneumococcal Conjugate Vaccine in Adults ≥65 Years Old David Fitz-Patrick, Mariano Young, Kari Yacisin, Kathleen McElwee, Todd Belanger, Kelly Belanger, et al. (+5)
265 [GO] 2023―May―08 Quantification of Sars-CoV-2 Spike Protein Expression from mRNA Vaccines Using Isotope Dilution Mass Spectrometry William J.H. Sutton, Paul J. Branham, Yulanda M. Williamson, Hans C. Cooper, Fabio N. Najjar, Carrie L. Pierce-Ruiz, et al. (+2)
266 [GO] 2023―May―08 Anti-tumor necrosis factor therapy is associated with attenuated humoral response to SARS-COV-2 vaccines in patients with inflammatory bowel disease Filipa Bordalo Ferreira, Maria Ana Rafael, Lúcia Coimbra, Nazaré Boavida, Fernando Arrobas, Fábio Pereira Correia, et al. (+5)
267 [GO] 2023―May―08 Immunogenicity and safety of a single booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: primary analysis report of a phase 3 open-label trial Kenji Kuriyama, Kyoko Murakami, Taisei Masuda, Kenkichi Sugiura, Sho Sakui, Ron P. Schuring, Mitsuhiro Mori
268 [GO] 2023―May―05 Dengue vaccine acceptability before and after the availability of COVID-19 vaccines in Puerto Rico Dania M. Rodriguez, Chelsea G. Major, Liliana Sánchez-González, Emma Jones, Mark J. Delorey, Claudia Alonso, et al. (+3)
269 [GO] 2023―May―03 Vaccine Effectiveness of the mRNA-1273 3-dose Primary Series Against COVID-19 in an Immunocompromised Population: A Prospective Observational Cohort Study Jennifer H. Ku, Lina S. Sy, Lei Qian, PBradley K. Ackerson, Yi Luo, Julia E. Tubert, et al. (+7)
270 [GO] 2023―May―02 Attitudes towards COVID-19 Vaccination among Incarcerated Persons in the Federal Bureau of Prisons, June-July 2021 Rena Fukunaga, Zoe E. Kaplan, Tami Rodriguez, Liesl Hagan, Kathleen Aarvig, Charles Dusseau, et al. (+2)
271 [GO] 2023―May―01 COVID-19 vaccination decisions among Gypsy, Roma and Traveller communities: a qualitative study moving beyond “vaccine hesitancy” Charlotte Kühlbrandt, Catherine R. McGowan, Rachel Stuart, Pippa Grenfell, Sam Miles, Alicia Renedo, Cicely Marston
272 [GO] 2023―May―01 COVID-19 vaccination rates among adolescents (12-17 years) by immigrant background and sociodemographic factors: a nationwide registry study in Norway Lema Hussaini, Angela S. Labberton, Brita A. Winje, Kristian B. Kraft, Marte Karoline R. Kjøllesdal, Rebecca N. Gleditsch, Anna A. Godøy
273 [GO] 2023―May―01 Hematologic Adverse Events Reported After COVID-19 Vaccination in the Philippines: A National Database Study Flordeluna Z. Mesina, Frances Alexandra D. Sapinoso, Joy Ann V. de Castro, Preeti Prerna M. Vaswani, Charles Eryll S. Sy, Rizza Ann A. Oquendo, Mark Ryann A. Lirasan
274 [GO] 2023―May―01 Effectiveness of the COVID-19 Vaccines on Preventing Symptomatic SARS-CoV-2 Infections and Hospitalizations in Southwestern Alaska, January-December, 2021 Brian Lefferts, Dana Bruden, Ian D. Plumb, Ellen Hodges, Elizabeth Bates, Gerald January, Michael G. Bruce
275 [GO] 2023―Apr―27 Efficacy of Primary Series AZD1222 (ChAdOx1 nCoV-19) Vaccination Against SARS-CoV-2 Variants of Concern: Final Analysis of a Randomized, Placebo-controlled, Phase 1b/2 Study in South African Adults (COV005) Anthonet L. Koen, Alane Izu, Vicky Baillie, Gaurav Kwatra, Clare L. Cutland, Lee Fairlie, et al. (+30)
276 [GO] 2023―Apr―26 Identifying Gaps in Vaccination Perception After Mandating the COVID-19 Vaccine in Saudi Arabia Nada Alsuhebany, Shuroug A. Alowais, Atheer Aldairem, Sumaya N. Almohareb, Khalid Bin Saleh, Khawla M. Kahtani, et al. (+5)
277 [GO] 2023―Apr―26 COVID-19 Vaccine Deliberation in Individuals Directly Impacted by Incarceration Charlotte Kim, Jenerius A. Aminawung, Lauren Brinkley-Rubinstein, Emily A. Wang, Lisa B. Puglisi
278 [GO] 2023―Apr―26 Safety and adverse effects of the coronavirus disease 2019 vaccine among the general Japanese adult population Xi Lu, Shota Masuda, Hasita Horlad, Takahiko Katoh
279 [GO] 2023―Apr―25 COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs Miao Jiang, Elina Väisänen, Pekka Kolehmainen, Moona Huttunen, Seppo Ylä-Herttuala, Seppo Meri, et al. (+2)
280 [GO] 2023―Apr―24 Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers Clare Nugent, Yasin Abul, Elizabeth M. White, Fadi Shehadeh, Matthew Kaczynski, Lewis Oscar Felix, et al. (+16)
281 [GO] 2023―Apr―19 Vaccine-induced immune thrombotic thrombocytopenia post dose 2 ChAdOx1 nCoV19 vaccination: Less severe but remains a problem Lisa Clarke, Timothy Brighton, Sanjeev D. Chunilal, Christine S.M. Lee, Freda Passam, Jennifer Curnow, et al. (+2)
282 [GO] 2023―Apr―18 Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines Alexis Pillsbury, Anastasia Phillips, Lucy Deng, Helen Quinn, Kristine Macartney, Heather Gidding
283 [GO] 2023―Apr―17 A tailored COVID-19 vaccination pathway for children 5 to 11 years in Victoria, Australia SF Gordon, J Lam, JT Vasquez, R Cercone, N Tenneti, J Hart, et al. (+5)
284 [GO] 2023―Apr―17 COVID-19 vaccine distribution: A high reliability organization approach Claire Houtsma, Amanda M. Raines, Amy Reggio, La-Kenya Rushing, Ebony Harding, Edward Payton, Caitlin Martin-Klinger
285 [GO] 2023―Apr―14 COVID-19 mRNA BNT162b2 vaccine immunogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) Kamila M Ludwikowska, Aneta Popiel, Agnieszka Matkowska-Kocjan, Mateusz Biela, Marta Wójcik, Filip Szenborn, et al. (+5)
286 [GO] 2023―Apr―14 Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models Tobias L. Freitag, Riku Fagerlund, Nihay Laham Karam, Veli-Matti Leppänen, Hasan Ugurlu, Ravi Kant, et al. (+21)
287 [GO] 2023―Apr―12 Safety and Immunogenicity of Homologous versus Heterologous Booster Dose with AZD1222, mRNA-1273, or MVC-COV1901 SARS-CoV-2 Vaccines in Adults: An Observer-blinded, Multi-center, Phase 2 Randomized Trial Lila Estephan, Ying-Chin Lin, Yi-Tsung Lin, Yen-Hsu Chen, Sung-Ching Pan, Szu-Min Hsieh, et al. (+7)
288 [GO] 2023―Apr―10 Promises and challenges of mucosal COVID-19 vaccines Abhay P.S. Rathore, Ashley L. St. John
289 [GO] 2023―Apr―10 Subunit vaccines with a saponin-based adjuvant boost humoral and cellular immunity to MERS coronavirus Chi-Chieh Chang, Abdullah Algaissi, Chia-Chun Lai, Chun-Kai Chang, Jr-Shiuan Lin, Yi-Shiang Wang, et al. (+12)
290 [GO] 2023―Apr―07 Methodological changes implemented over time to support accurate and timely COVID-19 vaccine coverage estimates: Ontario, Canada J. Leigh Hobbs, Lauren A. Paul, Sarah A. Buchan, Tara Harris, Sarah E. Wilson
291 [GO] 2023―Apr―07 Factors Impacting Parental Uptake of COVID-19 Vaccination for U.S. Children ages 5-17 Julen N. Harris, Christine M. Mauro, Tucker L. Morgan, Ariel de Roche, Gregory D. Zimet, Susan L. Rosenthal
292 [GO] 2023―Apr―05 Evaluation of mortality risk after COVID-19 vaccination, Utah 2021 Jessica R. Payne, Srimoyee Bose, Rachel W. Kubiak, Leisha D. Nolen
293 [GO] 2023―Apr―05 VACCINE EFFECTIVENESS AGAINST TRANSMISSION OF ALPHA, DELTA AND OMICRON SARS-COV-2-INFECTION, BELGIAN CONTACT TRACING, 2021-2022 Toon Braeye, Lucy Catteau, Ruben Brondeel, Joris van Loenhout, Kristiaan Proesmans, Laura Cornelissen, et al. (+9)
294 [GO] 2023―Apr―04 The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA) Martina Frodlund, Per Nived, Aikaterina Chatzidionysiou, Anna Södergren, Eva Klingberg, Anders Bengtsson, et al. (+5)
295 [GO] 2023―Apr―04 Public discourse and debate about vaccines in the midst of the covid-19 pandemic: a qualitative content analysis of Twitter Enrique Prada-Gonzalez, Andrea Langbecker, Daniel Catalan-Matamoros
296 [GO] 2023―Apr―04 What Accounts for the Variation in COVID-19 Vaccine Hesitancy in Eastern, Southern and Western Europe? Dimiter Toshkov
297 [GO] 2023―Apr―03 The added effect of non-pharmaceutical interventions and lifestyle behaviors on vaccine effectiveness against severe COVID-19 in Chile: A matched case-double control study Cinthya Urquidi, Emilio Santelices, Anne J. Lagomarcino, María Teresa Valenzuela, Nicolás Larrañaga, Emilio Gonzalez, et al. (+7)
298 [GO] 2023―Apr―03 Pediatricians’ Perceptions, Practices, and Barriers Regarding COVID-19 Vaccine for Children: A Cross-Sectional Survey in Ontario, Canada Yamna Ali, Pierre-Philippe Piche-Renaud, Elahe Karimi-Shahrbabak, Daniel S. Farrar, Sarah Abu Fadaleh, Sharon Burey, Shaun K. Morris
299 [GO] 2023―Apr―01 Lack of association between vaccination rates and excess mortality in Cyprus during the COVID-19 pandemic Theodore Lytras, Maria Athanasiadou, Anna Demetriou, Despina Stylianou, Alexandros Heraclides, Olga Kalakouta
300 [GO] 2023―Mar―31 Factors associated with COVID-19 vaccination during June-October, 2021: a multi-site prospective study Reva S. Datar, Lida M. Fette, Amy N. Hinkelman, E. Adrianne Hammershaimb, DeAnna J. Friedman-Klabanoff, Morgana Mongraw-Chaffin, et al. (+9)
301 [GO] 2023―Mar―30 Safety and immunogenicity of heterologous ChAdOx1-nCoV19 and BNT162b2 vaccination: a meta-analysis of the heterologous COVID-19 vaccination outcomes Yuxuan Hu, Yanning Wang, Taihang Shao, Wenxi Tang, Kerong Hu, Yujie Zhou, et al. (+4)
302 [GO] 2023―Mar―29 Development of a COVID-19 vaccine effectiveness and safety assessment system in Japan: The VENUS Study Haruhisa Fukuda, Megumi Maeda, Fumiko Murata
303 [GO] 2023―Mar―28 Real-life safety profile of mRNA vaccines for COVID-19: an analysis of VAERS database Greta Santi Laurini, Nicola Montanaro, Massimiliano Broccoli, Giulia Bonaldo, Domenico Motola
304 [GO] 2023―Mar―28 Acute Reactions After a Homologous Primary COVID-19 Vaccination Series: Analysis of Taiwan V-Watch Data Wei-Ju Su, K Arnold Chan, Jen-Hsiang Chuang, Ting-Ann Wang, Shu-Fong Chen, Yun-Cheng Chang, et al. (+3)
305 [GO] 2023―Mar―27 Conspiracies, Misinformation and Resistance to Public Health Measures During COVID-19 in White Nationalist Online Communication Dror Walter, Yotam Ophir, Hui Ye
306 [GO] 2023―Mar―27 Impact of vitamin D3 supplementation on COVID-19 vaccine response and immunoglobulin G antibodies in deficient women: A randomized controlled trial Fatih Cesur, Zeynep Atasever, Yavuz Özoran
307 [GO] 2023―Mar―27 Determinants of COVID-19 vaccine acceptance in Mozambique: The role of institutional trust Bo Hu, Wei Yang, Paul Bouanchaud, Yolanda Chongo, Jennifer Wheeler, Sergio Chicumbe, Marcos Chissano
308 [GO] 2023―Mar―27 Safety of COVID-19 vaccines during pregnancy: A systematic review and meta-analysis Agustín Ciapponi, Mabel Berrueta, Edward P. K. Parker, Ariel Bardach, Agustina Mazzoni, A. Steven Anderson, et al. (+15)
309 [GO] 2023―Mar―27 Comparison of culture-competent virus shedding duration of SARS-CoV-2 omicron variant in regard to vaccination status: a prospective cohort study Sung-Woon Kang, Heedo Park, Ji Yeun Kim, Joon-Yong Bae, Man-Seong Park, Sung-Han Kim
310 [GO] 2023―Mar―27 Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults Pieter Pannus, Stéphanie Depickère, Delphine Kemlin, Daphnée Georges, Sarah Houben, Véronique Olislagers, et al. (+19)
311 [GO] 2023―Mar―27 First hepatitis B vaccine uptake in neonates prior to and during the COVID-19 pandemic Anna M. Dugovich, Toby H. Cox, Erin R. Weeda, Sandra S. Garner
312 [GO] 2023―Mar―22 Divergent COVID-19 vaccine policies: Policy mapping of ten European countries Robin van Kessel, Rebecca Forman, Ricarda Milstein, Alicja Mastylak, Katarzyna Czabanowska, Thomas Czypionka, et al. (+10)
313 [GO] 2023―Mar―21 Effect of adjuvanting RBD-dimer-based subunit COVID-19 vaccines with Sepivac SWETM Senyu Xu, Huixin Duan, Yaling An, Xiyue Jin, Minrun Duan, Patrice M Dubois, et al. (+6)
314 [GO] 2023―Mar―21 Vaccine hesitancy against COVID-19 vaccine over time in Nigeria Ryoko Sato
315 [GO] 2023―Mar―21 Preclinical safety evaluation of intradermal SARS-CoV-2 inactivated vaccine (Vero cells) administration in macaques Jinling Yang, Xinqian Huo, Qinfang Jiang, Yun Liao, Caixing Zhang, Li Yu, et al. (+12)
316 [GO] 2023―Mar―21 Effectiveness of second booster compared to first booster and protection conferred by previous SARS-CoV-2 infection against symptomatic Omicron BA.2 and BA.4/5 in France Cynthia Tamandjou, Vincent Auvigne, Justine Schaeffer, Sophie Vaux, Isabelle Parent du Châtelet
317 [GO] 2023―Mar―21 Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant Waranyoo Phoolcharoen, Balamurugan Shanmugaraj, Narach Khorattanakulchai, Piyanate Sunyakumthorn, Sathit Pichyangkul, Pornnarin Taepavarapruk, et al. (+9)
318 [GO] 2023―Mar―15 Serologic Responses to COVID-19 Vaccination in Children with History of Multisystem Inflammatory Syndrome (MIS-C) Maria A. Perez, Hui-Mien Hsiao, Xuemin Chen, Amber Kunkel, Nadine Baida, Laila Hussaini, et al. (+11)
319 [GO] 2023―Mar―13 Immunocompromise among vaccinated versus unvaccinated COVID-19 cases admitted to critical care in Ireland, July to October 2021 David Kelly, Kate O'Donnell, Louise Marron, Rory Dwyer, Michael Power, Chantal Migone, et al. (+2)
320 [GO] 2023―Mar―13 Latent Class Analysis of Medical Mistrust and COVID-19 Vaccine Hesitancy Among Adults in the United States Just Prior to FDA Emergency Use Authorization Phoebe A. Lamuda, Ariel Azar, Bruce G. Taylor, Elizabeth Flanagan Balawajder, Harold A. Pollack, John A. Schneider
321 [GO] 2023―Mar―09 Estimated COVID-19 Vaccine Effectiveness Against Seroconversion from SARS-CoV-2 Infection, March-October, 2021 Ian D. Plumb, Lida M. Fette, Ashley H. Tjaden, Leora Feldstein, Sharon Saydah, Amina Ahmed, et al. (+12)
322 [GO] 2023―Mar―08 Antibody dependent disease enhancement (ADE) after COVID-19 vaccination and beta glucans as a safer strategy in management Nobunao Ikewaki, Gene Kurosawa, Gary A. Levy, Senthilkumar Preethy, Samuel J.K. Abraham
323 [GO] 2023―Mar―07 Pharmacy-based immunization in rural USA during the COVID-19 pandemic: A survey of community pharmacists from five southeastern states Sura O. AlMahasis, Brent Fox, David Ha, Jingjing Qian, Chih-hsuan Wang, Salisa C. Westrick
324 [GO] 2023―Mar―06 Factors associated with US caregivers’ uptake of pediatric COVID-19 vaccine by race and ethnicity Rebecca J. Hart, Shannon Baumer-Mouradian, Jeffrey N Bone, Prasra Olson, Stephanie Schroter, Rachel M. Weigert, et al. (+6)
325 [GO] 2023―Mar―03 A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 Protein Vaccine Lila Estephan, Luke Tzu-Chi Liu, Chia En Lien, Emily R. Smith, Marc Gurwith, Robert T. Chen
326 [GO] 2023―Mar―03 From COVID-19 Vaccines Candidates to Compulsory Vaccination: The Attitudes of Italian Citizens in the Key 7-month of Vaccination Campaign Andrea Grignolio Corsini, Roberta Martina Zagarella, Massimiliano Adamo, Cinzia Caporale
327 [GO] 2023―Mar―02 fvWillingness to Vaccinate Children against COVID-19 Declined During the Pandemic RD. Goldman, RJ. Hart, JN. Bone, M. Seiler, PG. Olson, k. Keitel, et al. (+18)
328 [GO] 2023―Mar―02 COVID-19 mRNA BNT162b2 vaccine safety and B-cell and T-cell reactogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) - preliminary study Kamila M. Ludwikowska, Aneta Popiel, Agnieszka Matkowska-Kocjan, Mateusz J. Olbromski, Mateusz Biela, Marta Wójcik, et al. (+6)
329 [GO] 2023―Mar―02 The mediating effect of health literacy on COVID-19 vaccine confidence among a diverse sample of urban adults in Boston and Chicago Emily E. Hurstak, Michael K Paasche-Orlow, Elizabeth A Hahn, Lori E. Henault, Michelle A. Taddeo, Patricia I. Moreno, et al. (+5)
330 [GO] 2023―Mar―02 Placing a value on increased flexible vaccine manufacturing capacity for future pandemics Anthony T. Newall, Philippe Beutels, Zoltán Kis, Adrian Towse, Mark Jit
331 [GO] 2023―Mar―01 Mediators of racial and ethnic disparities in COVID-19 vaccine uptake Ling Na, Sativa Banks, Peizhong Wang
332 [GO] 2023―Feb―27 Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort Masae Itamochi, Shunsuke Yazawa, Noriko Inasaki, Yumiko Saga, Emiko Yamazaki, Takahisa Shimada, et al. (+9)
333 [GO] 2023―Feb―27 Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France Cynthia Raissa TAMANDJOU, Vincent AUVIGNE, Sophie VAUX, Charline MONTAGNAT, Juliette PAIREAU, Stéphanie MONNIER BESNARD, et al. (+5)
334 [GO] 2023―Feb―27 Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: analysis of data reported to EudraVigilance Helena C. Maltezou, Sophia Hatziantoniou, Kalliopi Theodoridou, Konstantinos Vasileiou, Cleo Anastassopoulou, Athanasios Tsakris
335 [GO] 2023―Feb―27 Immunogenicity of adjuvanted plant-produced SARS-CoV-2 Beta spike VLP vaccine in New Zealand white rabbits Martha M O'Kennedy, Celia Abolnik, Tanja Smith, Thopisang Motlou, Kruger Goosen, Kamogelo M Sepotokele, et al. (+9)
336 [GO] 2023―Feb―26 Erratum to “Parental intentions to vaccinate children against COVID-19: Findings from a U.S. National Survey” [Vaccine 41(1) (2023) 101-108 Rebecca J. Guerin, Arash Naeim, Ryan Baxter-King, Andrea H. Okun, Derek Holliday, Lynn Vavreck
337 [GO] 2023―Feb―23 COVID-19 vaccine hesitancy among people living with HIV (PLHIV) in a low-resource setting: a multi-center study of prevalence, correlates and reasons Sahabi Kabir Sulaiman, Muhammad Sale Musa, Fatimah Isma'il Tsiga-Ahmed, Farouq Muhammad Dayyab, Abdulwahab Kabir Sulaiman, Bashir Dabo, et al. (+27)
338 [GO] 2023―Feb―23 A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452 Eline A. Feitsma, Yester F. Janssen, Hendrikus H. Boersma, Yannick van Sleen, Debbie van Baarle, David G. Alleva, et al. (+19)
339 [GO] 2023―Feb―21 The time is now for committed and comprehensive action to attain more broadly protective coronavirus vaccines: The coronavirus vaccines R&D roadmap Margaret Hamburg, Gregory A. Poland
340 [GO] 2023―Feb―21 A Research and Development (R&D) Roadmap for Broadly Protective Coronavirus Vaccines: A Pandemic Preparedness Strategy Kristine A. Moore, Tabitha Leighton, Julia T. Ostrowsky, Cory J. Anderson, Richard N. Danila, Angela K. Ulrich, et al. (+12)
341 [GO] 2023―Feb―20 Erroneous Consonance. How inaccurate beliefs about physician opinion influence COVID-19 vaccine hesitancy Matt Motta, Timothy Callaghan, Kristin Lunz-Trujillo, Alee Lockman
342 [GO] 2023―Feb―17 Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England Carly Meyer, Louis Goffe, Vivi Antonopoulou, Fiona Graham, Mei Yee Tang, Jan Lecouturier, et al. (+3)
343 [GO] 2023―Feb―16 Trusted Messengers and Trusted Messages: The Role for Community-Based Organizations in Promoting COVID-19 and Routine Immunizations Angela K. Shen, Safa Browne, Tuhina Srivastava, Melanie L. Kornides, Andy S.L. Tan
344 [GO] 2023―Feb―16 Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbidities Peter D Smits, Samuel Gratzl, Michael Simonov, Senthil K Nachimuthu, Brianna M Goodwin Cartwright, Michael D Wang, et al. (+5)
345 [GO] 2023―Feb―16 The social and socio-political embeddedness of COVID-19 vaccination decision-making: A five-country qualitative interview study from Europe Bettina M. Zimmermann, Katharina T. Paul, Emília R. Araújo, Alena Buyx, Sebastian Ferstl, Amelia Fiske, et al. (+7)
346 [GO] 2023―Feb―13 The impact of side effect framing on COVID-19 booster vaccine intentions in an Australian sample K. Barnes, K. Faasse
347 [GO] 2023―Feb―13 Examining confidence and hesitancy towards COVID-19 vaccines: a cross-sectional survey using in-person data collection in rural Ghana Afreh OK, P. Angwaawie, E. Attivor, LA. Boateng, K. Brackstone, MG. Head, et al. (+2)
348 [GO] 2023―Feb―13 Intent to vaccinate against SARS-CoV-2 and its determinants across six ethnic groups living in Amsterdam, the Netherlands: a cross-sectional analysis of the HELIUS study Sophie L. Campman, Gwen van Rossem, Anders Boyd, Liza Coyer, Janke Schinkel, Charles Agyemang, et al. (+12)
349 [GO] 2023―Feb―13 Determinants of humoral immune response to SARS-CoV-2 vaccines in solid cancer patients: A systematic review and meta-analysis Durgesh Wankhede, Sandeep Grover, Paul Hofman
350 [GO] 2023―Feb―13 Minority Health Social Vulnerability Index and COVID-19 vaccination coverage - The United States, December 14, 2020-January 31, 2022 Ryan Saelee, Neil Chandra Murthy, Bhavini Patel Murthy, Elizabeth Zell, Lauren Shaw, Lynn Gibbs-Scharf, et al. (+2)
351 [GO] 2023―Feb―10 Did the temporary suspension of Vaxzveria vaccinations influence COVID-19 vaccination intentions, vaccination perceptions and trust in the vaccination campaign? A repeated survey study in the Netherlands Marion de Vries, Liesbeth Claassen, Mattijs S. Lambooij, Aura Timen
352 [GO] 2023―Feb―10 Six-month safety follow-up of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in adults: a phase 2/3, double-blind, randomized study Romana Hosain, Peter Aquino, Carmen Baccarini, Igor Smolenov, Ping Li, Haijing Qin, et al. (+4)
353 [GO] 2023―Feb―09 Persuading the “Movable Middle”: Characteristics of Effective Messages to Promote Routine and COVID-19 Vaccinations for Adults and Children - The Impact of COVID-19 on Beliefs and Attitudes Angela K. Shen, Safa Browne, Tuhina Srivastava, Melanie L. Kornides, Andy S.L. Tan
354 [GO] 2023―Feb―09 Persistent SARS-COV-2 infection in vaccinated individual with three doses of COVID-19 vaccine Germana Silva Vasconcelos, Maria da Conceição Rodrigues Fernandes, Tamires Cardoso Matsui, Maria Claudia dos Santos Luciano, Cecilia Leite Costa, Clarissa Perdigão Mello Ferraz, et al. (+4)
355 [GO] 2023―Feb―09 Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization Daniel R. Feikin, Melissa M. Higdon, Nick Andrews, Shirley Collie, Maria Deloria Knoll, Jeffrey C. Kwong, et al. (+3)
356 [GO] 2023―Feb―09 Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naïve and exposed individuals in a phase 2/3, double-blind, randomized study Erik Buntinx, Leonardo Brochado, Charissa Borja-Tabora, Charles Y. Yu, Edison R Alberto, May E.B. Montellano, et al. (+13)
357 [GO] 2023―Feb―08 Make it or break it: On-time Vaccination intent at the time of Covid-19 Jacques Bughin, Michele Cincera, Kelly Peters, Dorota Reykowska, Marcin Żyszkiewicz, Rafal Ohmed
358 [GO] 2023―Feb―08 Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis Atsuyuki Watanabe, Masao Iwagami, Jun Yasuhara, Hisato Takagi, Toshiki Kuno
359 [GO] 2023―Feb―07 Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants Hye Won Kwak, Hyo-Jung Park, Seo-Yeon Jung, Eun Young Oh, Sang-In Park, Yeonhwa Kim, et al. (+21)
360 [GO] 2023―Feb―03 mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia Rui Li, Hanting Liu, Christopher K Fairley, Jason J Ong, Yuming Guo, Pengyi Lu, et al. (+6)
361 [GO] 2023―Feb―03 Temporal trends and determinants of COVID-19 vaccine coverage and series initiation during pregnancy in Ontario, Canada, December 2020 to December 2021: a population-based retrospective cohort study Deshayne B. Fell, Eszter Török, Ann E. Sprague, Annette K. Regan, Tavleen Dhinsa, Gillian D. Alton, et al. (+15)
362 [GO] 2023―Feb―03 Unlocking Infodemics and Mysteries in COVID-19 Vaccine Hesitancy: Nexus of Conspiracy Beliefs, Digital Informational Support, Psychological Well-being, and Religious Fatalism Syed Hassan Raza, Muhammad Yousaf, Umer Zaman, Sanan Waheed Khan, Rachel Core, Aqdas Malik
363 [GO] 2023―Feb―02 Effectiveness of full (booster) COVID-19 vaccination against severe outcomes and work absenteeism in hospitalized patients with COVID-19 during the Delta and Omicron waves in Greece Helena C. Maltezou, Dimitrios Basoulis, Konstantinos Bonelis, Maria N. Gamaletsou, Theodoros V. Giannouchos, Eleni Karantoni, et al. (+14)
364 [GO] 2023―Feb―01 Real-world uptake of COVID-19 vaccination among individuals expressing vaccine hesitancy: a registry-linkage study Kristin L. Andrejko, Jennifer F. Myers, Nozomi Fukui, Lauren Nelson, Rui Zhao, John Openshaw, et al. (+4)
365 [GO] 2023―Feb―01 The societal value of SARS-CoV-2 booster vaccination in Indonesia Rob Johnson, Bimandra Djaafara, David Haw, Patrick Doohan, Giovanni Forchini, Matteo Pianella, et al. (+3)
366 [GO] 2023―Jan―27 Ethics of age de-escalation in pediatric vaccine trials: Attending to the case of COVID-19 Ami Harbin, Naomi Laventhal, Mark Navin
367 [GO] 2023―Jan―27 Influenza and pneumococcal vaccine prescription for adults during COVID-19 first wave in three regions of Argentina María Gabriela Matta, Laura Pulido, Juan José Herrera-Paz, José M. Picco, Sebastian Wolff, Gary Tse, Sebastian Garcia-Zamora
368 [GO] 2023―Jan―27 Impact of COVID-19 vaccination in post-COVID cardiac complications Josefina B. Parodi, Agustín Indavere, Pamela Bobadilla Jacob, Guillermo C. Toledo, Rubén G. Micali, Gabriel Waisman, et al. (+3)
369 [GO] 2023―Jan―23 The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC’s COVID-19 pandemic response Tanya R. Myers, Paige L. Marquez, Julianne M. Gee, Anne M. Hause, Lakshmi Panagiotakopoulos, Bicheng Zhang, et al. (+11)
370 [GO] 2023―Jan―23 Safety and Efficacy of COVID-19 Prime-Boost Vaccinations: Homologous BBIBP-CorV versus Heterologous BNT162b2 Boosters in BBIBP-CorV-Primed Individuals Saad I. Mallah, Abdulla Alawadhi, Jaleela Jawad, Pearl Wasif, Basma Alsaffar, Ejlal Alalawi, et al. (+12)
371 [GO] 2023―Jan―23 Psychological determinants of COVID-19 vaccine acceptance: A comparison between immigrants and the host population in Japan Yuanyuan Teng, Tomoya Hanibuchi, Masaki Machida, Tomoki Nakaya
372 [GO] 2023―Jan―23 Health Belief Model and parents' acceptance of the Pfizer-BioNTech and Sinopharm COVID-19 vaccine for children aged 5-18 years Old: A national survey Pasitpon Vatcharavongvan, Napat Boonyanitchayakul, Panpassorn Khampachuea, Isawan Sinturong, Vanida Prasert
373 [GO] 2023―Jan―23 COVID-19 Vaccine Hesitancy Scale and its Association with Actual COVID-19 Vaccine Uptake in Israel Ariella Grossman-Giron, Dana Tzur Bitan, Sharon Shemesh, Yael Mayer, Noga Shiffman, Yuval Bloch
374 [GO] 2023―Jan―23 Education increases COVID-19 vaccine uptake among people in Canadian federal prisons in a prospective randomized controlled trial: The EDUCATE study Tetiana Zolotarova, Camille Dussault, Hyejin Park, Olivia Varsaneux, Nicole E. Basta, Lorena Watson, et al. (+8)
375 [GO] 2023―Jan―23 Predictors of COVID-19 vaccine uptake among people who inject drugs Steffanie A. Strathdee, Daniela Abramovitz, Carlos F. Vera, Irina Artamonova, Thomas L. Patterson, Davey M. Smith, et al. (+2)
376 [GO] 2023―Jan―23 Comparative performance of between-population vaccine allocation strategies with applications for emerging pandemics Keya Joshi, Eva Rumpler, Lee Kennedy-Shaffer, Rafia Bosan, Marc Lipsitch
377 [GO] 2023―Jan―21 COVID-19 vaccination hesitancy and uptake: Perspectives from people released from the Federal Bureau of Prisons Camille Kramer, Minna Song, Carolyn B. Sufrin, Gabriel B. Eber, Leonard S. Rubenstein, Brendan Saloner
378 [GO] 2023―Jan―20 COVID-19 Vaccination among Different Types of US Healthcare Personnel Matthew Z. Dudley, Holly B. Schuh, Jana Shaw, Rajiv N. Rimal, Steven A. Harvey, Kristian R. Balgobin, et al. (+2)
379 [GO] 2023―Jan―20 COVID-19 vaccination hesitancy in people affected by diabetes and strategies to increase vaccine compliance: A systematic narrative review and meta-analysis Francesco Paolo Bianchi, Pasquale Stefanizzi, Andrea Martinelli, Nazario Brescia, Silvio Tafuri
380 [GO] 2023―Jan―20 SARS-CoV-2 vaccine breakthrough infections in Virginia, January 17, 2021 - June 30, 2021 Brandy Darby, Victoria Alexander, Julia Murphy
381 [GO] 2023―Jan―16 COVID-19 Vaccine Hesitancy among Pregnant Women and their Reported Reasons for Vaccine Refusal- A Prospective Study in Tehran, Iran Ashraf Moini, Maryam Rabiei, Reihaneh Pirjani, Amene Abiri, Arezoo Maleki-Hajiagha
382 [GO] 2023―Jan―13 COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: A national prospective cohort study Stuart Bedston, Emily Lowthian, Christopher I Jarvis, Ashley Akbari, Jillian Beggs, Declan Bradley, et al. (+13)
383 [GO] 2023―Jan―13 Association of death or illness from COVID-19 among family and friends on vaccine uptake within four months of the Emergency Use Authorization. Findings from a national survey in the United States Saurabh Kalra, Deepak Kalra, Irina Grafova, Julia Sass Rubin, Alan Monheit, Joel Cantor, et al. (+2)
384 [GO] 2023―Jan―13 Decline in reported measles cases in Italy in the COVID-19 era, January 2020 - July 2022: the need to prevent a resurgence upon lifting non-pharmaceutical pandemic measures Giacomo Facchin, Antonino Bella, Martina Del Manso, Maria Cristina Rota, Antonietta Filia
385 [GO] 2023―Jan―13 Safety of primary immunization using inactivated SARS-CoV-2 vaccine (CoronaVac®) among population aged 3 years and older in a large-scale use: a multi-center open-label study in China Haitao Yang, Zhen Li, Ruizhi Zhang, Shicheng Guo, Binbing Wang, Xing Fang, et al. (+8)
386 [GO] 2023―Jan―09 Safety of Co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the Vaccine Adverse Event Reporting System (VAERS) during July 1, 2021 - June 30, 2022 Pedro L. Moro, Bicheng Zhang, Carol Ennulat, Margaret Harris, Rachel McVey, Gina Woody, et al. (+3)
387 [GO] 2023―Jan―09 School immunization coverage in adolescents during the COVID-19 pandemic: A retrospective cohort study Hannah Sell, Yuba Raj Paudel, Donald Voaklander, Shannon E. MacDonald
388 [GO] 2023―Jan―09 Experiences, risk perceptions, and COVID-19 vaccination outcomes among hospital workers Abram L. Wagner, Michelle H. Moniz, Molly J. Stout, Courtney Townsel, Sarah T. Hawley, Brian J. Zikmund-Fisher
389 [GO] 2023―Jan―09 Breastfeeding women’s attitudes towards and acceptance and rejection of COVID-19 vaccination: Implementation research Saifon Chawanpaiboon, Sanitra Anuwutnawin, Attapol Kanjanapongporn, Julaporn Pooliam, Vitaya Titapant
390 [GO] 2023―Jan―09 COVID-19 vaccine hesitancy in care home staff: a survey of Liverpool care homes John S P Tulloch, Karen Lawrenson, Adam L Gordon, Sam Ghebrehewet, Matthew Ashton, Steve Peddie, Paula Parvulescu
391 [GO] 2023―Jan―06 Baculoviral COVID-19 Delta DNA vaccine cross-protects against SARS-CoV2 variants in K18-ACE2 transgenic mice Yuyeon Jang, Hansam Cho, Jungmin Chun, Kihoon Park, Aleksandra Nowakowska, Jinha Kim, et al. (+6)
392 [GO] 2023―Jan―06 CNS demyelinating disease following inactivated or viral vector SARS-CoV-2 vaccines: a case series Narges Ebrahimi, Mahsa Mazdak, Vahid Shaygannejad, Omid Mirmosayyeb
393 [GO] 2023―Jan―05 Safety, Reactogenicity, and Immunogenicity of Ad26.COV2.S: Results of a Phase 1, Randomized, Double-blind, Placebo-controlled COVID-19 Vaccine Trial in Japan Yumi Tsuchiya, Hiroshi Tamura, Koji Fujii, Hirotaka Numaguchi, Kiichiro Toyoizumi, Tina Liu, et al. (+3)
394 [GO] 2023―Jan―03 COVID-19 vaccination refusal trends in Kenya over 2021 Ryan T Rego, Brooke Kenney, Anthony K Ngugi, Leon Espira, James Orwa, Geoffrey H Siwo, et al. (+13)
395 [GO] 2023―Jan―02 Assessment of a COVID-19 Vaccination Protocol for Persons Experiencing Homelessness in the Emergency Department James S. Ford, Sam G. Rouleau, Jenny L. Wagner, Christopher B. Adams, Larissa S. May, Aman K. Parikh, James F. Holmes
396 [GO] 2023―Jan―02 A Longitudinal Assessment of Variability in COVID-19 Vaccine Hesitancy and Psychosocial Correlates in a National United States Sample Natalie J. Shook, Benjamin Oosterhoff, Barış Sevi
397 [GO] 2022―Dec―29 Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants Sergio A. Rodriguez-Aponte, Neil C. Dalvie, Ting Y. Wong, Ryan S. Johnston, Christopher A. Naranjo, Sakshi Bajoria, et al. (+20)
398 [GO] 2022―Dec―26 COVID-19 booster vaccination in rural community pharmacies Abigail Gamble, Tessa J. Hastings, Salisa C. Westrick, Megan Smith, Ashley N. Hannings, Jessica M. Robinson, et al. (+4)
399 [GO] 2022―Dec―25 Effects of a booster dose of BNT162b2 on spike-binding antibodies to SARS-CoV-2 Omicron BA.2, BA.3, BA.4 and BA.5 subvariants in infection-naïve and previously-infected individuals Timothy G Kuzel, Jia Fu, Mark Anderson, Michael Stec, Michael Boler, Dylan Behun, et al. (+4)
400 [GO] 2022―Dec―23 Association of dual COVID-19 and seasonal influenza vaccination with COVID-19 infection and disease severity Zhigang Xie, Hanadi Y. Hamadi, Arch G. Mainous, Young-Rock Hong
401 [GO] 2022―Dec―23 Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021-2022 influenza season Kristin L. Andrejko, Jennifer F. Myers, John Openshaw, Nozomi Fukui, Sophia Li, James P. Watt, et al. (+5)
402 [GO] 2022―Dec―21 Cellular and Humoral Immune Response to the Fourth Pfizer-BioNTech COVID-19 Vaccine Dose in Individuals Aged 60 Years and Older Esther Saiag, Yifat Alcalay, Or Marudi, Avi Orr-Urtreger, David Hagin
403 [GO] 2022―Dec―21 One-year dynamics of antibody titers after three doses of SARS-CoV-2 BNT162b2 vaccine Ori Wand, Anna Breslavsky, Amir Bar-Shai, Chezy Levy, Shlomo Maayan, Avi Rimler, et al. (+5)
404 [GO] 2022―Dec―20 Effectiveness of Covid-19 vaccines against symptomatic and asymptomatic SARS-CoV-2 infections in an urgent care setting Madhura S. Rane, McKaylee Robertson, Sarah Kulkarni, Daniel Frogel, Chris Gainus, Denis Nash
405 [GO] 2022―Dec―20 A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination Stanley Xu, Runxin Huang, Lina S. Sy, Vennis Hong, Sungching C. Glenn, Denison S. Ryan, et al. (+10)
406 [GO] 2022―Dec―16 Changes in hepatitis B vaccine perception in response to the COVID-19 pandemic: Development of the Shift in Vaccine Confidence (SVC) survey tool Alix Boisson, Camille Morgan, Angela Stover, Patrick Ngimbi, Nana Mbonze, Sarah Ntambua, et al. (+7)
407 [GO] 2022―Dec―16 Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults Takuhiro Sonoyama, Satoshi Iwata, Masaharu Shinkai, Naoko Iwata-Yoshikawa, Nozomi Shiwa-Sudo, Takuya Hemmi, et al. (+11)
408 [GO] 2022―Dec―16 A broad assessment of covid-19 vaccine safety using tree-based data-mining in the vaccine safety datalink W. Katherine Yih, Matthew F. Daley, Jonathan Duffy, Bruce Fireman, David McClure, Jennifer Nelson, et al. (+7)
409 [GO] 2022―Dec―15 The impact of seasonal influenza vaccination uptake on COVID-19 vaccination attitudes in a rural area in Greece Andria Papazachariou, Constantinos Tsioutis, Theodore Lytras, Onoufrios Malikides, Maria Stamatelatou, Nektaria Vasilaki, et al. (+3)
410 [GO] 2022―Dec―14 Impact of prenatal COVID-19 vaccination on delivery and neonatal outcomes: Results from a New York City cohort Erona Ibroci, Xiaoqin Liu, Whitney Lieb, Rebecca Jessel, Frederieke A.J. Gigase, Kyle Chung, et al. (+19)
411 [GO] 2022―Dec―14 Association Between Caregiver Opposition to Topical Fluoride and COVID-19 Vaccines Sapna J. Saini, Adam C. Carle, Anna R. Forsyth, Donald L. Chi
412 [GO] 2022―Dec―13 Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July-August 2021 Phillip P. Salvatore, Christine C. Lee, Sadia Sleweon, David W. McCormick, Lavinia Nicolae, Kristen Knipe, et al. (+23)
413 [GO] 2022―Dec―13 Cold-adapted SARS-CoV-2 variants with different temperature sensitivity exhibit an attenuated phenotype and confer protective immunity Evgeny Faizuloev, Anastasiia Gracheva, Ekaterina Korchevaya, Daria Smirnova, Roman Samoilikov, Andrey Pankratov, et al. (+8)
414 [GO] 2022―Dec―12 Social cognitive predictors of vaccination status, uptake and mitigation behaviors in the Canadian COVID-19 Experiences Survey Peter A. Hall, Gang Meng, Christian Boudreau, Anna Hudson, Anne C.K. Quah, Thomas Agar, Geoffrey T. Fong
415 [GO] 2022―Dec―12 Patient flow time data of COVID-19 vaccination clinics in 23 sites, United States, April and May 2021 Bo-Hyun Cho, Heba M. Athar, Laurel G. Bates, Benjamin O. Yarnoff, LaTreace Q. Harris, Michael L. Washington, et al. (+2)
416 [GO] 2022―Dec―09 Willingness of Brazilian caregivers in having their children and adolescents vaccinated against Covid-19 Marcio Fernandes Nehab, Karla Gonçalves Camacho, Adriana Teixeira Reis, Maria de Fátima Junqueira-Marinho, Dimitri Marques Abramov, Zina Maria Almeida de Azevedo, et al. (+8)
417 [GO] 2022―Dec―09 Prior Immunization Status of COVID-19 Patients and Disease Severity: A Multicenter Retrospective Cohort Study Assessing the Different Types of Immunity Javaria Aslam, Faisal Shehzad, Muhammad Talha Haris, Hewad Hewadmal, Maryam Khalid, Mohammad Y. Alshahrani, et al. (+3)
418 [GO] 2022―Dec―06 Trusted information sources in the early months of the COVID-19 pandemic predict vaccination uptake over one year later Carl Latkin, Lauren Dayton, Jacob Miller, Evan Eschliman, Jingyan Yang, Amelia Jamison, Xiangrong Kong
419 [GO] 2022―Dec―05 A case-crossover study of the effect of vaccination on SARS-CoV-2 transmission relevant behaviours during a period of national lockdown in England and Wales Aimee Serisier, Sarah Beale, Yamina Boukari, Susan Hoskins, Vincent Nguyen, Thomas Byrne, et al. (+7)
420 [GO] 2022―Dec―02 Menstrual disturbances in 12- to 15-year-old girls after one dose of COVID-19 Comirnaty vaccine: population-based cohort study in Norway Ida Henriette Caspersen, Lene K Juvet, Berit Feiring, Ida Laake, Anna Hayman Robertson, Siri Mjaaland, et al. (+2)
421 [GO] 2022―Dec―02 Inequalities in infant vaccination coverage during the COVID-19 pandemic: a population-based study in Peru Ali Al-kassab-Córdova, Claudia Silva-Perez, Carolina Mendez-Guerra, Lucero Sangster-Carrasco, Iván Arroyave, Báltica Cabieses, Edward Mezones-Holguin
422 [GO] 2022―Dec―02 Exploring key informants’ perceptions of Covid-19 vaccine hesitancy in a disadvantaged urban community in Ireland: emergence of a ‘4Cs’ model Carolyn Ingram, Mark Roe, Vicky Downey, Lauren Phipps, Carla Perrotta
423 [GO] 2022―Dec―02 Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022 Anna Stoliaroff-Pepin, Caroline Peine, Tim Herath, Johannes Lachmann, Delphine Perriat, Achim Dörre, et al. (+25)
424 [GO] 2022―Dec―01 Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older Hui-Lee Wong, Ellen Tworkoski, Cindy Ke Zhou, Mao Hu, Deborah Thompson, Bradley Lufkin, et al. (+10)
425 [GO] 2022―Nov―29 Education level modifies parental hesitancy about COVID-19 vaccinations for their children Shuning Tang, Xin Liu, Yingnan Jia, Hao Chen, Pinpin Zheng, Hua Fu, Qianyi Xiao
426 [GO] 2022―Nov―29 What Attributes Influence Rural Household’s Willingness to Get Vaccinated for COVID-19? Perspectives from Six Chinese Townships Yingying Sun, Shih-Kai Huang, Sudha Arlikatti, Michael K. Lindell
427 [GO] 2022―Nov―25 “I won’t be a guinea pig”: Rethinking public health communication and vaccine hesitancy in the context of COVID-19 S. Michelle Driedger, Gabriela Capurro, Jordan Tustin, Cindy G. Jardine
428 [GO] 2022―Nov―25 What impact does the attitude toward COVID-19 vaccination have on physicians as vaccine providers? A cross sectional study from the German outpatient sector Arno Stöcker, Jan Hoffmann, Laura Mause, Julia Neufeind, Tim Ohnhäuser, Nadine Scholten
429 [GO] 2022―Nov―25 Spirituality is associated with Covid-19 vaccination scepticism Natalia Zarzeczna, Tisa Bertlich, Bojana Većkalov, Bastiaan T. Rutjens
430 [GO] 2022―Nov―24 Tree-based data mining for safety assessment of first COVID-19 BOOSTER doses in the Vaccine Safety Datalink W. Katherine Yih, Matthew F. Daley, Jonathan Duffy, Bruce Fireman, David McClure, Jennifer Nelson, et al. (+7)
431 [GO] 2022―Nov―24 Effect of the third dose of BNT162b2 COVID-19 mRNA vaccine on anti-SARS-CoV-2 antibody levels in healthcare workers Hidenori Tanaka, Junji Mukai, Kenichi Kushibiki, Sayuri Mizushima, Kyoko Maeda, Yuko Fujimoto, et al. (+9)
432 [GO] 2022―Nov―24 The impact of the COVID-19 pandemic on parents’ perceptions and acceptance of routine childhood vaccination in Canada: A national longitudinal study Robin M. Humble, Shannon D. Scott, Eve Dubé, Joanne Olson, Shannon E. MacDonald
433 [GO] 2022―Nov―22 Background rates of 41 Adverse Events of Special Interest for COVID-19 vaccines in 10 European healthcare databases - An ACCESS cohort study C Willame, C Dodd, CE Durán, RJHJ Elbers, R Gini, C Bartolini, et al. (+28)
434 [GO] 2022―Nov―22 Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials Aykut Ozdarendeli, Zafer Sezer, Shaikh Terkis Islam Pavel, Ahmet Inal, Hazel Yetiskin, Busra Kaplan, et al. (+11)
435 [GO] 2022―Nov―21 Assessing the long-stand antibody response induced by COVID-19 vaccines: A study in an educational cohort in San Luis, Argentina Ricardo Javier Elicabe, Matías Nicolás Distel, Brenda Lucila Jofré, Marianela Leporati, Juan Eduardo Silva, José Luis Arias, et al. (+6)
436 [GO] 2022―Nov―18 COVID-19 vaccination coverage in patients with chronic obstructive pulmonary disease - A cross-sectional study in Hungary Monika Fekete, Alpar Horvath, Balazs Santa, Gabor Tomisa, Gergo Szollosi, Zoltan Ungvari, et al. (+4)
437 [GO] 2022―Nov―18 SARS-CoV-2 viral shedding in vaccinated and unvaccinated persons: A case series David W. McCormick, Liesl M. Hagan, Phillip P. Salvatore, Reed Magleby, Christine Lee, Sadia Sleweon, et al. (+19)
438 [GO] 2022―Nov―17 COVID-19 vaccine policy development in a sample of 44 countries- Key findings from a December 2021 survey of National Immunization Technical Advisory Groups (NITAGs) Anna-Lea Kahn, Christoph A Steffen, Louise Henaff, Noni E MacDonald, Christopher Morgan, Ruth Faden, et al. (+2)
439 [GO] 2022―Nov―14 Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study Massimo Fabiani, Alberto Mateo-Urdiales, Chiara Sacco, Maria Cristina Rota, Daniele Petrone, Marco Bressi, et al. (+12)
440 [GO] 2022―Nov―14 COVID-19 vaccine coverage disparities in rural and farm children Jeffrey J. VanWormer, Gabriella Alicea, Bryan P. Weichelt, Richard L. Berg, Maria E. Sundaram
441 [GO] 2022―Nov―14 Misinformation and COVID-19 Vaccine Hesitancy Tara Zimmerman, Kristina Shiroma, Kenneth R Fleischmann, Bo Xie, Chenyan Jia, Nitin Verma, Min Kyung Lee
442 [GO] 2022―Nov―10 COVID-19 vaccine acceptance and its socio-demographic and emotional determinants: a multi-country cross-sectional study A. de Figueiredo, C. Simas, H.J. Larson
443 [GO] 2022―Nov―08 Background Rates of Adverse Events of Special Interest for COVID-19 Vaccine Safety Monitoring in the United States, 2019-2020 Keran Moll, Bradley Lufkin, Kathryn R. Fingar, Cindy Ke Zhou, Ellen Tworkoski, Chianti Shi, et al. (+30)
444 [GO] 2022―Nov―08 Homologous and heterologous booster vaccinations of S-268019-b, a recombinant S protein-based vaccine with a squalene-based adjuvant, enhance neutralization breadth against SARS-CoV-2 Omicron subvariants in cynomolgus macaques Masayuki Hashimoto, Shinpei Aoe, Yusuke Kawazu, Naomi M. Seki, Kumi Hashimoto, Ken Yoshihara, et al. (+3)
445 [GO] 2022―Nov―07 A post-marketing safety assessment of COVID-19 mRNA vaccination for serious adverse outcomes using administrative claims data linked with vaccination registry in a city of Japan Yoshinori Takeuchi, Masao Iwagami, Sachiko Ono, Nobuaki Michihata, Kohei Uemura, Hideo Yasunaga
446 [GO] 2022―Nov―07 Short-term safety of COVID-19 mRNA vaccines with respect to all-cause mortality in the older population in Norway Paz Lopez-Doriga Ruiz, Nina Gunnes, Jon Michael Gran, Øystein Karlstad, Randi Selmer, Jesper Dahl, et al. (+9)
447 [GO] 2022―Nov―07 Occupation, Worker Vulnerability, and COVID-19 Vaccination Uptake: Analysis of the Virus Watch prospective cohort study Sarah Beale, Rachel Burns, Isobel Braithwaite, Thomas Byrne, Wing Lam Erica Fong, Ellen Fragaszy, et al. (+10)
448 [GO] 2022―Nov―07 Demographic disparities in COVID-19 vaccine hesitancy among U.S. adults: Analysis of household pulse survey data from Jul 21 to Oct 11 in 2021 Yan Yan Wu, Wei Zhang
449 [GO] 2022―Nov―07 Parental Intentions to Vaccinate Children against COVID-19: Findings from a U.S. National Survey Rebecca J. Guerin, Arash Naeim, Ryan Baxter-King, Andrea H. Okun, Derek Holliday, Lynn Vavreck
450 [GO] 2022―Nov―07 Frequency and temporal evolution of COVID-19 vaccination rate among oncological patients undergoing 18F-FDG-PET Stephan Skawran, Helen Schiesser, Alexander Maurer, Thomas Sartoretti, Manuel Dittli, Cäcilia Mader, et al. (+4)
451 [GO] 2022―Nov―07 Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia Joshua Osowicki, Hannah J. Morgan, Adele Harris, Hazel J. Clothier, Jim P. Buttery, Lynette Kiers, Nigel W. Crawford
452 [GO] 2022―Nov―04 Perceived Threat and Coping Responses during the COVID-19 Pandemic: Prospective Associations with Vaccine Hesitancy Talia Morstead, Jason Zheng, Nancy L. Sin, Anita DeLongis
453 [GO] 2022―Nov―03 Reactions Following Pfizer-BioNTech COVID-19 mRNA Vaccination and Related Healthcare Encounters Among 7,077 Children Aged 5-11 Years Within an Integrated Healthcare System Deborah E. Malden, Julianne Gee, Sungching Glenn, Zhuoxin Li, Cheryl Mercado, Oluwaseye A Ogun, et al. (+7)
454 [GO] 2022―Nov―01 The impact of the COVID-19 pandemic on vaccine coverage in Kilifi, Kenya: a retrospective cohort study R.K. Lucinde, B. Karia, N. Ouma, D. Amadi, C. Nyundo, C. Mataza, et al. (+4)
455 [GO] 2022―Nov―01 Association Between History of SARS-CoV-2 Infection and Severe Systemic Adverse Events After mRNA COVID-19 Vaccination Among U.S. Adults Lindsay K. Tompkins, James Baggs, Tanya R. Myers, Julianne M. Gee, Paige L. Marquez, Sharon B. Kennedy, et al. (+8)
456 [GO] 2022―Nov―01 Preferences and Willingness of Accepting COVID-19 Vaccine Booster: Results from a Middle-Income Country Chang Chee Tao, Lim Xin Jie, Chew Chii Chii, Philip Rajan, Chan Huan Keat, Muhammad Radzi Abu Hassan, et al. (+2)
457 [GO] 2022―Oct―31 The early evolution of COVID-19 incidence and mortality among people aged under 80 years or 80 years and above after COVID-19 vaccine implementation in the state of Bahia, Brazil Mariana C. Cruz, Cristiana M. Nascimento-Carvalho
458 [GO] 2022―Oct―31 Is vaccine confidence an unexpected victim of the COVID-19 pandemic? Alessandro Siani, Amy Tranter
459 [GO] 2022―Oct―31 “They're trying to bribe you and taking away your freedoms”: COVID-19 vaccine hesitancy in communities with traditionally low vaccination rates Gabriela Capurro, Ryan Maier, Jordan Tustin, Cindy G. Jardine, S. Michelle Driedger
460 [GO] 2022―Oct―31 A socio-ecological exploration to identify factors influencing the COVID-19 vaccine decision-making process among pregnant and lactating women: Findings from Kenya Rupali J. Limaye, Alicia Paul, Rachel Gur-Arie, Eleonor Zavala, Clarice Lee, Berhaun Fesshaye, et al. (+9)
461 [GO] 2022―Oct―31 The role of trust in COVID-19 vaccine hesitancy and acceptance among Black and White Americans Amber Marie Reinhart, Yan Tian, Amanda E. Lilly
462 [GO] 2022―Oct―27 Strategic silences, eroded trust: The impact of divergent COVID-19 vaccine sentiments on healthcare workers' relations with peers and patients Leonardo W Heyerdahl, Stef Dielen, Hélène Dodion, Carla Van Riet, ToTran Nguyen, Clarissa Simas, et al. (+7)
463 [GO] 2022―Oct―26 The resurgence risk of COVID-19 in China in the presence of immunity waning and ADE: a mathematical modelling study Weike Zhou, Biao Tang, Yao Bai, Yiming Shao, Yanni Xiao, Sanyi Tang
464 [GO] 2022―Oct―26 Mandatory COVID-19 vaccination for healthcare personnel in the era of new SARS-CoV-2 variants Helena C. Maltezou, Caterina Ledda, Amandine Gagneux-Brunon, Elisabeth Botelho-Nevers
465 [GO] 2022―Oct―26 Association between COVID-19 vaccination status, time elapsed since the last vaccine dose, morbidity, and absenteeism among healthcare personnel: A prospective, multicenter study Helena C. Maltezou, Maria N. Gamaletsou, Dimitra-Maria Koukou, Theodoros V. Giannouchos, Flora Sourri, Natalia Syrimi, et al. (+9)
466 [GO] 2022―Oct―26 Parental Attitudes in the Pediatric Emergency Department about the COVID-19 Vaccine Jared Schiff, Anita R. Schmidt, Phung K. Pham, Jocelyn B. Pérez, Pia S. Pannaraj, Pradip P. Chaudhari, Danica B. Liberman
467 [GO] 2022―Oct―25 Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipients Anand V Kulkarni, Shashidhar Jaggaiahgari, Sowmya Iyengar, Venu Simhadri, Deepika Gujjarlapudi, Hardik Rugwani, et al. (+8)
468 [GO] 2022―Oct―24 Comparison of Test-Negative and Syndrome-Negative Controls in SARS-CoV-2 Vaccine Effectiveness Evaluations for Preventing COVID-19 Hospitalizations in the United States Caitlin Turbyfill, Katherine Adams, Mark W. Tenforde, Nancy L. Murray, Manjusha Gaglani, Adit A. Ginde, et al. (+48)
469 [GO] 2022―Oct―21 Negative sentiments toward novel coronavirus (COVID-19) vaccines Ruoyan Sun, Henna Budhwani
470 [GO] 2022―Oct―21 Identifying early adopters of COVID-19 vaccines in Latin America Alejandro Arrieta, Ariadna García-Prado, Juan Pablo Sarmiento, Carmen Paz Castro
471 [GO] 2022―Oct―21 The quest for more effective vaccine markets - Opportunities, challenges, and what has changed with the SARS-CoV-2 pandemic Tania Cernuschi, Stefano Malvolti, Shanelle Hall, Luc Debruyne, Hanne Bak Pedersen, Helen Rees, Emer Cooke
472 [GO] 2022―Oct―20 Do the unvaccinated perform more distancing, mask wearing and hand hygiene? A test of the risk compensation hypothesis in a representative sample during the COVID-19 pandemic Peter A. Hall, Gang Meng, Mohammad N. Sakib, Anne C. K. Quah, Thomas Agar, Geoffrey T. Fong
473 [GO] 2022―Oct―20 The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: A cross-sectional sero-epidemiological study Hanqing He, Yao Zhu, Mingjuan Jin, Yang Zhou, Xuewen Tang, Rui Yan, et al. (+2)
474 [GO] 2022―Oct―20 Using narratives to inform the development of a digital health intervention related to COVID-19 vaccination in Black young adults in Georgia, North Carolina and Alabama Marie C.D. Stoner, David Tweedy, Maria G. Leonora Comello, Christina Toval, Audrey E. Pettifor, Margo Adams Larsen, et al. (+8)
475 [GO] 2022―Oct―20 Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants Sebastián Blanco, Lorena Spinsanti, Juan Javier Aguilar, Adrián Diaz, María Elisa Rivarola, Mauricio Beranek, et al. (+4)
476 [GO] 2022―Oct―20 Where are children ages 5-17 years receiving their COVID-19 vaccinations? Variations over time and by sociodemographic characteristics, United States Tammy A. Santibanez, Carla L. Black, Tara M. Vogt, Kevin Chatham-Stephens, Tianyi Zhou, Jessica P. Lendon, James A. Singleton
477 [GO] 2022―Oct―17 Identifying COVID-19 optimal vaccine dose using mathematical Immunostimulation/Immunodynamic Modelling Sophie Rhodes, Neal Smith, Thomas Evans, Richard White
478 [GO] 2022―Oct―17 Measuring the impact of COVID-19 vaccination and immunity waning: a modelling study for Portugal Constantino Caetano, Maria Luísa Morgado, Paula Patrício, Andreia Leite, Ausenda Machado, André Torres, et al. (+5)
479 [GO] 2022―Oct―17 A Retrospective Evaluation of Side-Effects Associated with the Booster Dose of Pfizer-BioNTech/BNT162b2 COVID-19 Vaccine among females in Eastern Province, Saudi Arabia Yousif A. M. Hassan, Mohammad Daud Ali, Rawan Rashad Al-Eid, Fatimah Ali Al Ghuraya, Zainab Essa Alqasimi, Ayaz Ahmad, et al. (+2)
480 [GO] 2022―Oct―17 Evaluating correlates of protection for mix-match vaccine against COVID-19 VOCs with potential of evading immunity Sih-Han Liao, Wei-Jung Chang, Chen-Yang Hsu, Amy Ming-Fang Yen, Ting-Yu Lin, Sam Li-Sheng Chen, Tony Hsiu-Hsi Chen
481 [GO] 2022―Oct―17 COVID-19 vaccine literacy and vaccine hesitancy among pregnant women and mothers of young children in Japan Yoko Takahashi, Kazue Ishitsuka, Makiko Sampei, Sumiyo Okawa, Yoshihiko Hosokawa, Akira Ishiguro, et al. (+2)
482 [GO] 2022―Oct―13 Cognitive predictors of COVID-19 mitigation behaviors in vaccinated and unvaccinated general population members Anna Hudson, Peter A. Hall, Sara C. Hitchman, Gang Meng, Geoffrey T. Fong
483 [GO] 2022―Oct―05 COVID-19 Vaccine Perceptions & Hesitancy amongst Parents of School-aged Children during the Pediatric Vaccine Rollout Alexandra Byrne, Lindsay A. Thompson, Stephanie L. Filipp MPH, Kathleen Ryan
484 [GO] 2022―Oct―04 COVID-19 outbreak in an elderly care home: very low vaccine effectiveness and late impact of booster vaccination campaign Catharina E. van Ewijk, Elizabeth I. Hazelhorst, Susan J. M. Hahné, Mirjam J. Knol
485 [GO] 2022―Oct―03 Modelling optimal vaccination strategies against COVID-19 in a context of Gamma variant predominance in Brazil Leonardo Souto Ferreira, Gabriel Berg de Almeida, Marcelo Eduardo Borges, Lorena Mendes Simon, Silas Poloni, Ângela Maria Bagattini, et al. (+7)
486 [GO] 2022―Oct―03 Trends in HPV vaccine administration and HPV vaccine coverage in children by race/ethnicity and socioeconomic status during the COVID-19 pandemic in an integrated health care system in California Chun R. Chao, Lanfang Xu, Nancy Cannizzaro, David Bronstein, Yunsun Choi, Robert Riewerts, et al. (+7)
487 [GO] 2022―Oct―03 A queueing Network approach for capacity planning and patient Scheduling: A case study for the COVID-19 vaccination process in Colombia Carlos Franco, Nilson Herazo-Padilla, Jaime Andrés Castañeda
488 [GO] 2022―Oct―03 Counselling of non-communicable diseases’ patients for COVID-19 vaccine uptake in Jordan: Evaluating the intervention Ala'a Al-Shaikh, Refqi Ismail Mahmoud, Hala Boukerdenna, Nazeema Muthu, Chinara Aidyralieva, Saverio Bellizzi
489 [GO] 2022―Sep―28 With established safe and effective use, protein vaccines offer another choice against COVID-19 Anthony M. Marchese, Hadi Beyhaghi, Walter A. Orenstein
490 [GO] 2022―Sep―28 Immune response after COVID-19 vaccination among patients with chronic kidney disease and kidney transplant Thananda Trakarnvanich, Tanun Ngamvitchukorn, Uraporn Phumisantiphong, Kittisak Pholtawornkulchai, Krittima Phochanasomboon, Anan Manomaipiboon
491 [GO] 2022―Sep―28 Individual-level factors associated with COVID-19 vaccine acceptance among U.S. patients with cancer Cassandra A. Hathaway, Erin M. Siegel, Brian D. Gonzalez, Laura B. Oswald, Anita R. Peoples, Cornelia M. Ulrich, et al. (+3)
492 [GO] 2022―Sep―28 Relative vaccine effectiveness of the booster dose of COVID-19 vaccine for preventing death in individuals with a primary regimen based on the BBIBP-CorV, ChAdOx1-S, or BNT162b2 vaccines during the Omicron wave in Peru: A nested case-control study using national population data Silva-Valencia Javier, Soto-Becerra Percy, Escobar-Agreda Stefan, Fernandez-Navarro Manuel, Elorreaga-Reyes Oliver Antonio, Mayta-Tristán Percy, et al. (+2)
493 [GO] 2022―Sep―28 An intersectional analysis of sociodemographic disparities in Covid-19 vaccination: a nationwide register-based study in Sweden M. Spetz, L. Lundberg, C. Nwaru, H. Li, A. Santosa, N. Ng, et al. (+5)
494 [GO] 2022―Sep―27 Near Real-Time Surveillance of Safety Outcomes in US COVID-19 Vaccine Recipients aged 12 to 64 years Patricia C. Lloyd, Mao Hu, Hui-Lee Wong, Azadeh Shoaibi, Cindy Ke Zhou, An-Chi Lo, et al. (+21)
495 [GO] 2022―Sep―27 Towards the development of an epitope-focused vaccine for SARS-CoV-2 Jacquelynne Cervantes-Torres, Sergio Rosales, Carlos Cabello, Laura Montero, Juan Hernandez-Aceves, Guillermo Granados, et al. (+38)
496 [GO] 2022―Sep―26 Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation Tingting Deng, Tingting Li, Gege Chen, Yuhe Zhu, Lang Xu, Yanlin Lin, et al. (+18)
497 [GO] 2022―Sep―26 Prayer frequency and COVID-19 vaccine hesitancy among older adults in Europe Christian Tolstrup Wester, Lasse Lybecker Scheel-Hincke, Tine Bovil, Karen Andersen-Ranberg, Linda Juel Ahrenfeldt, Niels Christian Hvidt
498 [GO] 2022―Sep―23 Parental health beliefs, intention, and strategies about covid-19 vaccine for their children: A cross-sectional analysis from five Arab countries in the Middle East Ali Haider Mohammed, Bassam Abdul Rasool Hassan, Abdulrasool M. Wayyes, Ansam Qassim Gadhban, Ali Blebil, Sara Abu Alhija, et al. (+8)
499 [GO] 2022―Sep―22 Misinformation about vaccine safety and uptake of COVID-19 vaccines among adults and 5-11-year-olds in the United States Daniel Romer, Kenneth M. Winneg, Patrick E. Jamieson, Colleen Brensinger, Kathleen H. Jamieson
500 [GO] 2022―Sep―21 Association between Social Vulnerability and COVID-19 Vaccination Hesitancy and Vaccination in Pregnant and Postpartum Individuals Miranda K Kiefer, Rebecca Mehl, Kara M Rood, Katherine Germann, Divya Mallampati, Tracy Manuck, et al. (+4)
501 [GO] 2022―Sep―21 Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection Bette Liu, Heather Gidding, Sandrine Stepien, Michelle Cretikos, Kristine Macartney
502 [GO] 2022―Sep―20 The intersection of gender and race in older adults’ decision to receive COVID-19 vaccines Janna R. Shapiro, Lois Privor-Dumm, Erica N. Rosser, Sean X. Leng, Sabra L. Klein, Rosemary Morgan
503 [GO] 2022―Sep―19 Protection of vaccination versus hybrid immunity against infection with COVID-19 Omicron variants among Health-Care Workers Fotinie Ntziora, Evangelia Georgia Kostaki, Amalia Karapanou, Maria Mylona, Ioulia Tseti, Nikolaos V. Sipsas, et al. (+2)
504 [GO] 2022―Sep―14 COVID-19 vaccine hesitancy among Israeli adults before and after vaccines’ availability: a cross-sectional national survey Dvora Frankenthal, Miri Zatlawi, Ziv Karni-Efrati, Lital Keinan-Boker, Osnat Luxenburg, Michal Bromberg
505 [GO] 2022―Sep―13 Impact of the COVID-19 pandemic on uptake of immunization services in rural Gambia Isaac Osei, Golam Sarwar, Ilias Hossain, Kemo Sonko, Lamin Ceesay, B뫊rr Baldeh, et al. (+2)
506 [GO] 2022―Sep―12 Vaccine-induced seroconversion in participants in the North Carolina COVID-19 Community Research Partnership DeAnna J. Friedman-Klabanoff, Ashley H. Tjaden, Michele Santacatterina, Iqra Munawar, John W. Sanders, David M. Herrington, et al. (+2)
507 [GO] 2022―Sep―12 Declining Influenza Vaccines in an Underserved Primary Care Center in the COVID-19 Pandemic Melissa E. Day, Melissa Klein, Heidi Sucharew, Mary Carol Burkhardt, Allison Reyner, Destiney Giles, et al. (+2)
508 [GO] 2022―Sep―12 The connection between COVID-19 vaccine abundance, vaccination coverage, and public trust in government across the globe Ida G. Monfared
509 [GO] 2022―Sep―12 The impact of COVID-19 vaccines on fertility-A systematic review and metanalysis D. Zaçe, E. La Gatta, L. Petrella, M.L. Di Pietro
510 [GO] 2022―Sep―12 Strategies to increase the intention to get vaccinated against COVID-19: Findings from a nationally representative survey of US adults, October 2020 to October 2021 Arash Naeim, Rebecca J. Guerin, Ryan Baxter-King, Andrea H. Okun, Neil Wenger, Karen Sepucha, et al. (+5)
511 [GO] 2022―Sep―08 Supply, then demand? Health expenditure, political leanings, cost obstacles to care, and vaccine hesitancy predict state-level COVID-19 vaccination rates Joshua Teperowski Monrad, Sebastian Q꫞, Timothy Powell-Jackson
512 [GO] 2022―Sep―08 A Research and Development (R&D) Roadmap for Broadly Protective Coronavirus Vaccines: Setting a Path to Address Coronavirus Threats Kristine A. Moore, Michael T. Osterholm, Eve M. Lackritz, Gregory A. Poland
513 [GO] 2022―Sep―07 Covid-19 Vaccine Hesitancy and Resistance Amongst Parents of Children Under 18 Years of Age in Ireland Ruth Ceannt, Frederique Vallieres, Heather Burns, Jamie Murphy, Philip Hyland
514 [GO] 2022―Sep―06 How health workers can make a difference in the public COVID-19 vaccination response Katrine B Habersaat, Sideeka Narayan, Siff Malue Nielsen, Martha Scherzer, Cristiana Salvi, Holly Seale
515 [GO] 2022―Sep―06 SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients Quentin Perrier, Julien Lupob, Théophile Gerster, Caroline Augier, Loïc Falque, Lionel Rostaing, et al. (+8)
516 [GO] 2022―Sep―06 Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus Chi Chiu Mok, Kar Li Chan, Sau Mei Tse
517 [GO] 2022―Aug―31 Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults Joseph Fraiman, Juan Erviti, Mark Jones, Sander Greenland, Patrick Whelan, Robert M. Kaplan, Peter Doshi
518 [GO] 2022―Aug―31 Development and validation of a COVID-19 vaccine hesitancy scale for adults in the United States Matthew L. Hrin, Veronica K. Emmerich, Edward H. Ip, Steven R. Feldman
519 [GO] 2022―Aug―30 Can financial incentives and other nudges increase COVID-19 vaccinations among the vaccine hesitant? A randomized trial Mireille Jacobson, Tom Y. Chang, Manisha Shah, Rajiv Pramanik, Samir B. Shah
520 [GO] 2022―Aug―30 Permissive omicron breakthrough infections in individuals with binding or neutralizing antibodies to ancestral sars-cov-2 Erin Williams, Jordan Colson, Ranjini Valiathan, Juan Manuel Carreño, Florian Krammer, Michael Hoffer, et al. (+3)
521 [GO] 2022―Aug―29 COVID-19 vaccine hesitancy among health care worker-parents (HCWP) in Puducherry, India and its implications on their children: a cross sectional descriptive study Pratik Sarkar, Venkatesh Chandrasekaran, Dhandapany Gunasekaran, Palanivel Chinnakali
522 [GO] 2022―Aug―29 Side effects during the week after first dose vaccination with four Covid-19 vaccines. Results of the ProVaVac Survey Study with 13,837 people in Spain Francisco Sánchez-Saez, Salvador Peiró, Llanos Cuenca-Gonzalez, Hermelinda Vanaclocha, Ramón Limón, Dolores Salas, et al. (+9)
523 [GO] 2022―Aug―29 Intranasal immunization with recombinant Vaccinia virus encoding trimeric SARS-CoV-2 spike receptor-binding domain induces neutralizing antibody Xiaoling Cao, Junjie Zai, Qingzhen Zhao, Lilan Xie, Yaoming Li
524 [GO] 2022―Aug―26 Strengthened belief in vaccine effectiveness predicted increased COVID-19 vaccination intention and behaviour: Results from a nationally representative longitudinal survey of U.S. adults from July 2020 to April/May 2021 Ava Kikut, Danielle Clark, Emma Jesch, Robert Hornik
525 [GO] 2022―Aug―26 Determinants of COVID-19 vaccine hesitancy and resistance in Russia Yana Roshchina, Sergey Roshchin, Ksenia Rozhkova
526 [GO] 2022―Aug―26 Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology Takuya Hemmi, Akira Ainai, Takao Hashiguchi, Minoru Tobiume, Takayuki Kanno, Naoko Iwata-Yoshikawa, et al. (+12)
527 [GO] 2022―Aug―26 Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection Maria Teresa Vietri, Giovanna D'Elia, Gemma Caliendo, Luana Passariello, Luisa Albanese, Anna Maria Molinari, Italo Francesco Angelillo
528 [GO] 2022―Aug―25 Vasovagal reactions after COVID-19 vaccination in Japan Mai Okuyama, Saeko Morino, Kaori Tanaka, Haruna Nakamura-Miwa, Sayaka Takanashi, Satoru Arai, et al. (+6)
529 [GO] 2022―Aug―22 Advanced vaccinology training globally: Update and impact of the COVID-19 crisis Carine Dochez, Philippe Duclos, Noni MacDonald, Christoph Steffen, Paul-Henri Lambert
530 [GO] 2022―Aug―22 The impact of a vaccine mandate and the COVID-19 pandemic on influenza vaccination uptake in Western Australian health care students G.A. Willis, L. Bloomfield, M. Berry, C. Bulsara, M. Bulsara, G. Chaney, et al. (+5)
531 [GO] 2022―Aug―22 No Significant Increase in Guillain-Barré Syndrome after COVID-19 Vaccination in Adults: A Vaccine Adverse Event Reporting System Study M. Jaffry, F. Mostafa, K. Mandava, S. Rosario, Y. Jagarlamudi, K. Jaffry, et al. (+4)
532 [GO] 2022―Aug―22 Short-term mortality following COVID-19 vaccination in Bologna, Italy: a one-year study Elisa Stivanello, Chiara Beghelli, Francesco Cardoni, Chiara Giansante, Paolo Marzaroli, Muriel Assunta Musti, et al. (+3)
533 [GO] 2022―Aug―22 Views on COVID-19 vaccination of young children in Ireland, results from a cross-sectional survey of parents Louise Marron, Annamaria Ferenczi, Katie M O'Brien, Suzanne Cotter, Lucy Jessop, Yvonne Morrissey, Chantal Migone
534 [GO] 2022―Aug―22 Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine Sitthichai Kanokudom, Suvichada Assawakosri, Nungruthai Suntronwong, Jira Chansaenroj, Chompoonut Auphimai, Pornjarim Nilyanimit, et al. (+14)
535 [GO] 2022―Aug―22 Safety of the Fiocruz ChAdOx COVID-19 vaccine used in a mass vaccination campaign in Botucatu, Brazil Sue Ann Costa Clemens, Carlos Magno Castelo Branco Fortaleza, Madeleine Crowe, Andrew Pollard, Karen Ingrid Tasca, Rejane Maria Tommasini Grotto, et al. (+5)
536 [GO] 2022―Aug―22 Safety, immunogenicity, and immune persistence of two inactivated COVID-19 vaccines replacement vaccination in China: an observational cohort study Xiaoqi Wang, Yao Deng, Li Zhao, Lei Wang, Zhenwang Fu, Lin Tang, et al. (+13)
537 [GO] 2022―Aug―22 Antibody titers among healthcare workers for coronavirus disease 2019 at 6 months after BNT162b2 vaccination Kazuyoshi Kurashima, Tsuyoshi Numano, Atsuki Yoshino, Akiko Osawa, Yotaro Takaku, Naho Kagiyama, Tsutomu Yanagisawa
538 [GO] 2022―Aug―22 Humoral response to different SARS-CoV-2 vaccines in orthotopic liver transplant recipients Liz Toapanta-Yanchapaxi, Erwin Chiquete, Esmeralda Ávila-Rojo, Silvia López-Yánez, Sonia Luna del Villar Velasco, Sergio Rivera Monroy, et al. (+19)
539 [GO] 2022―Aug―19 Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associations Michael A Laffan, Sue Rees, Madhavi Yadavalli, Lisa Beth Ferstenberg, Nirmal Kumar Shankar, Jennie Medin, et al. (+5)
540 [GO] 2022―Aug―19 Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infection Loukia Psaridi, Helena C. Maltezou, Sofia Simonidou, Ioanna Lialliou, Despina Athanasopoulou, Zoi Haila, et al. (+8)
541 [GO] 2022―Aug―18 Challenges, Best Practices, and Lessons Learned from Cholera Mass vaccination campaign in Urban Cameroon during COVID-19 era Adidja AMANI, Solange NGO BAMA, Mariette DIA, Skinner NGUEFACK LEKELEM, Abdou LINJOUOM, Hans MOSSI MAKEMBE, et al. (+5)
542 [GO] 2022―Aug―18 Stamping the vaccine passport? Public support for lifting COVID-19 related restrictions for vaccinated citizens in France, Germany, and Sweden Florian Stoeckel, Sabrina Stöckli, Joseph Phillips, Benjamin Lyons, Vittorio Mérola, Matthew Barnfield, et al. (+3)
543 [GO] 2022―Aug―15 People’s perspectives about COVID-19 vaccination certificate: Findings from a representative Italian sample Marta Caserotti, Teresa Gavaruzzi, Paolo Girardi, Roberta Sellaro, Enrico Rubaltelli, Alessandra Tasso, Lorella Lotto
544 [GO] 2022―Aug―15 Parents’ views on the acceptability of a COVID-19 vaccine for their children: A cross-sectional study in Abu Dhabi-United Arab Emirates Latifa Mohammad Baynouna AlKetbi, Farida Al Hosani, Shammah Al Memari, Shereena Al Mazrouei, Badreyya Al Shehhi, Noura AlShamsi, et al. (+4)
545 [GO] 2022―Aug―15 A Historical Analysis of Vaccine Mandates in the United States Military and Its Application to the COVID-19 Vaccine Mandate Capt Brian P. Elliott, Col Steven Chambers
546 [GO] 2022―Aug―15 Reminders of existing vaccine mandates increase support for a COVID-19 vaccine mandate: Evidence from a survey experiment Filip Viskupič, David L. Wiltse, Abdallah Badahdah
547 [GO] 2022―Aug―08 COVID-19 vaccine hesitancy cannot fully explain disparities in vaccination coverage across the contiguous United States Songhua Hu, Chenfeng Xiong, Qingchen Li, Zitong Wang, Yuan Jiang
548 [GO] 2022―Aug―05 A Behavior Change Model to Address Caregiver Hesitancy around COVID-19 Vaccination in Pediatrics Jordan Yeo, Caitlyn Furr Gudmundsen, Sajjad Fazel, Alex Corrigan, Madison M. Fullerton, Jia Hu, et al. (+4)
549 [GO] 2022―Aug―05 COVID-19 vaccine confidence and reasons for vaccination among health care workers and household members Angela K Ulrich, Grace K Pankratz, Bruno Bohn, Stephanie Yendell, Timothy J Beebe, Craig W Hedberg, Ryan T Demmer
550 [GO] 2022―Aug―05 Unravelling the drivers behind COVID-19 vaccination hesitancy and refusal among teachers: A nationwide study Marta Estrela, Tânia Magalhães Silva, Vítor Roque, Eva Rebelo Gomes, Adolfo Figueiras, Fátima Roque, Maria Teresa Herdeiro
551 [GO] 2022―Aug―03 Response to mRNA COVID-19 vaccination in three XLA patients J.D. Squire, A.Y. Joshi
552 [GO] 2022―Aug―03 Crowdfunding narratives and the valuation of vaccines for COVID-19 Jeremy Snyder, Maya Goldenberg, Valorie A. Crooks, Rachel Katz
553 [GO] 2022―Aug―02 COVID-19 Vaccine Uptake Among Arkansas Public K-12 School Teachers and Staff Michael J. Cima, Donald McCormick, Austin Porter, Namvar Zohoori, Scott Alsbrook, José R. Romero
554 [GO] 2022―Aug―01 Should COVID-19 Vaccines Be Mandated in Schools? - An International Caregiver Perspective Shannon H. Baumer-Mouradian, Rebecca J. Hart, Jeffrey N. Bone, Michelle Seiler, Prasra Olson, Kristina Keitel, et al. (+17)
555 [GO] 2022―Aug―01 Longitudinal determination of BNT162b2 vaccine induced strongly binding SARS-CoV-2 IgG antibodies in a cohort of Romanian healthcare workers Mónika Korodi, István Horváth, Kinga Rákosi, Zsuzsanna Jenei, Gabriella Hudák, Melinda Kákes, et al. (+14)
556 [GO] 2022―Jul―30 Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: a multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial Haiping Chen, Zhuoying Huang, Shaoying Chang, Mei Hu, Qingbin Lu, Yuntao Zhang, et al. (+20)
557 [GO] 2022―Jul―28 COVID-19 vaccinations in German pharmacies: A survey on patient and provider satisfaction Olaf Rose, Susanne Erzkamp, Wiebke Schöbel, Marcia Grajeda, Juliane Köberlein-Neu
558 [GO] 2022―Jul―26 Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation Philip R Krause, Narendra Arora, William Dowling, César Muñoz-Fontela, Simon Funnell, Rogerio Gaspar, et al. (+7)
559 [GO] 2022―Jul―26 Safety and Immunogenicity of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: a randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China Wang Shenyu, Duan Xiaoqian, Chen Bo, Deng Xuan, Wang Zeng, Zhang Hangjie, et al. (+6)
560 [GO] 2022―Jul―18 COVID-19 Vaccine Express strategy in Malawi: An effort to Reach the Un-Reach Ghanashyam Sethy, Mike Chisema, Lokesh Sharma, Krupal Joshi, Sanjay Singhal, Patrick Omar Nicks, et al. (+7)
561 [GO] 2022―Jul―18 Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern Christopher L.D. McMillan, Alberto A. Amarilla, Naphak Modhiran, Jovin J.Y. Choo, Armira Azuar, Kate Honeyman, et al. (+4)
562 [GO] 2022―Jul―13 COVID-19 vaccination intention and activation among health care system employees: A mixed methods study Lavanya Vasudevan, Rebecca Bruening, Anna Hung, Sandra Woolson, Adrian Brown, Susan N. Hastings, et al. (+7)
563 [GO] 2022―Jul―12 Risk of Myocarditis and Pericarditis Following BNT162b2 and mRNA-1273 COVID-19 Vaccination Kristin Goddard, Ned Lewis, Bruce Fireman, Eric Weintraub, Tom Shimabukuro, Ousseny Zerbo, et al. (+13)
564 [GO] 2022―Jul―12 COVID-19 vaccination in pregnant women in Sweden and Norway Anne K. Örtqvist, Elisabeth Dahlqwist, Maria C. Magnus, Rickard Ljung, Jerker Jonsson, Bernice Aronsson, et al. (+3)
565 [GO] 2022―Jul―12 Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults Frances H. Priddy, Michael Williams, Simon Carson, Brittany Lavender, Julia Mathieson, Chris Frampton, et al. (+7)
566 [GO] 2022―Jul―11 Humoral and cellular responses to SARS-CoV-2 BNT162b2 vaccination in allogeneic hematopoietic stem cell transplantation recipients Alexis Cuffel, Sarah Maylin, Helene Le Buanec, Constance Delaugerre, Marine Minier, David Bergerat, et al. (+8)
567 [GO] 2022―Jul―06 Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental challenge infection in hamsters Rik L. de Swart, Olav S. de Leeuw, Nadia Oreshkova, Nora M. Gerhards, Irina C. Albulescu, Sandra Vreman, et al. (+6)
568 [GO] 2022―Jul―04 The impact of the COVID-19 pandemic on hepatitis B virus vaccination and transmission among men who have sex with men: a mathematical modelling study Maria Xiridou, Philippe Adam, Annemarie Meiberg, Maartje Visser, Amy Matser, John de Wit, Eline Op de Coul
569 [GO] 2022―Jul―04 SARS-CoV-2 infection risk among vaccinated and unvaccinated household members during the Alpha variant surge - Denver, Colorado, and San Diego, California, January-April 2021 David W. McCormick, Stacey L. Konkle, Reed Magleby, Ayan K. Chakrabarti, Blake Cherney, Kristine Lindell, et al. (+30)
570 [GO] 2022―Jul―01 Women's views and experiences of accessing pertussis vaccination in pregnancy and infant vaccinations during the COVID-19 pandemic: A multi-methods study in the UK Helen Skirrow, Sara Barnett, Sadie Bell, Sandra Mounier-Jack, Beate Kampmann, Beth Holder
571 [GO] 2022―Jul―01 Hesitancy to receive the novel coronavirus vaccine and potential influences on vaccination among a cohort of healthcare workers in the Democratic Republic of the Congo Angelica Barrall, Nicole A. Hoff, Dalau Mukadi Nkamba, Kamy Musene, Nick Ida, Anna Bratcher, et al. (+12)
572 [GO] 2022―Jun―29 The effect of needle length and skin to deltoid muscle distance in adults receiving an mRNA COVID-19 vaccine Thomas Hills, Aimee Paterson, Rebecca Woodward, Francis Middleton, Lauren H. Carlton, Reuben McGregor, et al. (+18)
573 [GO] 2022―Jun―27 The impact of personal coaching on influenza vaccination among healthcare workers before and during COVID-19 pandemic Shuk-Ching Wong, Veronica Wing-Man Chan, Germaine Kit-Ming Lam, Lithia Lai-Ha Yuen, Christine Ho-Yan AuYeung, Xin Li FRCPath, et al. (+4)
574 [GO] 2022―Jun―27 Employer Requirements and COVID-19 Vaccination and Attitudes among Healthcare Personnel in the U.S.: Findings from National Immunization Survey Adult COVID Module, August - September 2021 James T. Lee, S. Sean Hu, Tianyi Zhou, Kim Bonner, Jennifer L. Kriss, Elisabeth Wilhelm, et al. (+7)
575 [GO] 2022―Jun―27 Vaccine innovation model: A technology transfer perspective in pandemic contexts Maurício Z. Medeiros, Priscila F. Soares, Beatriz C. Fialho, Leandro Gauss, Fábio S. Piran, Daniel P. Lacerda
576 [GO] 2022―Jun―24 Artificial intelligence and clinical data suggest the T cell mediated SARS-CoV-2 nonstructural protein intranasal vaccines for global COVID-19 immunity Murat Seyran
577 [GO] 2022―Jun―24 COVID-19 Vaccine Safety monitoring in low and middle income countries - Time for a bold new approach Walter Straus, Harvey Rubin
578 [GO] 2022―Jun―24 Considerations for the Chemistry, Manufacturing and Controls (CMC) - quality package for COVID-19 vaccines- interim lessons learnt by the European medicines Agency (EMA) Ragini Shivji, Roberto Conocchia, Evdokia Korakianiti, Veronika Jekerle
579 [GO] 2022―Jun―23 COVID-19 differentiated measures for unvaccinated individuals: The need for clear goals and strong justifications Teck Chuan Voo, Julian Savulescu, Owen Schaefer, Abel Ho Zhi Ling, Clarence C. Tam
580 [GO] 2022―Jun―23 A national survey of COVID-19 vaccine acceptance in Nigeria Ahmad Ibrahim Al-Mustapha, Ochulor Okechukwu, Ademola Olayinka, Oyeniyi Rasheed Muhammed, Muftau Oyewo, Samuel A. Owoicho, et al. (+8)
581 [GO] 2022―Jun―23 Relationship between double covid-19 vaccine uptake and trust in effectiveness and safety of vaccination in 23 european member states: an ecological study Àurea Cartanyà-Hueso, Jose M Martínez-Sánchez, Juan Carlos Martín-Sánchez, Cristina Lidón-Moyano, Hipólito Pérez-Martín, Adrián González-Marrón
582 [GO] 2022―Jun―21 Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis Caroline Korves, Hector S. Izurieta, Jeremy Smith, Gabrielle M. Zwain, Ethan I. Powell, Abirami Balajee, et al. (+2)
583 [GO] 2022―Jun―20 BCG vaccine safety in COVID-19 convalescent adults: BATTLE a randomized controlled trial Franciele A.V. Dionato, Mehrsa Jalalizadeh, Keini Buosi, Marília B. Visacri, Luciana S.B. Dal Col, Cristiane F. Giacomelli, et al. (+4)
584 [GO] 2022―Jun―16 Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil Patricia Mouta Nunes de Oliveira, Daniela P. Mendes-de-Almeida, Victor Bertollo Gomes Porto, Catherine Crespo Cordeiro, Gabriellen Vitiello Teixeira, Renata Saraiva Pedro, et al. (+15)
585 [GO] 2022―Jun―15 Estimating the number of US children susceptible to measles resulting from COVID-19-related vaccination coverage declines Ashley Gambrell, Maria Sundaram, Robert A. Bednarczyk
586 [GO] 2022―Jun―15 Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine design Rima Moghnieh, Dania Abdallah, Mohamed H. Sayegh, Abdul Rahman Bizri
587 [GO] 2022―Jun―15 Immunophenotyping of SARS-CoV-2 and vaccine design Nevio Cimolai
588 [GO] 2022―Jun―13 COVID-19 vaccination coverage and intent among women aged 18-49 years by pregnancy status, United States, April-November 2021 Hilda Razzaghi, David Yankey, Kushagra Vashist, Peng-jun Lu, Jennifer L. Kriss, Kimberly H Nguyen, et al. (+8)
589 [GO] 2022―Jun―13 RelCoVax®, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice Abhishek Phatarphekar, G.E.C. Vidyadhar Reddy, Abhiram Gokhale, Gopala Karanam, Pushpa Kuchroo, Ketaki Shinde, et al. (+10)
590 [GO] 2022―Jun―09 A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273) Brett Leav, Walter Straus, Phil White, Alison Leav, Tashawnee Gaines, Grace Maggiacomo, et al. (+4)
591 [GO] 2022―Jun―08 The effect of health literacy on COVID-19 vaccine hesitancy among community population in China: The moderating role of stress Huiqiao Zhang, Yue Li, Sihui Peng, Yue Jiang, Huihui Jin, Fan Zhang
592 [GO] 2022―Jun―08 Safety and Protective Capability of an Inactivated SARS-CoV-2 Vaccine on Pregnancy, Lactation and the Growth of offspring in hACE2 Mice Kaili Lin, Meixuan Liu, Linlin Bao, Qi Lv, Hua Zhu, Dan Li, et al. (+17)
593 [GO] 2022―Jun―08 Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands: a test-negative case-control study F.A. Niessen, J. Mirjam Knol, J.M. Susan Hahné, VECTOR study group, M.J.M. Bonten, P.C.J.L. Bruijning-Verhagen
594 [GO] 2022―Jun―08 Shoulder Injury Related to Vaccine Administration (SIRVA) After COVID-19 Vaccination Jessica R. Bass, Gregory A. Poland
595 [GO] 2022―Jun―08 Corowa-kun: A messenger app chatbot delivers COVID-19 vaccine information, Japan 2021 Takaaki Kobayashi, Yuka Nishina, Hana Tomoi, Ko Harada, Kyuto Tanaka, Eiyu Matsumoto, et al. (+8)
596 [GO] 2022―Jun―07 The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study Elke Wynberg, Alvin X. Han, Anders Boyd, Hugo D.G. van Willigen, Anouk Verveen, Romy Lebbink, et al. (+8)
597 [GO] 2022―Jun―07 Safety of COVID-19 vaccination and acute neurological events: a self-controlled case series in England using the OpenSAFELY platform Jemma L Walker, Anna Schultze, John Tazare, Arina Tamborska, Bhagteshwar Singh, Katherine Donegan, et al. (+31)
598 [GO] 2022―Jun―06 A socio-ecological perspective on parents’ intention to vaccinate their children against COVID-19 Lauren Dayton, Jacob Miller, Justin Strickland, Melissa Davey-Rothwell, Carl Latkin
599 [GO] 2022―Jun―06 Induced humoral immunity of different types of vaccines against most common variants of SARS-CoV-2 in Egypt prior to Omicron outbreak Rabeh El-Shesheny, Ahmed El Taweel, Mokhtar R. Gomaa, Wael H. Roshdy, Ahmed Kandeil, Richard J. Webby, et al. (+2)
600 [GO] 2022―Jun―06 Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys Masayuki Hashimoto, Noriyo Nagata, Tomoyuki Homma, Hiroki Maeda, Keiji Dohi, Naomi M. Seki, et al. (+14)
601 [GO] 2022―Jun―06 Preclinical Evaluation of a Plant-derived SARS-CoV-2 Subunit Vaccine: Protective Efficacy, Immunogenicity, Safety, and Toxicity Balamurugan Shanmugaraj, Narach Khorattanakulchai, Chalisa Panapitakkul, Ashwini Malla, Rawiwan Im-erbsin, Manutsanun Inthawong, et al. (+13)
602 [GO] 2022―Jun―03 A “step too far” or “perfect sense”? A qualitative study of British adults’ views on mandating COVID-19 vaccination and vaccine passports Martine Stead, Allison Ford, Douglas Eadie, Hannah Biggs, Claire Elliott, Michael Ussher, et al. (+6)
603 [GO] 2022―May―30 COVID-19 IMPACT ON ROUTINE IMMUNISATIONS FOR VACCINE-PREVENTABLE DISEASES: PROJECTING THE EFFECT OF DIFFERENT ROUTES TO RECOVERY Jaspreet Toor, Xiang Li, Mark Jit, L. Caroline Trotter, Susy Echeverria-Londono, Anna-Maria Hartner, et al. (+5)
604 [GO] 2022―May―30 COVID-19 management landscape- A need for an affordable to manufacture safe and efficacious bio-therapeutic and prophylactic for developing countries Vyankatesh Pidiyar, Ganesh Kumraj, Kafil Ahmed, Syed Ahmed, Sanket Shah, Bhawna Verma, et al. (+2)
605 [GO] 2022―May―30 Comparative Effectiveness of Mandates and Financial Policies Targeting COVID-19 Vaccine Hesitancy: A Randomized, Controlled Survey Experiment Jessica Fishman, Mandy K. Salmon, Daniel Scheitrum, K. Aleks Schaefer, Christopher T. Robertson
606 [GO] 2022―May―30 Thrombocytopenia after Ad.26.COV2.S COVID-19 vaccine: reports to the Vaccine Adverse Event Reporting System Emily Jane Woo, Rositsa B. Dimova
607 [GO] 2022―May―30 Nanomedicine to deliver biological macromolecules for treating COVID-19 Barnabas Wilson, Kannoth Mukundan Geetha
608 [GO] 2022―May―30 Utilizing Google trends to monitor coronavirus vaccine interest and hesitancies Emily Merrick, Joshua P. Weissman, Sameer J. Patel
609 [GO] 2022―May―27 Relationship Between the Use of Nonpharmaceutical Interventions and COVID-19 Vaccination Among U.S. Child Care Providers: A Prospective Cohort Study Kavin M. Patel, Mehr Shafiq, Amyn A. Malik, Ayse Cobanoglu, Madeline Klotz, John Eric Humphries, et al. (+10)
610 [GO] 2022―May―27 Benefit-Risk Evaluation of COVID-19 Vaccination in Special Population Groups of Interest Paul Moss, Francis Berenbaum, Giuseppe Curigliano, Ayelet Grupper, Thomas Berg, Shanti Pather
611 [GO] 2022―May―27 Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2 Gatot Soegiarto, Laksmi Wulandari, Dewajani Purnomosari, Karin Dhia Fahmita, Hendra Ikhwan Gautama, Satrio Tri Hadmoko, et al. (+20)
612 [GO] 2022―May―27 Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines Charlotte Dubé, Sarah Paris-Robidas, Guadalupe Andreani, Cindy Gutzeit, Marc-André D'Aoust, Brian J. Ward, Sonia Trépanier
613 [GO] 2022―May―27 COVID-19 and seasonal flu vaccination hesitancy: Links to personality and general intelligence in a large, UK cohort Isaac N. Halstead, Ryan T. McKay, Gary J. Lewis
614 [GO] 2022―May―25 Between persuasion and compulsion: The case of COVID-19 vaccination in Canada Eve Dubé, Dominique Gagnon, Noni MacDonald
615 [GO] 2022―May―25 Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: a Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines Natalia Abraham, Sarah Spruin, Tanya Rossi, Bruce Fireman, Joseline Zafack, Christine Blaser, et al. (+3)
616 [GO] 2022―May―20 A log-odds system for waning and boosting of COVID-19 vaccine effectiveness Joshua Szanyi, Tim Wilson, Nick Scott, Tony Blakely
617 [GO] 2022―May―19 Risk-based cost-benefit analysis of alternative vaccines against COVID-19 in Brazil: Coronavac vs. Astrazeneca vs. Pfizer Paulo Gabriel Siqueira, Heitor Oliveira Duarte, Márcio das Chagas Moura
618 [GO] 2022―May―19 Jabbing together? The complementarity between social capital, formal public health rules, and COVID-19 vaccine rates in the United States Byron Carson, Justin Isaacs, Tony Carilli
619 [GO] 2022―May―17 Parental socioeconomic and psychological determinants of the 2009 pandemic influenza A(H1N1) vaccine uptake in children Krista Salo-Tuominen, Tamara Teros-Jaakkola, Laura Toivonen, Helena Ollila, Päivi Rautava, Minna Aromaa, et al. (+3)
620 [GO] 2022―May―16 Experimental pre-tests of public health communications on the COVID-19 vaccine: A null finding for medical endorsement, risk and altruism Deirdre A. Robertson, Kieran S. Mohr, Martina Barjaková, Peter D. Lunn
621 [GO] 2022―May―14 Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam Anh Duc Dang, Thiem Dinh Vu, Ha Hai Vu, Van Thanh Ta, Anh Thi Van Pham, Mai Thi Ngoc Dang, et al. (+27)
622 [GO] 2022―May―14 Effects of vaccination status in the United States on willingness to undergo surgery during a pandemic: A prospective survey study Anna Clebone Ruskin, Stephen Rice, Michael O'Connor, Keith J. Ruskin
623 [GO] 2022―May―13 Catch-up vaccination campaign in children between 6 and 8 years old during COVID-19 pandemic: The experience in a COVID hub in Milan, Italy Matteo Mancarella, Federica Natarelli, Caterina Bertolini, Antonino Zagari, Maria Enrica Bettinelli, Silvana Castaldi
624 [GO] 2022―May―13 Phase 1/2 Clinical Trial of COVID-19 Vaccine in Japanese Participants: A Report of Interim Findings Satoshi Iwata, Takuhiro Sonoyama, Akari Kamitani, Risa Shibata, Tomoyuki Homma, Shinya Omoto, et al. (+2)
625 [GO] 2022―May―13 COVID-19 vaccine uptake and its associated factors among Palestinian healthcare workers: Expectations beaten by reality Walaa Abu Alia, Beesan Maraq, Zaher Nazzal, Mahmoud Odeh, Rabee Makhalfa, Ali Nassif, Mousa Aabed
626 [GO] 2022―May―12 Safety of Pfizer-BioNTech vaccine in a cohort of healthcare providers: differences between naïve and previously infected by SARS-CoV-2 Andrea Chong-Valbuena, Isabel De-Jesús-María, Adriana Agurto-Ramírez, Francesc Puchades-Gimeno, Mercedes Melero-García
627 [GO] 2022―May―11 Acceptability of COVID-19 vaccine mandates among New York City parents, November 2021 Chloe A. Teasdale, Scott Ratzan, Hannah Stuart Lathan, Lauren Rauh, Spencer Kimball, Ayman El-Mohandes
628 [GO] 2022―May―11 Decay of anti-Bordetella pertussis antibodies in women of childbearing age following COVID-19 non-pharmaceutical measures Frederic Reicherz, Liam Golding, Pascal M Lavoie, Bahaa Abu-Raya
629 [GO] 2022―May―08 Impact of National Covid-19 Vaccination Campaign, South Korea Seonju Yi, Young June Choe, Do Sang Lim, Hye Roen Lee, Jia Kim, Yoo-Yeon Kim, et al. (+6)
630 [GO] 2022―May―08 Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern Jeroen Pollet, Ulrich Strych, Wen-Hsiang Chen, Leroy Versteeg, Brian Keegan, Bin Zhan, et al. (+16)
631 [GO] 2022―May―07 Flu and pertussis vaccination during pregnancy in Geneva during the COVID-19 pandemic: A multicentric, prospective, survey-based study M. Lumbreras Areta, A. Valiton, A. Diana, M. Morales, J. Wiederrecht-Gasser, S. Jacob, et al. (+5)
632 [GO] 2022―May―06 Building population and health system resilience: Using lessons learned during the COVID pandemic to implement life-course immunisation policy Sandra Evans, Daphné Holt, Catherine Weil-Olivier, Gary Finnegan, Vytautas Usonis
633 [GO] 2022―May―05 Measuring parents’ readiness to vaccinate themselves and their children against COVID-19 Franziska Rees, Mattis Geiger, Lau Lilleholt, Ingo Zettler, Cornelia Betsch, Robert Böhm, Oliver Wilhelm
634 [GO] 2022―May―05 COVID-19 and seasonal influenza: The potential 2021-22 “Twindemic” Saverio Bellizzi, Catello M. Panu Napodano, Sergio Pinto, Giuseppe Pichierri
635 [GO] 2022―May―05 Prevalence and factors of influenza vaccination during the COVID-19 pandemic among university students in China Yanqiu Yu, Yee-ling Ma, Sitong Luo, Suhua Wang, Junfeng Zhao, Guohua Zhang, et al. (+3)
636 [GO] 2022―May―05 Characteristics associated with the willingness to receive a COVID-19 vaccine and an exploration of the general public's perceptions: A mixed-methods approach Norina Gasteiger, Chiara Gasteiger, Kavita Vedhara, Elizabeth Broadbent
637 [GO] 2022―May―05 Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries Jeanna Parsons Leigh, Stephana J. Moss, Trenton M. White, Camila A. Picchio, Kenneth H. Rabin, Scott C. Ratzan, et al. (+3)
638 [GO] 2022―May―05 Covid-19 vaccine immunogenicity in people living with HIV-1 Lauriane Nault, Lorie Marchitto, Guillaume Goyette, Daniel Tremblay-Sher, Claude Fortin, Valérie Martel-Laferrière, et al. (+6)
639 [GO] 2022―May―03 Readability of COVID-19 Vaccine Information for the General Public Luke S. Bothun, Scott E. Feeder, Gregory A. Poland
640 [GO] 2022―May―02 Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization Daniel R. Feikin, Laith J. Abu-Raddad, Nick Andrews, Mary-Ann Davies, Melissa M. Higdon, Walter A. Orenstein, Minal K. Patel
641 [GO] 2022―Apr―28 Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies Basharat Hussain, Asam Latif, Stephen Timmons, Kennedy Nkhoma, Laura B. Nellums
642 [GO] 2022―Apr―27 Commentary: “The vaccine Selfie” and its influence on COVID-19 vaccine acceptance Netana H. Markovitz, Arianna L. Strome, Payal K. Patel
643 [GO] 2022―Apr―27 Differences in clinical outcomes of COVID-19 among vaccinated and unvaccinated kidney transplant recipients Erol Demir, Hamad Dheir, Seda Safak, Ayse Serra Artan, Savas Sipahi, Aydin Turkmen
644 [GO] 2022―Apr―27 Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance Sharifa Nasreen, Andrew Calzavara, Sarah A. Buchan, Nisha Thampi, Caitlin Johnson, Sarah E. Wilson, Jeffrey C. Kwong
645 [GO] 2022―Apr―23 War, pandemic and vaccination - Upcoming health problems by the refugee wave in Europe? Antonio Perciaccante, Victor Asensi, Andrei I. Cucu, Philippe Charlier, Simon T. Donell, Andreas G. Nerlich, Raffaella Bianucci
646 [GO] 2022―Apr―22 Self-Reported COVID-19 Vaccination Acceptance and Hesitancy among Autistic Adults Lindsay L. Shea, Alec Becker, Brian K. Lee, Kaitlin Koffer Miller, Dylan Cooper, Kristy Anderson, et al. (+2)
647 [GO] 2022―Apr―22 COVID-19 vaccinations in Bhutan - Mix-and-Match to Boosters: an experience Saran Tenzin Tamang, Thinley Dorji
648 [GO] 2022―Apr―22 SARS-CoV-2 immunogenicity: is S protein the best target for vaccination? Tania Antonopoulou, Irene Athanassakis
649 [GO] 2022―Apr―22 Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: a population-based register study with implications to vaccinations Heini Salo, Toni Lehtonen, Kari Auranen, Ulrike Baum, Tuija Leino
650 [GO] 2022―Apr―18 Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among healthcare workers Anastasia Saade, Leo Cha, Emilie Tadié, Bruno Jurado, Alix Le Bihan, Pauline Baron-Latouche, et al. (+5)
651 [GO] 2022―Apr―18 De-escalation of asymptomatic testing and potential of future COVID-19 outbreaks in U.S. nursing homes amidst rising community vaccination coverage: a modeling study Brajendra K. Singh, Joseph Walker, Prabasaj Paul, Sujan Reddy, Camden D. Gowler, John Jernigan, Rachel B. Slayton
652 [GO] 2022―Apr―18 Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic Stanley Xu, Vennis Hong, Lina S. Sy, Sungching C. Glenn, Denison S. Ryan, Kerresa Morrissette, et al. (+10)
653 [GO] 2022―Apr―18 Impact of COVID-19 Vaccine-Associated Side Effects on Health Care Worker Absenteeism and Future Booster Vaccination Ara A. Chrissian, Udochukwu E. Oyoyo, Pranjal Patel, W. Lawrence Beeson, Lawrence K. Loo, Shahriyar Tavakoli, Alex Dubov
654 [GO] 2022―Apr―18 Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: real-world data Nasamon Wanlapakorn, Nungruthai Suntronwong, Harit Phowatthanasathian, Ritthideach Yorsaeng, Thanunrat Thongmee, Preeyaporn Vichaiwattana, et al. (+5)
655 [GO] 2022―Apr―18 Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters Lei Li, Yoshikazu Honda-Okubo, Jeremy Baldwin, Richard Bowen, Helle Bielefeldt-Ohmann, Nikolai Petrovsky
656 [GO] 2022―Apr―12 Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the Vaccine Adverse Event Reporting System (VAERS), December 2020 - October 2021 Pedro L. Moro, Christine K. Olson, Elizabeth Clark, Paige Marquez, Penelope Strid, Sascha Ellington, et al. (+5)
657 [GO] 2022―Apr―12 Screening for SARS-CoV-2 antibodies to save vaccine doses Florence Fenollar, Laurence Thomas, Didier Raoult, Philippe Gautret
658 [GO] 2022―Apr―12 Increased Delta variant SARS-CoV-2 infections in a highly vaccinated medical center in Japan Yan Yan, Toshio Naito, Yoko Tabe, Kanami Ito, Shuko Nojiri, Gautam A. Deshpande, et al. (+2)
659 [GO] 2022―Apr―12 VACCINE EFFECTIVENESS AGAINST ONWARD TRANSMISSION OF SARS-COV2-INFECTION BY VARIANT OF CONCERN AND TIME SINCE VACCINATION, BELGIAN CONTACT TRACING, 2021 Toon Braeye, Lucy Catteau, Ruben Brondeel, Joris van Loenhout, Kristiaan Proesmans, Laura Cornelissen, et al. (+9)
660 [GO] 2022―Apr―11 A Case Of Myocarditis And Isolated Hypopotassemia After Biontech-Pfizer Vaccine For Covid-19 Mehmet Emin Ceylan, Barış Önen Ünsalver, Aslıhan Dönmez, Fatma Duygu Kaya Yertutanol, Alper Evrensel, Hatice Zeynep Ceylan
661 [GO] 2022―Apr―11 Trends in effectiveness of inactivated influenza vaccine in children by age groups in seven seasons immediately before the COVID-19 era Masayoshi Shinjoh, Munehiro Furuichi, Hisato Kobayashi, Yoshio Yamaguchi, Naonori Maeda, Mizuki Yaginuma, et al. (+18)
662 [GO] 2022―Apr―11 Evaluation of weekly Covid-19 vaccination and case data supports negative correlation between incidence and vaccination in German federal states and cities during 4th wave Steffen Springer, Martin Kaatz, Michael Zieger
663 [GO] 2022―Apr―11 Patterns and influencing factors of COVID-19 vaccination willingness among college students in China Xi-Mei Zhu, Wei Yan, Jie Sun, Lin Liu, Yi-Miao Zhao, Yong-Bo Zheng, et al. (+15)
664 [GO] 2022―Apr―11 Need for a contingency dimension when planning vaccine development in a pandemic environment Paul Beninger
665 [GO] 2022―Apr―11 Differences by region of birth in SARS-CoV-2 vaccine coverage and positive SARS-CoV-2 test among 400 000 healthcare workers and the general population in Sweden Rickard Ljung, Maria Feychting, Bo Burström, Jette Möller
666 [GO] 2022―Apr―08 Impact of COVID-19 immunisation on COVID-19 incidence, hospitalisations, and deaths by age group in Germany from December 2020 to October 2021 Nita Perumal, Annika Steffen, Alexander Ullrich, Anette Siedler
667 [GO] 2022―Apr―08 Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine Helen J. Mayfield, Colleen L. Lau, Jane E. Sinclair, Samuel J. Brown, Andrew Baird, John Litt, et al. (+4)
668 [GO] 2022―Apr―08 Ask Me Anything”: Lessons learned in implementing a COVID-19 vaccine information initiative in Massachusetts jails Parsa Erfani, Raquel Sofia Sandoval, Katherine M. Rich, Ayotomiwa Ojo, Liz Walker MDiv, Gloria White-Hammond, et al. (+2)
669 [GO] 2022―Apr―08 Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink Tat'Yana A. Kenigsberg, Anne M. Hause, Michael M. McNeil, Jennifer C. Nelson, Jo Ann Shoup, Kristin Goddard, et al. (+4)
670 [GO] 2022―Apr―07 Extended Reporting Guidance for Vaccine Effectiveness Studies for Variants of Concern for COVID-19 Lori-Ann Linkins, Alfonso Iorio, Julian Little, John Lavis
671 [GO] 2022―Apr―07 Factors associated with the intention to participate in COVID-19 vaccine clinical trials: A cross-sectional study in Peru Abraham De-Los-Rios-Pinto, Daniel Fernandez-Guzman, David R. Soriano-Moreno, Lucero Sangster-Carrasco, Noelia Morocho-Alburqueque, Antony Pinedo-Soria, et al. (+5)
672 [GO] 2022―Apr―05 Factors associated with COVID-19 vaccination intent in Singapore, Australia and Hong Kong Shimoni Shah, Hao Gui, Pearleen Ee Yong Chua, Jing-Yu Benjamin Tan, Lorna Kwai-ping Suen, Sally Wai-chi Chan, Junxiong Pang
673 [GO] 2022―Apr―04 Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates Jewell N. Walters, Blake Schouest, Ami Patel, Emma L. Reuschel, Katherine Schultheis, Elizabeth Parzych, et al. (+18)
674 [GO] 2022―Apr―01 Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: evidence from an outbreak in Yunnan, China, 2021 Chao Ma, Weiwei Sun, Tingting Tang, Manhong Jia, Yonghua Liu, Yongfang Wan, et al. (+12)
675 [GO] 2022―Apr―01 A self-amplifying RNA vaccine protects against SARS-CoV-2 (D614G) and Alpha variant of concern (B.1.1.7) in a transmission-challenge hamster model Rebecca Frise, Laury Baillon, Jie Zhou, Ruthiran Kugathasan, Thomas P. Peacock, Jonathan C. Brown, et al. (+4)
676 [GO] 2022―Apr―01 Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for Vaccine Strategies MA. Sughayer, L. Souan, MM. Abu Alhowr, D. Al Rimawi, M. Siag, S. Albadr. M. Owdeh, T. Al Atrash
677 [GO] 2022―Mar―29 Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic Kun Li, Tianzhou Yu, Seth A. Seabury, Avi Dor
678 [GO] 2022―Mar―29 Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination Hideaki Kato, Kei Miyakawa, Norihisa Ohtake, Yutaro Yamaoka, Satoshi Yajima, Etsuko Yamazaki, et al. (+4)
679 [GO] 2022―Mar―29 The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden Catherine Isitt, Daniel Sjöholm, Maria-Pia Hergens, Fredrik Granath, Pontus Nauclér
680 [GO] 2022―Mar―28 Supporting Immunization Programs to Address COVID-19 Vaccine Hesitancy: Recommendations for National and Community-Based Stakeholders Katelyn Wells, Kelly L. Moore, Robert Bednarczyk
681 [GO] 2022―Mar―28 Benefit-Risk Assessment of COVID-19 Vaccine, mRNA (Comirnaty) for Age 16-29 years Patrick R. Funk, Osman N. Yogurtcu, Richard A. Forshee, Steve A. Anderson, Peter W. Marks, Hong Yang
682 [GO] 2022―Mar―28 Erythema nodosum triggered by BNT162b2 mRNA COVID-19 vaccine Vanessa Juddoo, Sonia Juddoo, Bruno Mégarbane
683 [GO] 2022―Mar―25 Disparities in COVID-19 Vaccine Uptake Among Health Care Workers Wigdan Farah, Laura Breeher, Vishal Shah, Caitlin Hainy, Christopher P. Tommaso, Melanie D. Swift
684 [GO] 2022―Mar―25 Understanding COVID-19 Vaccine Uptake during Pregnancy:‘Hesitance’, Knowledge, and Evidence-Based Decision-Making Leigh Ann Simmons, Mackenzie DM Whipps, Jennifer E Phipps, Nikita S Satish, Geeta K. Swamy
685 [GO] 2022―Mar―24 IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine Derar H. Abdel-Qader, Issa Hazza Alkhatatbeh, Wail Hayajneh, Hassan Annab, Ahmad Z. Al Meslamani, Reem A. Elmusa
686 [GO] 2022―Mar―22 Decreasing routine vaccination rates in children in the COVID-19 era Helena C. Maltezou, Snezana Medic, Dimitrios C. Cassimos, Evgnosia Effraimidou, Gregory A. Poland
687 [GO] 2022―Mar―22 Effectiveness of the Comirnaty and the Vaxzevria vaccines in preventing SARS-CoV-2 infection among residents in Lazio region (Italy) Valeria Fano, Alessia Crielesi, Enzo Coviello, Massimo Fabiani, Antonio Salvatore Miglietta, Giovanni Colaiocco, et al. (+5)
688 [GO] 2022―Mar―21 SIRVA (Shoulder Injury Related to Vaccine Administration) following mRNA COVID-19 Vaccination: Case discussion and literature review Wen Loong Paul Yuen, Sir Young James Loh, Dehao Bryan Wang
689 [GO] 2022―Mar―21 Why do Hong Kong parents have low intention to vaccinate their children against COVID-19? testing health belief model and theory of planned behavior in a large-scale survey Jian-Bin Li, Eva Yi Hung Lau, Derwin King Chung Chan
690 [GO] 2022―Mar―18 The Effect of Immunization with Inactivated SARS-CoV-2 Vaccine (CoronaVac) and/or SARS-CoV-2 Infection on Antibody Levels, Plasmablasts, Long-lived-plasma-cells, and IFN-γ Release by Natural Killer Cells Huseyin Bilgin, Marisa Marku, Sultan Seval Yilmaz, Aysegul Karahasan Yagci, Uluhan Sili, Baris Can, et al. (+5)
691 [GO] 2022―Mar―17 Erratum to ““Cultivating” acceptance of a COVID-19 vaccination program: Lessons from Italy” [Vaccine 38(48) (2020) 7585-7586] Guendalina Graffigna, Lorenzo Palamenghi, Serena Barello, Stefania Boccia
692 [GO] 2022―Mar―17 A candidate multi-epitope vaccine against porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae induces robust humoral and cellular response in mice Zhisong Gao, Lingxiao Chen, Tao Song, Xuan Pan, Xiaojing Li, Guangzong Lu, et al. (+4)
693 [GO] 2022―Mar―15 Hesitancy towards COVID-19 vaccines on social media in Canada Bobbi Rotolo, Eve Dubé, Maryline Vivion, Shannon E. MacDonald, Samantha B. Meyer
694 [GO] 2022―Mar―15 SARS-CoV-2 outbreak in a nursing home after vaccination with BNT162b2: a role for the quantification of circulating antibodies Jordi Càmara, Aida González-Díaz, Irene Barrabeig, Miguel Fernández-Huerta, Laura Calatayud, Jordi Niubó, et al. (+3)
695 [GO] 2022―Mar―14 Sociodemographic and psychological correlates of COVID-19 vaccine hesitancy and resistance in the young adult population in Italy Ughetta Moscardino, Pasquale Musso, Cristiano Inguglia, Chiara Ceccon, Diana Miconi, Cécile Rousseau
696 [GO] 2022―Mar―09 Healthcare Worker Perspectives on COVID-19 Vaccines: Implications for Increasing Vaccine Acceptance among Healthcare Workers and Patients Christine M. Thomas, Kelly Searle, Alma Galván, Amy K Liebman, Erin M. Mann, Jonathan D. Kirsch, William M. Stauffer
697 [GO] 2022―Mar―09 Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination? Lotus L. van den Hoogen, Gaby Smits, Cheyenne C.E. van Hagen, Denise Wong, Eric R.A. Vos, Michiel van Boven, et al. (+15)
698 [GO] 2022―Mar―07 Political Attitudes and Efficacy of Health Expert Communication on the Support for COVID-19 Vaccination Program: Findings from a Survey in Hong Kong Vera Wing Han YUEN
699 [GO] 2022―Mar―07 COVID-19 vaccine preferences in India Prateek Bansal, Alok Raj, Dhirendra Mani Shukla, Naveen Sunder
700 [GO] 2022―Mar―03 COVID-19 vaccine intention among young adults: Comparative results from a cross-sectional study in Canada and France Pierre-julien Coulaud, Aidan Ablona, Naseeb Bolduc, Danya Fast, Karine Bertrand, Jeremy Ward, et al. (+3)
701 [GO] 2022―Mar―03 Public opinion on global distribution of COVID-19 vaccines: evidence from two nationally representative surveys in Germany and the United States Matthias Klumpp, Ida G. Monfared, Sebastian Vollmer
702 [GO] 2022―Mar―03 IgG antibody production and persistence to 6 months following SARS-CoV-2 vaccination: a Northern Ireland observational study Louise J. Robertson, Ruth Price, Julie S. Moore, Grace Curry, John Farnan, Amy Black, et al. (+4)
703 [GO] 2022―Mar―02 How do COVID-19 vaccine mandates affect attitudes toward the vaccine and participation in mandate-affected activities? Evidence from the United States S.E. Kreps, D.L. Kriner
704 [GO] 2022―Mar―01 The impact of COVID-19 on routine pediatric vaccination delivery in Brazil Carolina Moura, Paul Truche, Lucas Sousa Salgado, Thiaro Meireles, Vitor Santana, Alexandra Buda, et al. (+3)
705 [GO] 2022―Feb―28 Aggregating human judgment probabilistic predictions of the safety, efficacy, and timing of a COVID-19 vaccine Thomas McAndrew, Juan Cambeiro, Tamay Besiroglu
706 [GO] 2022―Feb―28 WHO Guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: ethical considerations Jerome Amir Singh, Sonali Kochhar, Jonathan Wolff, Caesar Atuire, Anant Bhan, Ezekiel Emanuel, et al. (+10)
707 [GO] 2022―Feb―28 Nepal Measles outbreak response immunization during COVID-19: a risk-based intervention strategy Anindya Sekhar Bose, Pasang Rai, Binod Prasad Gupta, Rahul Pradhan, Mona Lacoul, Sushil Shakya, et al. (+10)
708 [GO] 2022―Feb―25 Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2 Takahiro Kageyama, Shigeru Tanaka, Keishi Etori, Koto Hattori, Kazusa Miyachi, Tadamichi Kasuya, et al. (+5)
709 [GO] 2022―Feb―22 Monitoring COVID-19 vaccine use in Italian Long Term Care Centers: the GeroCovid VAX Study Angela Marie Abbatecola, Raffaele Antonelli Incalzi, Alba Malara, Annapina Palmieri, Anna Di Lonardo, Giorgio Fedeli, et al. (+19)
710 [GO] 2022―Feb―22 Understanding the Influence of Political Orientation, Social Network, and Economic Recovery on COVID-19 Vaccine Uptake among Americans Feng Hao, Wanyun Shao
711 [GO] 2022―Feb―21 Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received two doses of CoronaVac: A randomized controlled trial Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Kasiruck Wittayasak, Nawarat Thonwirak, Kamonwan Soonklang, et al. (+3)
712 [GO] 2022―Feb―18 Couples and COVID-19 Vaccination: Frequency and Reasons for Discordance Karen B. Schmaling
713 [GO] 2022―Feb―17 The correlates and dynamics of COVID-19 vaccine-specific hesitancy Eric Merkley, Peter John Loewen
714 [GO] 2022―Feb―17 Localising vaccination services: Qualitative insights on public health and minority group collaborations to co-deliver coronavirus vaccines Ben Kasstan, Sandra Mounier-Jack, Louise Letley, Katherine M. Gaskell, Chrissy H. Roberts, Neil R.H. Stone, et al. (+4)
715 [GO] 2022―Feb―17 The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats Bartlomiej Kalaska, Joanna Miklosz, Justyna Swieton, Aleksandra Jakimczuk, Dariusz Pawlak, Andrzej Mogielnicki
716 [GO] 2022―Feb―16 Immune response to one dose of BNT162b2 mRNA Covid-19 vaccine followed by Sars-CoV-2 infection: an Italian prospective observational study Pasquale Stefanizzi, Angela Maria Vittoria Larocca, Andrea Martinelli, Savino Soldano, Maria Dell'Aera, Giovanni Migliore, et al. (+4)
717 [GO] 2022―Feb―15 Influenza virus vaccine compliance among pregnant women during the COVID-19 pandemic (pre-vaccine era) in Israel and future intention to uptake BNT162b2 mRNA COVID-19 vaccine Ola Ali Saleh, Ofra Halperin
718 [GO] 2022―Feb―15 A cell-based ELISA as surrogate of virus neutralization assay for RBD SARS-CoV-2 specific antibodies Franciscary Pi-Estopiñan, Maria Teresa Pérez, Anitza Fraga, Gretchen Bergado, Geidy D. Diaz, Ivette Orosa, et al. (+12)
719 [GO] 2022―Feb―15 How to accelerate the supply of vaccines to all populations worldwide? Part I: Initial industry lessons learned and practical overarching proposals leveraging the COVID-19 situation Mic McGoldrick, Thierry Gastineau, Diane Wilkinson, Cristiana Campa, Norbert De Clercq, Andrea Mallia-Milanes, et al. (+14)
720 [GO] 2022―Feb―15 How to accelerate the supply of vaccines to all populations worldwide? Part II: Initial industry lessons learned and detailed technical reflections leveraging the COVID-19 situation Mic McGoldrick, Thierry Gastineau, Diane Wilkinson, Cristiana Campa, Norbert De Clercq, Andrea Mallia-Milanes, et al. (+15)
721 [GO] 2022―Feb―14 Ethics review of COVID-19 human challenge studies: a joint HRA/WHO workshop Eloise Williams, Kathrine Craig, Christopher Chiu, Hugh Davies, Stephanie Ellis, Claudia Emerson, et al. (+15)
722 [GO] 2022―Feb―14 Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine Shohei Yamamoto, Ami Fukunaga, Akihito Tanaka, Junko S. Takeuchi, Yosuke Inoue, Moto Kimura, et al. (+6)
723 [GO] 2022―Feb―14 Promoting Immunization Equity in Latin America and the Caribbean: Case Studies, Lessons Learned and their Implication for COVID-19 Vaccine Equity Isabella L. Chan, Robin Mowson, Juan Pedro Alonso, Javier Roberti, Marcela Contreras, Martha Velandia-González
724 [GO] 2022―Feb―14 Mumps to COVID-19: Vaccinated Persons Remain Vulnerable When Community Uptake Is Low Kristin K. Gaffney, M. Jana Broadhurst, David M. Brett-Major
725 [GO] 2022―Feb―14 The effect of the E484K mutation of SARS-CoV-2 on the neutralizing activity of antibodies from BNT162b2 vaccinated individuals Yoshifumi Uwamino, Takashi Yokoyama, Takako Shimura, Tomoyasu Nishimura, Yasunori Sato, Masatoshi Wakui, et al. (+3)
726 [GO] 2022―Feb―14 Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccine Fan Gao, Chaoqiang An, Lianlian Bian, Yiping Wang, Jialu Zhang, Bopei Cui, et al. (+12)
727 [GO] 2022―Feb―14 Unmet need for COVID-19 vaccination coverage in Kenya Samuel K. Muchiri, Rose Muthee, Hellen Kiarie, Joseph Sitienei, Ambrose Agweyu, Peter M. Atkinson, et al. (+3)
728 [GO] 2022―Feb―11 “On the last day of the last month, I will go”: A qualitative exploration of COVID-19 vaccine confidence among Ivoirian adults Natalie Tibbels, Abdul Dosso, Corinne Fordham, William Benie, Jeanne Aka Brou, Diarra Kamara, et al. (+2)
729 [GO] 2022―Feb―11 Public perceptions and the willingness to get vaccinated against COVID-19: Lessons from Israel Oren Heller, Yung Chun, Yaniv Shlomo, Ateret Gewirtz-Meydan, Mary Acri, Saneel Kulkarni, Michal Grinstein-Weiss
730 [GO] 2022―Feb―10 Impact of vaccination status on mortality among symptomatic COVID-19 patients during the second wave of the pandemic: a cohort study Kundavaram Paul Prabhakar Abhilash, Ponnivalavan Mathiyalagan, Vivek Raja K. Krishnaraj, Saravanan Selvan, Rohini Kanagarajan, Narmadha P. Reddy, et al. (+17)
731 [GO] 2022―Feb―09 How frequent are acute reactions to COVID-19 vaccination and who is at risk? Nancy Dreyer, Matthew W Reynolds, Lisa Albert, Emma Brinkley, Tom Kwon, Christina Mack, Stephen Toovey
732 [GO] 2022―Feb―09 Effectiveness of Covishield vaccine in preventing Covid-19 - A test-negative case-control study Stuti Pramod, Dhanajayan Govindan, Premkumar Ramasubramani, Sitanshu Sekhar Kar, Rakesh Aggarwal
733 [GO] 2022―Feb―08 Impact of the COVID-19 pandemic on routine immunization coverage in children under 2 years old in Ontario, Canada: A retrospective cohort study Catherine Ji, Pierre-Philippe Piché-Renaud, Jemisha Apajee, Ellen Stephenson, Milena Forte, Jeremy N. Friedman, et al. (+4)
734 [GO] 2022―Feb―08 A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: safety, reactogenicity and immunogenicity Sonia Pérez-Rodríguez, Meiby de la Caridad Rodríguez-González, Rolando Ochoa-Azze, Yanet Climent-Ruiz, Carlos Alberto González-Delgado, Beatriz Paredes-Moreno, et al. (+22)
735 [GO] 2022―Feb―08 A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: an interim report Taisei Masuda, Kyoko Murakami, Kenkichi Sugiura, Sho Sakui, Ron Philip Schuring, Mitsuhiro Mori
736 [GO] 2022―Feb―07 Conspiracy theories and misinformation about COVID-19 in Nigeria: implications for vaccine demand generation communications Chizoba Wonodi, Chisom Obi-Jeff, Funmilayo Adewumi, Somto Chloe Keluo-Udeke, Rachel Gur-Arie, Carleigh Krubiner, et al. (+4)
737 [GO] 2022―Feb―07 The impact of COVID-19 on income and employment and willingness to become vaccinated among African Americans enrolled in a smoking cessation randomized trial Erica Cruvinel, Kimber Richter, Taneisha Scheuermann, Nathalia Munck Machado, Matthew S. Mayo, Alexandra Brown, Nikki Nollen
738 [GO] 2022―Feb―07 Attitude toward a mandatory COVID-19 vaccination policy and its determinants: Evidence from serial cross-sectional surveys conducted throughout the pandemic in Germany Philipp Sprengholz, Lars Korn, Sarah Eitze, Lisa Felgendreff, Regina Siegers, Laura Goldhahn, et al. (+4)
739 [GO] 2022―Feb―07 Myocarditis following mRNA Covid-19 vaccination: a pooled analysis Ioannis Bellos, Vasilios Karageorgiou, Dana Viskin
740 [GO] 2022―Feb―07 Towards a Predictive Model of COVID-19 Vaccine Hesitancy among American Adults Jack Mewhirter, Mustafa Sagir, Rebecca Sanders
741 [GO] 2022―Feb―07 Effect of the 2020/21 season influenza vaccine on SARS-CoV-2 infection in a cohort of Italian healthcare workers Alexander Domnich, Andrea Orsi, Laura Sticchi, Donatella Panatto, Guglielmo Dini, Allegra Ferrari, et al. (+7)
742 [GO] 2022―Feb―07 Modeling Strategies for the Allocation of SARS-CoV-2 Vaccines in the United States Joseph Walker, Prabasaj Paul, Kathleen Dooling, Sara Oliver, Pragati Prasad, Molly Steele, et al. (+4)
743 [GO] 2022―Feb―04 Exploring the attitudes, concerns, and knowledge regarding COVID-19 vaccine by the parents of children with rheumatic disease: Cross-sectional online survey Özlem Akgün, Gülşah Kavrul Kayaalp, Fatma Gül Demirkan, Figen Çakmak, Ayşe Tanatar, Vefa Guliyeva, et al. (+2)
744 [GO] 2022―Feb―04 Estimating the cost of COVID-19 vaccine deployment and introduction in Ghana using the CVIC Tool Justice Nonvignon, Richmond Owusu, Brian Asare, Alex Adjagba, Wei Aund, Yeung Karene Hoi Ting, et al. (+9)
745 [GO] 2022―Feb―03 Italy’s rollout of COVID-19 vaccinations: the crucial contribution of the first experimental mass vaccination site in Lombardy Francesco Oliani, Antonella Savoia, Giulia Gallo, Navpreet Tiwana, Matteo Letzgus, Flaminia Gentiloni, et al. (+5)
746 [GO] 2022―Feb―01 COVID-19 vaccination intention and behavior in a large, diverse, U.S. refugee population Jana Shaw, Kathryn B. Anderson, Rachel E. Fabi, Carlie A. Thompson, Megan Harris, Nidaa Aljabbarin, et al. (+6)
747 [GO] 2022―Feb―01 Looking Ahead: Caregivers’ COVID-19 vaccination intention for children 5 years old and younger using the health belief model Morgan E. Ellithorpe, Fashina Aladé, Robyn B. Adams, Glen J. Nowak
748 [GO] 2022―Feb―01 Conditionality of COVID-19 vaccine acceptance in European countries Leonardo W. Heyerdahl, Muriel Vray, Benedetta Lana, Nastassia Tvardik, Nina Gobat, Marta Wanat, et al. (+4)
749 [GO] 2022―Feb―01 Immunity Debt or Vaccination Crisis? A Multi-Method Evidence on Vaccine Acceptance and Media Framing for Emerging COVID-19 Variants Muhammad Yousaf, Syed Hassan Raza, Nasir Mahmood, Rachel Core, Umer Zaman, Aqdas Malik
750 [GO] 2022―Jan―31 Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452 Yester F. Janssen, Eline A. Feitsma, Hendrikus H. Boersma, David G. Alleva, Thomas M. Lancaster, Thillainaygam Sathiyaseelan, et al. (+17)
751 [GO] 2022―Jan―26 Worldwide routine immunisation coverage regressed during the first year of the COVID-19 pandemic Beth Evans, Thibaut Jombart
752 [GO] 2022―Jan―26 The Role of Perceived Social Norms in College Student Vaccine Hesitancy: Implications for COVID-19 Prevention Strategies Anna E. Jaffe, Scott Graupensperger, Jessica A. Blayney, Jennifer C. Duckworth, Cynthia A. Stappenbeck
753 [GO] 2022―Jan―24 B-CELL CYTOPENIA AND TIME TO LAST B-CELL-DEPLETING THERAPY PREDICT RESPONSE TO SARS-COV-2 VACCINES IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS Mégane Tanguay, Marianne Boutin, Annemarie Laumaea, Matthew Salaciak, Alma Mendoza, Chantal Cassis, et al. (+6)
754 [GO] 2022―Jan―20 Priming with social benefit information of vaccination to increase acceptance of COVID-19 vaccines Qiuyan Liao, Benjamin J Cowling, Jingyi Xiao, Jiehu Yuan, Meihong Dong, Michael Y Ni, et al. (+2)
755 [GO] 2022―Jan―20 An AAV vaccine targeting the RBD of the SARS-CoV-2 S protein induces effective neutralizing antibody titers in mice and canines Fei Liu, Canbin Feng, Shiqi Xu, Qiang Wu, Jian Tang, Yan Chen, et al. (+9)
756 [GO] 2022―Jan―19 Reducing the Rates of Household Transmission: The Impact of COVID-19 Vaccination in Healthcare Workers with a Known Household Exposure Catherine L. Passaretti, Jennifer S. Priem, Tammie G. Agner, Lewis McCurdy
757 [GO] 2022―Jan―19 Impact of Prior SARS-CoV-2 Infection on Incidence of Hospitalization and Adverse Events Following mRNA SARS-CoV-2 vaccination: A Nationwide, Retrospective Cohort Study Lucy Li, Chunlei Zheng, Jennifer La, Nhan Do, Paul Monach, Judith Strymish, et al. (+2)
758 [GO] 2022―Jan―19 A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in mice Laura Lazo, Monica Bequet-Romero, Gilda Lemos, Alexis Musacchio, Ania Cabrales, Andy J. Bruno, et al. (+8)
759 [GO] 2022―Jan―19 Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine Jacob Pitcovski, Nady Gruzdev, Anna Abzach, Chen Katz, Ran Ben-Adiva, Michal Brand-Shwartz, et al. (+15)
760 [GO] 2022―Jan―17 COVID-19 vaccine reactogenicity - A cohort event monitoring study in the Netherlands using patient reported outcomes Leàn Rolfes, Linda Härmark, Agnes Kant, Leontine van Balveren, Wil Hilgersom, Florence van Hunsel
761 [GO] 2022―Jan―15 COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: A national prospective cohort study in Wales Stuart Bedston, Ashley Akbari, Christopher I. Jarvis, Emily Lowthian, Fatemeh Torabi, Laura North, et al. (+19)
762 [GO] 2022―Jan―12 Adolescents’ attitudes to the COVID-19 Vaccination W.H.S. Wong, D. Leung, G.T. Chua, J.S.R. Duque, S. Peare, H.K. So, et al. (+4)
763 [GO] 2022―Jan―10 Factors Associated with COVID-19 Vaccination Intentions among Adults in the Deep South Casey L. Daniel, Jacob Williams, Rachel Legg, Chelsea Green, Jesse Stutzman
764 [GO] 2022―Jan―10 Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine Kah-Whye Peng, Timothy Carey, Patrycja Lech, Rianna Vandergaast, Miguel Á. Muñoz-Alía, Nandakumar Packiriswamy, et al. (+24)
765 [GO] 2022―Jan―07 Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational study of 646 Japanese healthcare workers and university staff Yoshifumi Uwamino, Toshinobu Kurafuji, Yasunori Sato, Yukari Tomita, Ayako Shibata, Akiko Tanabe, et al. (+12)
766 [GO] 2022―Jan―05 Understanding COVID-19 vaccination willingness among youth: A survey study in the Netherlands Saskia Euser, Floor M. Kroese, Mare Derks, Marijn de Bruin
767 [GO] 2022―Jan―01 Impact of the COVID-19 pandemic on pediatric and adolescent vaccinations and well child visits in the United States: A database analysis Stephanie A. Kujawski, Lixia Yao, Echo Wang, Cristina Da Silva Carias, Ya-Ting Chen
768 [GO] 2021―Dec―31 Modulation of immunosuppressant drug treatment to improve SARS-CoV-2 vaccine efficacy in mice Amy V. Paschall, Ahmet Ozdilek, Sydney L. Briner, Melinda A. Brindley, Fikri Y. Avci
769 [GO] 2021―Dec―30 Protection against avian coronavirus conferred by oral vaccination with live bacteria secreting LTB-fused viral proteins Avishai Lublin, Chen Katz, Nady Gruzdev, Itamar Yadid, Itai Bloch, Yigal Farnoushi, et al. (+5)
770 [GO] 2021―Dec―30 Intranasal immunization with a Middle East respiratory syndrome-coronavirus antigen conjugated to the M-cell targeting ligand Co4B enhances antigen-specific mucosal and systemic immunity and protects against infection Ye Lin Yang, Ju Kim, Yongsu Jeong, Yong-Suk Jang
771 [GO] 2021―Dec―27 Optimizing vaccine distribution via mobile clinics: a case study on COVID-19 vaccine distribution to long-term care facilities Samta Shukla, Francois Fressin, Michelle Un, Henriette Coetzer, Sreekanth K. Chaguturu
772 [GO] 2021―Dec―24 COVID-19 and Routine Childhood and Adolescent Immunizations: Evidence from Louisiana Medicaid Brigham Walker, Andrew Anderson, Charles Stoecker, Yixue Shao, Thomas A. LaVeist, Kevin Callison
773 [GO] 2021―Dec―24 Safety and Effectiveness of BNT162b2 mRNA Covid-19 Vaccine in Adolescents Young June Choe, Seonju Yi, Insob Hwang, Jia Kim, Young-Joon Park, Eunhee Cho, et al. (+3)
774 [GO] 2021―Dec―24 Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial Stephen J. Thomas, John L. Perez, Stephen P. Lockhart, Subramanian Hariharan, Nicholas Kitchin, Ruth Bailey, et al. (+10)
775 [GO] 2021―Dec―22 COVID-19 vaccine is correlated with favourable epidemiological indicators in the Auvergne-Rhône-Alpes region (France): an ecological study Nicolas Romain-Scelle, Christelle Elias, Philippe Vanhems
776 [GO] 2021―Dec―22 Immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 with 12-dose vials: An interim analysis Anan Manomaipiboon, Uraporn Phumisantiphong, Jakravoot Maneerit, Yupin Chalearmchai, Warissara Jirawathin, Achiraya Prajongsai, et al. (+2)
777 [GO] 2021―Dec―21 COVID-19 and missed or delayed vaccination in 26 middle- and high-income countries: An observational survey Gilla K. Shapiro, Nisha Gottfredson, Julie Leask, Kerrie Wiley, Francine E. Ganter-Restrepo, Sarah P. Jones, et al. (+2)
778 [GO] 2021―Dec―21 Did the European suspension of the AstraZeneca vaccine decrease vaccine acceptance during the COVID-19 pandemic? Michael Bang Petersen, Frederik Jørgensen, Marie Fly Lindholt
779 [GO] 2021―Dec―20 Evaluation of the Gam-COVID-Vac and vaccine-induced neutralizing response against SARS-CoV-2 lineage P.1 variant in an Argentinean cohort Sebastián Blanco, Brenda Salomé Konigheim, Adrian Diaz, Lorena Spinsanti, Juan Javier Aguilar, María Elisa Rivarola, et al. (+6)
780 [GO] 2021―Dec―18 Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021 Eero Poukka, Ulrike Baum, Arto A. Palmu, Toni O. Lehtonen, Heini Salo, Hanna Nohynek, Tuija Leino
781 [GO] 2021―Dec―17 Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein Nai-Hsiang Chung, Ying-Chin Chen, Shiu-Ju Yang, Yu-Ching Lin, Horng-Yunn Dou, Lily Hui-Ching Wang, et al. (+2)
782 [GO] 2021―Dec―16 Does a major change to a COVID-19 vaccine program alter vaccine intention? A qualitative investigation Samantha J. Carlson, Lara McKenzie, Leah Roberts, Christopher C. Blyth, Katie Attwell
783 [GO] 2021―Dec―15 Levels and Factors derived from the Health Action Process Approach of Behavioral Intentions to Take up COVID-19 Vaccination: a random Population-based study Yanqiu Yu, Wanru Jia, Mason M.C. Lau, Joseph T.F. Lau
784 [GO] 2021―Dec―15 Towards A Population-Based Threshold of Protection for COVID-19 Vaccines David Goldblatt, Andrew Fiore-Gartland, Marina Johnson, Adam Hunt, Christopher Bengt, Dace Zavadska, et al. (+10)
785 [GO] 2021―Dec―14 On the rise of the new B.1.1.529 variant: Five dimensions of access to a COVID-19 vaccine Xiang Chen, Hui Wang
786 [GO] 2021―Dec―11 Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines Jérémie Botton, Rosemary Dray-Spira, Bérangère Baricault, Jérôme Drouin, Marion Bertrand, Marie-Joëlle Jabagi, et al. (+2)
787 [GO] 2021―Dec―11 Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States Yuli Lily Hsieh, Summer Rak, Gillian K SteelFisher, Sebastian Bauhoff
788 [GO] 2021―Dec―11 COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers Karen Lutrick, Holly Groom, Ashley L. Fowlkes, Kimberly D Groover, Manjusha Gaglani, Patrick Rivers, et al. (+12)
789 [GO] 2021―Dec―11 Humoral response to the SARS-CoV-2 BTN161b2 mRNA vaccine: Real-world data from a large cohort of healthcare workers Joana Oliveira-Silva, Teresa Reis, Cristiana Lopes, Ricardo Batista-Silva, Ricardo Ribeiro, Gilberto Marques, et al. (+7)
790 [GO] 2021―Dec―10 Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI) Mark A. Katz, Efrat Bron Harlev, Bibiana Chazan, Michal Chowers, David Greenberg, Alon Peretz, et al. (+23)
791 [GO] 2021―Dec―09 Adverse event of Sinovac Coronavirus vaccine: Deafness Hai Zhao, Yongtuan Li, Zhiyuan Wang
792 [GO] 2021―Dec―04 Prior COVID-19 infection is associated with increased Adverse Events (AEs) after the first, but not the second, dose of the BNT162b2/Pfizer vaccine Rachael K. Raw, Jon Rees, Clive Kelly, Caroline Wroe, David R. Chadwick
793 [GO] 2021―Dec―04 oInfluenza vaccination uptake among Canadian adults before and during the COVID-19 pandemic: An analysis of the Canadian Longitudinal Study on Aging (CLSA) Giorgia Sulis, Nicole E. Basta, Christina Wolfson, Susan A. Kirkland, Jacqueline McMillan, Lauren E. Griffith, Parminder Raina
794 [GO] 2021―Dec―04 Willingness to Vaccinate Against SARS-CoV-2: The Role of Reasoning Biases and Conspiracist Ideation Michael V. Bronstein, Erich Kummerfeld, Angus MacDonald, Sophia Vinogradov
795 [GO] 2021―Dec―03 Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults Ritthideach Yorsaeng, Nungruthai Suntronwong, Harit Phowatthanasathian, Suvichada Assawakosri, Sitthichai Kanokudom, Thanunrat Thongmee, et al. (+9)
796 [GO] 2021―Dec―03 Correlation of Anti-SARS-CoV-2 S1-specific IgG antibody levels and adverse events following vaccination with BNT162b2 mRNA COVID-19 Vaccine in healthcare workers Marina Izak, Evgeniy Stoyanov, Keren Dezuraev, Eilat Shinar
797 [GO] 2021―Dec―03 SARS-CoV-2-antibody response in health care workers after vaccination or natural infection in a longitudinal observational study Jonas Herzberg, Tanja Vollmer, Bastian Fischer, Heiko Becher, Ann-Kristin Becker, Human Honarpisheh, et al. (+3)
798 [GO] 2021―Dec―02 Pacific Eclipse - A tabletop exercise on smallpox pandemic response C. Raina MacIntyre, David J. Heslop, Phi Nguyen, Dillon Adam, Mallory Trent, Brian J. Gerber
799 [GO] 2021―Dec―02 AZD1222 (ChAdOx1 nCov-19): A Single-Dose biodistribution study in mice Richard Stebbings, Gillian Armour, Vivian Pettis, Joanne Goodman
800 [GO] 2021―Dec―01 COVID-19 from a polio perspective Robert Hill
801 [GO] 2021―Dec―01 Individual factors influencing COVID-19 vaccine acceptance in between and during pandemic waves (July-December 2020) Sara Valckx, Jonas Crèvecoeur, Frederik Verelst, Maren Vranckx, Greet Hendrickx, Niel Hens, et al. (+4)
802 [GO] 2021―Nov―30 COVID-19 vaccine Mandates: An Australian attitudinal study Katie Attwell, Marco Rizzi, Lara McKenzie, Samantha J Carlson, Leah Roberts, Sian Tomkinson, Chris Blyth
803 [GO] 2021―Nov―27 Predicting Vaccine Uptake during COVID-19 Crisis: A Motivational Approach Mathias Schmitz, Olivier Luminet, Olivier Klein, Sofie Morbée, Omer Van den Bergh, Pascaline Van Oost, et al. (+3)
804 [GO] 2021―Nov―27 Mass vaccination campaign during the 2016 influenza outbreak in Panama: challenges and implications for COVID-19 vaccination efforts Franz Castro, Juan Miguel Pascale, Itzel Slocum Hewitt, Arlene Calvo
805 [GO] 2021―Nov―27 Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines Helena C. Maltezou, Cleo Anastassopoulou, Sophia Hatziantoniou, Gregory A. Poland, Athanasios Tsakris
806 [GO] 2021―Nov―22 A Retrospective Analysis of Social Media posts pertaining to COVID-19 vaccination side effects Max-Philipp Lentzen, Viola Huebenthal, Rolf Kaiser, Matthias Kreppel, Joachim E. Zoeller, Matthias Zirk
807 [GO] 2021―Nov―22 Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection Harika Oyku Dinc, Nese Saltoglu, Gunay Can, Ilker Inanc Balkan, Beyhan Budak, Dogukan Ozbey, et al. (+9)
808 [GO] 2021―Nov―20 Moving the Needle on Racial Disparity: COVID-19 Vaccine Trust and Hesitancy Cheryl Lin, Pikuei Tu, Thomas C. Terry
809 [GO] 2021―Nov―19 Perceived Facilitators and Barriers to Intentions of Receiving the COVID-19 Vaccines among Elderly Chinese Adults Tianen Chen, Minhao Dai, Shilin Xia
810 [GO] 2021―Nov―19 Increasing acceptance of a vaccination program for coronavirus disease 2019 in france: a challenge for one of the world’s most vaccine-hesitant countries L. Cambon, M. Schwarzinger, F. Alla
811 [GO] 2021―Nov―18 Inclusiveness of prisons in COVID-19 vaccination deployment: Evidence from Jordan Saverio Bellizzi, Chinara Aidyralieva, Ala'a Al-Shaikh, Nazeema Muthu, Anwar Al-Sadder, Jamela Al-Raiby
812 [GO] 2021―Nov―18 Disparities in national and state estimates of COVID-19 vaccination receipt and intent to vaccinate by race/ethnicity, income, and age group among adults ≥ 18 years, United States Kimberly H. Nguyen, Elyssa Anneser, Alexander Toppo, Jennifer D. Allen, J. Scott Parott, Laura Corlin
813 [GO] 2021―Nov―17 Acceptance, attitude, and factors affecting the intention to accept COVID-19 vaccine among Thai people and expatriates living in Thailand Amornphat Kitro, Wachiranun Sirikul, Chanodom Piankusol, Pawaruj Rirermsoonthorn, Mathuramat Seesen, Kampanat Wangsan, et al. (+4)
814 [GO] 2021―Nov―15 A Meta-Analysis of Influenza Vaccination Following Correspondence: Considerations for COVID-19 Robert P. Murphy, Carol Taaffe, Elayne Ahern, Grace McMahon, Orla Muldoon
815 [GO] 2021―Nov―15 Trends in COVID-19 vaccination intent and factors associated with deliberation and reluctance among adult homeless shelter residents and staff, 1 November 2020 to 28 February 2021 - King County, Washington Julia H. Rogers, Sarah N. Cox, James P. Hughes, Amy C. Link, Eric J. Chow, Idabelle Fosse, et al. (+10)
816 [GO] 2021―Nov―15 The seductive allure of technical language and its effect on covid-19 vaccine beliefs and intentions Jonathan Silas, Alexander Jones, Leonardo Weiss-Cohen, Peter Ayton
817 [GO] 2021―Nov―13 Influence of Rapid COVID-19 Vaccine Development on Vaccine Hesitancy Sonny Rosenthal, Christopher L. Cummings
818 [GO] 2021―Nov―11 A Long Shot: The Importance of Needle Length in Vaccinating Patients with Obesity Against COVID-19 Shradha Chhabria, Fatima Cody Stanford
819 [GO] 2021―Nov―11 BNT162b2 mRNA COVID-19 Vaccine Reactogenicity: The Key Role of Immunity Pilar Vizcarra, Johannes Haemmerle, Hector Velasco, Tamara Velasco, Marina Fernández-Escribano, Alejandro Vallejo, José L. Casado
820 [GO] 2021―Nov―08 Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada Britt McKinnon, Caroline Quach, Ève Dubé, Cat Tuong Nguyen, Kate Zinszer
821 [GO] 2021―Nov―08 Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice Kai Wu, Angela Choi, Matthew Koch, Sayda Elbashir, LingZhi Ma, Diana Lee, et al. (+19)
822 [GO] 2021―Nov―06 SARS-CoV-2 vaccine for domestic and captive animals: An effort to counter COVID-19 pandemic at the human-animal interface Khan Sharun, Ruchi Tiwari, AbdulRahman A. Saied, Kuldeep Dhama
823 [GO] 2021―Nov―06 Early Experience with COVID-19 Vaccine in a Federally-Qualified Healthcare Center for the Homeless Jean-Venable R. Goode, Patricia Cook, Stephanie Cuttino, Sharon B. S. Gatewood
824 [GO] 2021―Nov―04 Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework Colleen L Lau, Helen J Mayfield, Jane E Sinclair, Samuel J Brown, Michael Waller, Anoop K Enjeti, et al. (+4)
825 [GO] 2021―Nov―03 Evaluation of a prototype decontamination mobile unit (UMDEO) for COVID-19 vaccination: a cross-sectional survey in France Anna Ribera-Cano, Maud Dupont, Charles-Henri Houzé-Cerfon, Vanessa Houzé-Cerfon, Alexander Hart, Attila J. Hertelendy, et al. (+2)
826 [GO] 2021―Nov―02 Vaccination of healthcare personnel in the COVID-19 era: a call for actions Helena C. Maltezou
827 [GO] 2021―Nov―01 Multicomponent vaccines to fight sars-cov-2 variants of concern Antonio Cassone, Roberto Cauda
828 [GO] 2021―Oct―30 COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: a prospective multicenter study Helena C. Maltezou, Periklis Panagopoulos, Flora Sourri, Theodoros V. Giannouchos, Vasilios Raftopoulos, Maria N. Gamaletsou, et al. (+9)
829 [GO] 2021―Oct―30 COVID-19 Vaccine - Long Term Immune Decline and breakthrough infections Johad Khoury, Ronza Najjar Debbiny, Ayman Hanna, Adel Jabbour, Yara Abu Ahmad, Aamir Saffori, et al. (+4)
830 [GO] 2021―Oct―30 Development of Recombinant COVID-19 Vaccine based on CHO-produced, prefusion Spike Trimer and Alum/CpG Adjuvants Haitao Liu, Chenliang Zhou, Jiao An, Yujiao Song, Ping Yu, Jiadai Li, et al. (+24)
831 [GO] 2021―Oct―29 Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study Miguel García-Grimshaw, Santa Elizabeth Ceballos-Liceaga, Anaclara Michel-Chávez, Mario García-Alanis, Arturo Cadena-Fernández, Javier Andrés Galnares-Olalde, et al. (+14)
832 [GO] 2021―Oct―28 “Any idea how fast ‘It’s just a mask!’ can turn into ‘It’s just a vaccine!’”: From mask mandates to vaccine mandates during the COVID-19 pandemic Sam Martin, Samantha Vanderslott
833 [GO] 2021―Oct―28 COVAX No Fault Compensation Program for COVID-19 Vaccine Injuries in 92 Low and Middle Income Countries Anne Mazur, Stefanie Benitez, Stéphanie Chuffart-Finsterwald, Rafael La Rotta, Lee M. Hampton
834 [GO] 2021―Oct―25 Changes in COVID-19 Vaccine Acceptance Rate Among Recovered Critically Ill atients: A 12 Month Follow-up Study Titilope Olanipekun, Temidayo Abe, Valery Effoe, Gloria Westney, Richsard Snyder
835 [GO] 2021―Oct―22 The immediate impact of the COVID-19 pandemic on polio immunization and surveillance activities Brent Burkholder, Zubair Wadood, Ahmed M. Kassem, Derek Ehrhardt, Delayo Zomahoun
836 [GO] 2021―Oct―22 Would COVID-19 vaccination willingness increase if mobile technologies prohibit unvaccinated individuals from public spaces? A nationwide discrete choice experiment from China Jing Wang, Abram L. Wagner, Ying Chen, Etienne Jaime, Xinwen Hu, Shiqiang Wu, et al. (+3)
837 [GO] 2021―Oct―22 Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate Arik Makovitzki, Elad Lerer, Yaron Kafri, Yaakov Adar, Lilach Cherry, Edith Lupu, et al. (+15)
838 [GO] 2021―Oct―22 Covid-19 vaccine hesitancy, conspiracist beliefs, paranoid ideation and perceived ethnic discrimination in a sample of University students in Venezuela Gabriel Andrade
839 [GO] 2021―Oct―22 Persuasive Messaging to Increase COVID-19 Vaccine Uptake Intentions Erin K. James, Scott E. Bokemper, Alan S. Gerber, Saad B. Omer, Gregory A. Huber
840 [GO] 2021―Oct―22 Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine Shengtao Fan, Dandan Li, Heng Zhao, Li Yu, Pingfang Cui, Lichun Wang, et al. (+5)
841 [GO] 2021―Oct―19 Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system Johanna Chapin-Bardales, Tanya Myers, Julianne Gee, David K. Shay, Paige Marquez, James Baggs, et al. (+3)
842 [GO] 2021―Oct―19 Resource Allocation for Different Types of Vaccines against COVID-19: Tradeoffs and Synergies between Efficacy and Reach Daniel Kim, Pelin Pekgün, İnci Yildirim, Pınar Keskinocak
843 [GO] 2021―Oct―19 Effect of Inactivated Influenza Vaccination on Human Coronavirus Infection: Secondary Analysis of a Randomized Trial in Hutterite Colonies Andrew T Chen, Hannah D Stacey, Art Marzok, Pardeep Singh, Jann Ang, Matthew S Miller, Mark Loeb
844 [GO] 2021―Oct―09 Canadian parents’ perceptions of COVID-19 vaccination and intention to vaccinate their children: results from a cross-sectional national survey Robin M. Humble, Hannah Sell, Eve Dubé, Noni E. MacDonald, Joan Robinson, S. Michelle Driedger, et al. (+6)
845 [GO] 2021―Oct―09 A Self-administered Virtual Reality Intervention Increases COVID-19 Vaccination Intention Aske Mottelson, Clara Vandeweerdt, Michael Atchapero, Tiffany Luong, Christian Holz, Robert Böhm, Guido Makransky
846 [GO] 2021―Oct―09 Trends, patterns and psychological influences on COVID-19 vaccination intention: findings from a large prospective community cohort study in England and Wales (Virus Watch) Thomas Byrne, Parth Patel, Madhumita Shrotri, Sarah Beale, Susan Michie, Jabeer Butt, et al. (+25)
847 [GO] 2021―Oct―06 Development of an IgG-Fc Fusion COVID-19 Subunit Vaccine, AKS-452 David G. Alleva, Andrea R. Delpero, Melanie M. Scully, Sylaja Murikipudi, Ramya Ragupathy, Emma K. Greaves, et al. (+16)
848 [GO] 2021―Oct―06 A Case Series of Acute Pericarditis following COVID-19 Vaccination in the Context of Recent Reports from Europe and the United States George Lazaros, Cleo Anastassopoulou, Sophia Hatziantoniou, Theodoros Kalos, Stergios Soulaidopoulos, Emilia Lazarou, et al. (+4)
849 [GO] 2021―Oct―02 Christian Nationalism and COVID-19 Vaccine Hesitancy and Uptake Katie E. Corcoran, Christopher P. Scheitle, Bernard D. DiGregorio
850 [GO] 2021―Sep―29 History of pandemic H1N1-containing influenza vaccination and risk for spontaneous abortion and birth defects Celeste J. Romano, Clinton Hall, Zeina G. Khodr, Anna T. Bukowinski, Gia R. Gumbs, Ava Marie S. Conlin
851 [GO] 2021―Sep―27 Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic Natalia A Molodecky, Hamid Jafari, Rana M Safdar, Jamal A Ahmed, Abdirahman Mahamud, Ananda S Bandyopadhyay, et al. (+6)
852 [GO] 2021―Sep―27 Parental consent for vaccination of minors against COVID-19 Nina Shevzov-Zebrun, Arthur Caplan
853 [GO] 2021―Sep―27 Preferences for COVID-19 vaccination information and location: Associations with vaccine hesitancy, race and ethnicity Kimberly A. Fisher, Ngoc Nguyen, Sybil Crawford, Hassan Fouayzi, Sonal Singh, Kathleen M. Mazor
854 [GO] 2021―Sep―27 Early exploration of COVID-19 vaccination safety and effectiveness during pregnancy: interim descriptive data from a prospective observational study Inna Bleicher, Einav Kadour-Peero, Lena Sagi-Dain, Shlomi Sagi
855 [GO] 2021―Sep―27 Characteristics associated with COVID-19 vaccine hesitancy: A nationwide survey of 1000 patients with immune-mediated inflammatory diseases Rodrigo Poubel Vieira Rezende, Alessandra S. Braz, Maria Fernanda B. Guimarães, Sandra Lúcia E. Ribeiro, Rejane Maria R. Abreu Vieira, Blanca E. Bica, et al. (+14)
856 [GO] 2021―Sep―24 Title: Antibody Response after First and Second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among Health Care Workers in India: The Final Results of Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) study Awadhesh Kumar Singh, Sanjeev Ratnakar Phatak, Ritu Singh, Kingshuk Bhattacharjee, Nagendra Kumar Singh, Arvind Gupta, Arvind Sharma
857 [GO] 2021―Sep―24 A Phase III, Observer-blind, Randomized, Placebo-controlled Study of the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 Years: An Interim Analysis in Indonesia Eddy Fadlyana, Kusnandi Rusmil, Rodman Tarigan, Andri Reza Rahmadi, Susantina Prodjosoewojo, Yulia Sofiatin, et al. (+14)
858 [GO] 2021―Sep―17 COVID-19 diagnosis in a Senegalese company: a model for COVID-19 vaccination? Jean Michel MANSUY, Asséga Sylvain SAGNA, Michael LAURENT, Jacques IZOPET
859 [GO] 2021―Sep―16 Supporting National Immunization Technical Advisory Groups in the WHO European Region in developing national COVID-19 vaccination recommendations through online communication platform Liudmila Mosina, Wiebe Külper-Schiek, Lisa Jacques-Carroll, Andrew Earnshaw, Thomas Harder, Federico Martinón-Torres, et al. (+3)
860 [GO] 2021―Sep―08 Inequalities in coverage of COVID-19 vaccination: a population register based cross-sectional study in Wales, UK Malorie Perry, Ashley Akbari, Simon Cottrell, Michael B Gravenor, Richard Roberts, Ronan A Lyons, et al. (+3)
861 [GO] 2021―Sep―07 UAE Efforts in Promoting COVID-19 Vaccination and Building Vaccine Confidence Duaa Mohamed Suliman, Faisal A. Nawaz, Parvathy Mohanan, Mohamed Abdul Kareem Adam Modber, Muhammad Kabir Musa, Mohamed Babiker Musa, et al. (+6)
862 [GO] 2021―Sep―07 Prenatal maternal COVID-19 vaccination and pregnancy outcomes Tamar Wainstock, Israel Yoles, Ruslan Sergienko, Eyal Sheiner
863 [GO] 2021―Sep―07 Predicting COVID-19 Vaccination Intention Using Protection Motivation Theory and Conspiracy Beliefs Judith Eberhardt, Jonathan Ling
864 [GO] 2021―Sep―07 Racial differences in anticipated COVID-19 vaccine acceptance among religious populations in the US Christopher Justin Jacobi, Brandon Vaidyanathan
865 [GO] 2021―Sep―07 Low COVID-19 Vaccine Hesitancy in Brazil Daniella Campelo Batalha Cox Moore, Marcio Fernandes Nehab, Karla Gonçalves Camacho, Adriana Teixeira Reis, Maria de Fátima Junqueira-Marinho, Dimitri Marques Abramov, et al. (+10)
866 [GO] 2021―Sep―04 Myocarditis following COVID-19 vaccination - a case series Dan Levin, Gil Shimon, Maggie Fadlon-Derai, Liron Gershovitz, Amiram Shovali, Anat Sebbag, et al. (+3)
867 [GO] 2021―Sep―03 Unmethylated CpG Motif-Containing Genomic DNA Fragments of Bacillus Calmette-Guerin Improves Immune Response towards a DNA Vaccine for COVID-19 Zehua Zhou, Xinyu Zhang, Qianqian Li, Lili Fu, Meiyu Wang, Shuo Liu, et al. (+11)
868 [GO] 2021―Sep―03 Legal and Regulatory Processes for Japan’s COVID-19□Immunization Program Norihisa Yamamoto, Yuichi Takahashi, Shuichiro Hayashi
869 [GO] 2021―Sep―02 COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout Mazin Barry, Mohamad-Hani Temsah, Fadi Aljamaan, Basema Saddik, Ayman Al-Eyadhy, Shuliweeh Alenezi, et al. (+12)
870 [GO] 2021―Sep―02 Collaboration in Times of Crisis: A Study on COVID-19 Vaccine R&D Partnerships Louise C. Druedahl, Timo Minssen, W. Nicholson Price
871 [GO] 2021―Aug―31 The Impact of COVID-19 Vaccination Delay: A Data-Driven Modelling Analysis for Chicago and New York City Vinicius V.L. Albani, Jennifer Loria, Eduardo Massad, Jorge P. Zubelli
872 [GO] 2021―Aug―31 Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: Large population-based cohort study Lill Trogstad, Anna Hayman Robertson, Siri Mjaaland, Per Magnus
873 [GO] 2021―Aug―30 Oropharyngeal shedding of herpesviruses before and after BNT162b2 mRNA vaccination against COVID-19 Tal Brosh-Nissimov, Nadav Sorek, Michal Yeshayahu, Irena Zherebovich, Maria Elmaliach, Amos Cahan, et al. (+2)
874 [GO] 2021―Aug―30 Association of Flu specific and SARS-CoV-2 specific CD4 T cell responses in SARS-CoV-2 infected asymptomatic heath care workers Suresh Pallikkuth, Erin Williams, Rajendra Pahwa, Michael Hoffer, Savita Pahwa
875 [GO] 2021―Aug―26 SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1 John Lok Man Law, Michael Logan, Michael A. Joyce, Abdolamir Landi, Darren Hockman, Kevin Crawford, et al. (+13)
876 [GO] 2021―Aug―25 A Hub-and-spoke Design for Ultra-cold COVID-19 Vaccine Distribution Xinglu Xu, Mark D. Rodgers, Weihong (Grace) Guo
877 [GO] 2021―Aug―25 COVID-19 Vaccine Safety Monitoring: Might Differential Healthcare Seeking Introduce Detection Bias Into Rates of Medical Events and Cause False Safety Signals? Rafael Harpaz
878 [GO] 2021―Aug―24 Making COVID-19 vaccinations accessible for people with disabilities Sara Rotenberg, Matthew B Downer, Jane Cooper
879 [GO] 2021―Aug―19 Walking the Tightrope: Reevaluating Science Communication in the Era of COVID-19 Vaccines Matthew Z. Dudley, Roger Bernier, Janesse Brewer, Daniel A. Salmon
880 [GO] 2021―Aug―19 Vaccine effectiveness against infection and onwards transmission of COVID-19: analysis of Belgian contact tracing data, January-June 2021 Toon Braeye, Laura Cornelissen, Lucy Catteau, Freek Haarhuis, Kristiaan Proesmans, Karin De Ridder, et al. (+9)
881 [GO] 2021―Aug―17 Public Attitudes toward COVID-19 Vaccines on English-language Twitter: A Sentiment Analysis Siru Liu, Jialin Liu
882 [GO] 2021―Aug―16 Continuity of routine immunization programs in Canada during the COVID-19 pandemic Hannah Sell, Ali Assi, S. Michelle Driedger, Eve Dubé, Arnaud Gagneur, Samantha B. Meyer, et al. (+4)
883 [GO] 2021―Aug―16 Immune efficacy of a candidate porcine reproductive and respiratory syndrome vaccine rHN-NP49 administered by a Needle-free intradermal delivery system in comparison with intramuscular injection Yifeng Jiang, Xianbin Li, Lingxue Yu, Wu Tong, Pengfei Chen, Shuaiyong Wang, et al. (+10)
884 [GO] 2021―Aug―14 COVID-19 Vaccination in the Federal Bureau of Prisons, December 2020-April 2021 Liesl M. Hagan, Charles Dusseau, Michael Crockett, Tami Rodriguez, Michael J. Long
885 [GO] 2021―Aug―13 Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review Agustín Ciapponi, Ariel Bardach, Agustina Mazzoni, Tomás Alconada, A. Steven Anderson, Fernando J. Argento, et al. (+19)
886 [GO] 2021―Aug―11 Could live attenuated vaccines better control COVID-19? Shinya Okamura, Hirotaka Ebina
887 [GO] 2021―Aug―11 Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination Daniel Grupel, Sivan Gazit, Licita Schreiber, Varda Nadler, Tamar Wolf, Rachel Lazar, et al. (+7)
888 [GO] 2021―Aug―11 Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests Jamil N Kanji, Ashley Bailey, Jayne Fenton, Sean H Ling, Rafael Rivera, Sabrina Plitt, et al. (+5)
889 [GO] 2021―Aug―11 Does BCG provide long-term protection against SARS-CoV-2 infection? A case-control study in Q, Canada Jacques Pépin, Annie-Claude Labbé, Alex Carignan, Marie-Elise Parent, Jennifer Yu, Cynthia Grenier, et al. (+4)
890 [GO] 2021―Aug―10 The Next Frontier in Vaccine Safety and VAERS: Lessons from COVID-19 and Ten Recommendations for Action John G. Rizk, Charles E. Barr, Youssef Rizk, John C. Lewin
891 [GO] 2021―Aug―08 From program suspension to the pandemic: A qualitative examination of Australia’s vaccine pharmacovigilance system over 10 years Anastasia Phillips, Samantha Carlson, Margie Danchin, Frank Beard, Kristine Macartney
892 [GO] 2021―Aug―06 Semi-quantitative, high throughput analysis of SARS-CoV-2 neutralizing antibodies: Measuring the level and duration of immune response antibodies post infection/vaccination Sean C. Taylor, Beth Hurst, Ian Martiszus, Marvin S. Hausman, Samar Sarwat, Jeffrey M. Schapiro, et al. (+2)
893 [GO] 2021―Aug―05 Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study) Piia Jõgi, Hiie Soeorg, Diana Ingerainen, Mari Soots, Freddy Lättekivi, Paul Naaber, et al. (+13)
894 [GO] 2021―Aug―05 Sub-cutaneous Pfizer/BioNTech COVID-19 vaccine administration results in seroconversion among young adults Limor Friedensohn, Meital Zur, Maxim Timofeyev, Saar Burshtein, Yossi Ben Michael, Noam Fink, Elon Glassberg
895 [GO] 2021―Aug―05 Perceived public health threat a key factor for willingness to get the COVID-19 vaccine in Australia Rachael H Dodd, Kristen Pickles, Erin Cvejic, Samuel Cornell, Jennifer MJ Isautier, Tessa Copp, et al. (+6)
896 [GO] 2021―Aug―03 Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection Lei Li, Yoshikazu Honda-Okubo, Ying Huang, Hyesun Jang, Michael A. Carlock, Jeremy Baldwin, et al. (+11)
897 [GO] 2021―Jul―31 Geo-prioritization framework for COVID-19 vaccine allocation in India Akshay Mahajan, Jasmine Kaur, Chirag Sidana, Shashwat Shivam, Harpreet Singh
898 [GO] 2021―Jul―31 An overview of procurement, pricing, and uptake of COVID-19 vaccines in Pakistan Adeel Siddiqui, Ali Ahmed, Maria Tanveer, Muhammad Saqlain, Chia Siang Kow, Syed Shahzad Hasan
899 [GO] 2021―Jul―27 Optimal Planning of the COVID-19 Vaccine Supply Chain Georgios P. Georgiadis, Michael C. Georgiadis
900 [GO] 2021―Jul―24 COVID-19 vaccination for cancer patients: evidence, priority, and practice Shiv Rajan, Naseem Akhtar, Sonali Sharma, Deep Chakrabarti, Vijay Kumar
901 [GO] 2021―Jul―24 Association of total and neutralizing SARS-CoV-2 spike -Receptor Binding Domain antibodies with epidemiological and clinical characteristics after immunization with the 1st and 2nd doses of the BNT162b2 vaccine Athanasios Michos, Elizabeth-Barbara Tatsi, Fillipos Filippatos, Charilaos Dellis, Dimitra Koukou, Vasiliki Efthymiou, et al. (+3)
902 [GO] 2021―Jul―24 Quantification of SARS-CoV-2 spike and nucleocapsid proteins using isotope dilution tandem mass spectrometry Carrie Pierce-Ruiz, Wanda I. Santana, William J. H. Sutton, David A. Fischler, Hans C. Cooper, Lidoshka R. Marc, et al. (+2)
903 [GO] 2021―Jul―23 Parental plans to vaccinate children for COVID-19 in New York City Chloe A. Teasdale, Luisa N. Borrell, Yanhan Shen, Spencer Kimball, Michael L. Rinke, Sasha A. Fleary, Denis Nash
904 [GO] 2021―Jul―23 Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments Maria Sundaram, Sharifa Nasreen, Andrew Calzavara, Siyi He, Hannah Chung, Susan E. Bronskill, et al. (+6)
905 [GO] 2021―Jul―23 Enablers and barriers to COVID-19 vaccine uptake: an international study of perceptions and intentions Paul F. Burke, Daniel Masters, Graham Massey
906 [GO] 2021―Jul―22 Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine Noémie Tissot, Anne-Sophie Brunel, Fabienne Bozon, Béatrice Rosolen, Catherine Chirouze, Kevin Bouiller
907 [GO] 2021―Jul―22 Will COVID-19 vaccine equity be possible in India? Kanagavalli Mathivathanan
908 [GO] 2021―Jul―20 Playing vaccine roulette: Why the current strategy of staking everything on Covid-19 vaccines is a high-stakes wager Elisabeth Paul, Garrett W. Brown, Andreas Kalk, Valéry Ridde
909 [GO] 2021―Jul―16 An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity Anne-Catherine Fluckiger, Barthelemy Ontsouka, Jasminka Bozic, Abebaw Diress, Tanvir Ahmed, Tamara Berthoud, et al. (+7)
910 [GO] 2021―Jul―16 Vitamin D supplementation: an alternative to enhance the effectiveness of vaccines against SARS-CoV-2? Felipe Inserra, Carlos Tajer, Laura Antonietti, Javier Mariani, León Ferder, Walter Manucha
911 [GO] 2021―Jul―13 Marketing the COVID-19 vaccine and the implications for public health Emmanuel Mogaji
912 [GO] 2021―Jul―13 COVID-19 Vaccine Capacity: Challenges and Mitigation - The DCVMN perspective Benoit Hayman, Rajinder Suri, Sai D. Prasad
913 [GO] 2021―Jul―13 The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying Mechanism George Lazaros, Allan L. Klein, Sophia Hatziantoniou, Costas Tsioufis, Athanasios Tsakris, Cleo Anastassopoulou
914 [GO] 2021―Jul―10 Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - a risk-benefit analysis for people <60 years in Australia Chandini Raina MacIntyre, Benjamin Veness, David Berger, Nada Hamad, Noor Bari
915 [GO] 2021―Jul―07 Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy- Update on the 28th of March 2021 Alberto Mateo-Urdiales, Martina Del Manso, Xanthi Andrianou, Matteo Spuri, Fortunato D'Ancona, Antonietta Filia, et al. (+7)
916 [GO] 2021―Jun―30 Henoch-Schönlein Purpura Presenting Post COVID-19 Vaccination Adam M. Hines, Neal Murphy, Christine Mullin, Julia Barillas, Jacqueline C. Barrientos
917 [GO] 2021―Jun―29 Cost of vaccine delivery strategies in low- and middle-income countries during the COVID-19 pandemic Christina Banks, Allison Portnoy, Flavia Moi, Laura Boonstoppel, Logan Brenzel, Stephen C. Resch
918 [GO] 2021―Jun―29 COVID-19 vaccine roll-out in middle-income countries: lessons learned from the Jordan experience Ala'a Al-Shaikh, Nazeema Muthu, Chinara Aidyralieva, Maria Cristina Profili, Saverio Bellizzi
919 [GO] 2021―Jun―26 Significance of SARS-CoV-2 Specific Antibody Testing during COVID-19 Vaccine Allocation Akane B. Fujimoto, Inci Yildirim, Pinar Keskinocak
920 [GO] 2021―Jun―26 Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding Sandra Scheiblhofer, Stephan Drothler, Werner Braun, Reinhard Braun, Maximilian Boesch, Richard Weiss
921 [GO] 2021―Jun―25 Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site Ian A Myles, Joshua S Vinciguerra, Robert T Premus
922 [GO] 2021―Jun―23 Tolerance of BNT162b2 mRNA COVI-19 vaccine in patients with a medical history of COVID-19 disease : a case control study Aurelie Baldolli, Jocelyn Michon, Fanny Appia, Caroline Galimard, Renaud Verdon, Jean Jacques Parienti
923 [GO] 2021―Jun―23 Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration Aditya P. Desai, Aryan P. Desai, Gregory J. Loomis
924 [GO] 2021―Jun―23 Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: a comparative survey of five large cities in the United States, United Kingdom, and Australia Mallory Trent, Holly Seale, Abrar Ahmad Chughtai, Daniel Salmon, C. Raina MacIntyre
925 [GO] 2021―Jun―23 One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model Karen E. Gooch, Trevor R.F. Smith, Francisco J. Salguero, Susan A. Fotheringham, Robert J. Watson, Mike J. Dennis, et al. (+19)
926 [GO] 2021―Jun―22 Adapting the Motors of Influenza Vaccination Acceptance Scale into the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students I-Hua Chen, Daniel Kwasi Ahorsu, Nai-Ying Ko, Cheng-Fang Yen, Chung-Ying Lin, Mark D. Griffiths, Amir H. Pakpour
927 [GO] 2021―Jun―22 Recent MMR vaccination in Health Care Workers and Covid-19: a test negative case-control study Lisa Lundberg, Maria Bygdell, Gustaf Stukat von Feilitzen, Susanne Woxenius, Claes Ohlsson, Jenny M Kindblom, Susannah Leach
928 [GO] 2021―Jun―21 Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis Kenneth J. Smith, Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner, Richard K. Zimmerman
929 [GO] 2021―Jun―17 Early influenza vaccination rates in children during the COVID-19 pandemic Benjamin Fogel, Eric W. Schaefer, Steven D. Hicks
930 [GO] 2021―Jun―17 COVID-19 Vaccination Rates Vary By Community Vulnerability: A County-level Analysis Clare C. Brown, Sean G. Young, George C. Pro
931 [GO] 2021―Jun―15 Title: Helping patients with ethical concerns about COVID-19 vaccines in light of fetal cell lines used in some COVID-19 vaccines Richard K Zimmerman
932 [GO] 2021―Jun―14 The Need for Broadly Protective COVID-19 Vaccines: Beyond S-Only Approaches Gregory A. Poland, Inna G. Ovsyannikova, Richard B. Kennedy
933 [GO] 2021―Jun―12 COVID-19 RELATED IMMUNIZATION DISRUPTIONS IN RAJASTHAN, INDIA: A RETROSPECTIVE OBSERVATIONAL STUDY Radhika Jain, Ambika Chopra, Camille Falézan, Mustufa Patel, Pascaline Dupas
934 [GO] 2021―Jun―12 Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects Davide Ferrari, Chiara Di Resta, Rossella Tomaiuolo, Eleonora Sabetta, Marina Pontillo, Andrea Motta, Massimo Locatelli
935 [GO] 2021―Jun―10 Estimating the number of averted illnesses and deaths as a result of vaccination against an influenza pandemic in nine low- and middle-income countries Chelsea S. Lutz, Matthew Biggerstaff, Melissa A. Rolfes, Kathryn E. Lafond, Eduardo Azziz-Baumgartner, Rachael M. Porter, et al. (+2)
936 [GO] 2021―Jun―09 Twitter discourse reveals geographical and temporal variation in concerns about COVID-19 Vaccines in the United States Sharath Chandra Guntuku, Alison M. Buttenheim, Garrick Sherman, Raina M. Merchant
937 [GO] 2021―Jun―08 A new group at increased risk of a SARS-CoV-2 infection emerges: The recently vaccinated Sebastian Hoehl, Sandra Ciesek, Jürgen Graf, Sabine Wicker
938 [GO] 2021―Jun―07 Knowledge and attitude of Kenyan healthcare workers towards pandemic influenza disease and vaccination: 9 years after the last influenza pandemic Fred Andayi, Gideon O. Emukule, Eric Osoro, Linus K. Ndegwa, Fredrick Otiato, Peter Muturi, et al. (+7)
939 [GO] 2021―Jun―05 One size does not fit all: Lessons from Israel's Covid-19 vaccination drive and hesitancy Aviad Raz, Yael Keshet, Ariela Popper-Giveon, Maha Sabbah Karkabi
940 [GO] 2021―Jun―04 Public trust on regulatory decisions: the European Medicines Agency and the AstraZeneca COVID-19 vaccine label Rafael Dal-Ré, Odile Launay
941 [GO] 2021―Jun―01 Impact of the COVID-19 pandemic on the provision of routine childhood immunizations in Ontario, Canada Pierre-Philippe Piché-Renaud, Catherine Ji, Daniel S. Farrar, Jeremy N. Friedman, Michelle Science, Ian Kitai, et al. (+3)
942 [GO] 2021―Jun―01 Evaluation of post-introduction COVID-19 Vaccine Effectiveness: Summary of interim guidance of the World Health Organization Minal K. Patel, Isabel Bergeri, Joseph S. Bresee, Benjamin J. Cowling, Natasha S. Crowcroft, Kamal Fahmy, et al. (+21)
943 [GO] 2021―Jun―01 Immunogenic Potential of DNA Vaccine candidate, ZyCoV-D against SARS-CoV-2 in Animal Models Ayan Dey, T.M. Chozhavel Rajanathan, Harish Chandra, Hari P.R. Pericherla, Sanjeev Kumar, Huzaifa S. Choonia, et al. (+14)
944 [GO] 2021―May―30 The missing season: The impacts of the COVID-19 pandemic on influenza Casey M. Zipfel, Vittoria Colizza, Shweta Bansal
945 [GO] 2021―May―28 Myocarditis following COVID-19 mRNA vaccination Saif Abu Mouch, Ariel Roguin, Elias Hellou, Amorina Ishai, Uri Shoshan, Lamis Mahamid, et al. (+4)
946 [GO] 2021―May―28 Adverse Events Following mRNA SARS-CoV-2 Vaccination among U.S. Nursing Home Residents Barbara H. Bardenheier, Stefan Gravenstein, Carolyn Blackman, Roee Gutman, Indra Neil Sarkar, Richard A. Feifer, et al. (+4)
947 [GO] 2021―May―27 COVID-19 vaccine hesitancy: lessons from Israel David Gurwitz
948 [GO] 2021―May―26 Willingness to get vaccinated against Covid-19 and attitudes towards vaccination in general Roselinde Kessels, Jeroen Luyten, Sandy Tubeuf
949 [GO] 2021―May―24 A breath of humanity in the era of Covid-19 vaccine Philippe Vanhems
950 [GO] 2021―May―24 Evidence for antibody as a protective correlate for COVID-19 vaccines Kristen A. Earle, Donna M. Ambrosino, Andrew Fiore-Gartland, David Goldblatt, Peter B. Gilbert, George R. Siber, et al. (+2)
951 [GO] 2021―May―21 Changes in Childhood Vaccination During the Coronavirus Disease 2019 Pandemic in Japan Yuta Aizawa, Tomohiro Katsuta, Hiroshi Sakiyama, Keiko Tanaka-Taya, Hiroyuki Moriuchi, Akihiko Saitoh
952 [GO] 2021―May―21 Lessons from the 1656 Neapolitan Plague:Something to Learn for the Current Coronavirus Pandemic? Maurizio Bifulco, Simona Pisanti, Idamaria Fusco
953 [GO] 2021―May―19 The first Chinese national standards for SARS-CoV-2 neutralizing antibody Lidong Guan, Yuanling Yu, Xiaohong Wu, Jianhui Nie, Jun Zhang, Zejun Wang, et al. (+10)
954 [GO] 2021―May―18 An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose Kakon Nag, Juwel Chandra Baray, Maksudur Rahman Khan, Asif Mahmud, Jikrul Islam, Sanat Myti, et al. (+20)
955 [GO] 2021―May―18 Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: a population-based survey Tzu Tsun LUK, Shengzhi ZHAO, Yongda WU, Janet Yuen-ha WONG, Man Ping WANG, Tai Hing LAM
956 [GO] 2021―May―14 Operational research for the safe and effective design of COVID-19 mass vaccination centres Richard M. Wood, Ben J. Murch, Simon J. Moss, Joshua M.B. Tyler, Alexander L. Thompson, Christos Vasilakis
957 [GO] 2021―May―14 U.S. Population-Based Background Incidence Rates of Medical Conditions for Use in Safety Assessment of COVID-19 Vaccines Diane Gubernot, Amelia Jazwa, Manette Niu, Jane Baumblatt, Julianne Gee, Pedro Moro, et al. (+12)
958 [GO] 2021―May―12 COVID-19 vaccine hesitancy among persons living in homeless shelters in France C Longchamps, S Ducarroz, L Crouzet, N. Vignier, L. Pourtau, C Allaire, et al. (+3)
959 [GO] 2021―May―12 Older Adolescents and Young Adults Willingness to Receive the COVID-19 Vaccine: Implications for Informing Public Health Strategies Tracie O. Afifi, Samantha Salmon, Tamara Taillieu, Ashley Stewart-Tufescu, Janique Fortier, S. Michelle Driedger
960 [GO] 2021―May―11 Covid-19 vaccine trials: ethnic diversity and immunogenicity Hannah Jethwa, Richard Wong, Sonya Abraham
961 [GO] 2021―May―09 Influenza and pneumococcal vaccinations are not associated to COVID-19 outcomes among patients admitted to a university hospital Roberta Pastorino, Leonardo Villani, Daniele Ignazio La Milia, Roberto Ieraci, Francesco Chini, Enrico Volpe, et al. (+5)
962 [GO] 2021―May―06 Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines Masaharu Somiya, Sohtaro Mine, Kosuke Yasukawa, Saki Ikeda
963 [GO] 2021―Apr―30 Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests Nir Eyal, Tobias Gerhard, Brian L. Strom
964 [GO] 2021―Apr―30 Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS) Kerry J. Welsh, Jane Baumblatt, Wambui Chege, Ravi Goud, Narayan Nair
965 [GO] 2021―Apr―27 Missed childhood immunizations during the COVID-19 pandemic in Brazil: analyses of routine statistics and of a national household survey Mariangela F Silveira, Cristian T Tonial, Ana Goretti K Maranhão, Antonia MS Teixeira, Pedro C Hallal, Ana Maria B Menezes, et al. (+4)
966 [GO] 2021―Apr―27 Childhood immunization during the COVID-19 pandemic in Texas Tasmiah Nuzhath, Kobi V. Ajayi, Qiping Fan, Peter Hotez, Brian Colwell, Timothy Callaghan, Annette K. Regan
967 [GO] 2021―Apr―27 The impact of disruptions caused by the COVID-19 pandemic on global polio eradication Dominika A. Kalkowska, Arie Voorman, Mark A. Pallansch, Steven G. F. Wassilak, Stephen L. Cochi, Kamran Badizadegan, Kimberly M. Thompson
968 [GO] 2021―Apr―24 Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia C Raina MacIntyre, Valentina Costantino, Mallory Trent
969 [GO] 2021―Apr―24 Factors Influencing Covid-19 Vaccine Acceptance across Subgroups in the United States: Evidence from a Conjoint Experiment S.E. Kreps, D.L. Kriner
970 [GO] 2021―Apr―15 Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: a national cross-sectional study Chao Wang, Bingfeng Han, Tianshuo Zhao, Hanyu Liu, Bei Liu, Linyi Chen, et al. (+10)
971 [GO] 2021―Apr―09 The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: a phase I randomized, double-blinded, controlled trial Jing Pu, Qin Yu, Zhifang Yin, Ying Zhang, Xueqi Li, Qiongzhou Yin, et al. (+41)
972 [GO] 2021―Apr―08 Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: a mathematical modelling analysis Alexandra B. Hogan, Peter Winskill, Oliver J. Watson, Patrick G.T. Walker, Charles Whittaker, Marc Baguelin, et al. (+14)
973 [GO] 2021―Apr―06 Impact of Reduced Human Papillomavirus Vaccination Coverage Rates Due to COVID-19 in the United States: A Model Based Analysis Vincent Daniels, Kunal Saxena, Craig Roberts, Smita Kothari, Shelby Corman, Linda Niccolai
974 [GO] 2021―Apr―06 When politics collides with public health: COVID-19 vaccine country of origin and vaccination acceptance in Brazil Wladimir G. Gramacho, Mathieu Turgeon
975 [GO] 2021―Apr―06 Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study Sophia Hatziantoniou, Helena C. Maltezou, Athanasios Tsakris, Gregory A. Poland, Cleo Anastassopoulou
976 [GO] 2021―Mar―26 strategy to identify priority groups for covid-19 vaccination: a population based cohort STUDY Antonio Giampiero Russo, Adriano Decarli, Maria Grazia Valsecchi
977 [GO] 2021―Mar―26 The Development of COVID-19 Vaccines in the United States: Why and How So Fast? Barbara J. Kuter, Paul Offit, Gregory A. Poland
978 [GO] 2021―Mar―24 COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization Daniel A. Salmon, Matthew Z. Dudley, Janesse Brewer, Lilly Kan, Jennifer E. Gerber, Haley Budigan, et al. (+4)
979 [GO] 2021―Mar―23 Are vaccines against COVID-19 tailored to the most vulnerable people? Raffaele Antonelli Incalzi, Caterina Trevisan, Susanna Del Signore, Stefano Volpato, Stefano Fumagalli, Fabio Monzani, et al. (+7)
980 [GO] 2021―Mar―23 COVID-19 Vaccine Safety Questions and Answers for Healthcare Providers (CONSIDER) Sonali Kochhar, Eve Dubé, Janice Graham, Youngmee Jee, Ziad A. Memish, Lisa Menning, et al. (+4)
981 [GO] 2021―Mar―23 Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines Aris Angelis, Jonathan Darrow
982 [GO] 2021―Mar―23 The role of multiple SARS-CoV-2 viral antigens in a vaccine-induced integrated immune response Ying Zhang, Dandan Li, Heng Zhao, Lichun Wang, Yun Liao, Xueqi Li, et al. (+2)
983 [GO] 2021―Mar―23 Joining the Herd? U.S. Public Opinion and Vaccination Requirements Across Educational Settings During the COVID-19 Pandemic Simon F. Haeder
984 [GO] 2021―Mar―20 Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada Thomas N. Vilches, Kevin Zhang, Robert Van Exan, Joanne M. Langley, Seyed M. Moghadas
985 [GO] 2021―Mar―20 Safety monitoring of COVID-19 vaccines - Lessons learned from the 1976 national influenza immunization program about detecting rare vaccine-related severe adverse events in emergency mass-vaccination programs Alan Kendal
986 [GO] 2021―Mar―18 Media usage predicts intention to be vaccinated against SARS-CoV-2 in the US and the UK Daniel Allington, Siobhan McAndrew, Vivienne Louisa Moxham-Hall, Bobby Duffy
987 [GO] 2021―Mar―13 Developing standard safety outcomes for COVID-19 vaccines Jim P. Buttery
988 [GO] 2021―Mar―11 COVID-19 vaccination and critical care capacity: perilous months ahead Leslie A Reperant, Albert DME Osterhaus
989 [GO] 2021―Mar―11 COVID-19 vaccine intentions in the United States, a social-ecological framework Carl Latkin, Lauren Dayton, Grace Yi, Arianna Konstantopoulos, Ju Park, Catherine Maulsby, Xiangrong Kong
990 [GO] 2021―Mar―11 The social experience of participation in a COVID-19 vaccine trial: Subjects’ motivations, others’ concerns, and insights for vaccine promotion Emily Wentzell, Ana-Monica Racila
991 [GO] 2021―Mar―09 NIH funding for vaccine readiness before the COVID-19 pandemic Anthony E. Kiszewski, Ekaterina Galkina Cleary, Matthew J. Jackson, Fred D. Ledley
992 [GO] 2021―Mar―09 Importance of COVID-19 vaccine efficacy in older age groups Manish Sadarangani, Bahaa Abu Raya, Jessica M. Conway, Sarafa A. Iyaniwura, Rebeca Cardim Falcao, Caroline Colijn, et al. (+2)
993 [GO] 2021―Mar―09 U.S. Public Support for COVID-19 Vaccine Donation to Low- and Middle-Income Countries during the COVID-19 Pandemic Jeanine P.D. Guidry, Paul B. Perrin, Linnea I. Laestadius, Emily K. Vraga, Carrie A. Miller, Bernard F. Fuemmeler, et al. (+3)
994 [GO] 2021―Mar―07 The Critical Role Background Rates of Possible Adverse Events in the Assessment of COVID-19 Vaccine Safety Steven B Black, Barbara Law, Robert T. Chen, Cornelia L. Dekker, Miriam Sturkenboom, Wan-Ting Huang, et al. (+2)
995 [GO] 2021―Mar―07 Vaccine Hesitancy and Anti-Vaccination in the Time of COVID-19: a Google Trends Analysis Samuel Pullan, Mrinalini Dey
996 [GO] 2021―Mar―05 Influenza Vaccination in the Time of COVID-19: A National U.S. Survey of Adults Lynne Sturm, Monica L. Kasting, Katharine J. Head, Jane A. Hartsock, Gregory D. Zimet
997 [GO] 2021―Mar―05 Intranasal Administration of a Recombinant RBD Vaccine Induced Protective Immunity Against SARS-CoV-2 in Mouse Yingying Du, Yuhua Xu, Jin Feng, Longbo Hu, Yanan Zhang, Bo Zhang, et al. (+6)
998 [GO] 2021―Mar―05 Assessment of SARS-CoV-2 Specific CD4(+) and CD8 (+) T Cell Responses MHC Class I and II Tetramers Yuri Poluektov, Pirouz Daftarian, Marybeth George, Marc C. Delcommenne
999 [GO] 2021―Mar―02 Guidance for design and analysis of observational studies of fetal and newborn outcomes following COVID-19 vaccination during pregnancy Deshayne B. Fell, Michelle C. Dimitris, Jennifer A. Hutcheon, Justin R. Ortiz, Robert W. Platt, Annette K. Regan, David A. Savitz
1000 [GO] 2021―Feb―27 Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use Mingwang Shen, Jian Zu, Christopher K. Fairley, José A. Pagán, Li An, Zhanwei Du, et al. (+6)
1001 [GO] 2021―Feb―27 Willingness to Pay and Financing Preferences for COVID-19 Vaccination in China Jiahao Wang, Yun Lyu, Haijun Zhang, Rize Jing, Xiaozhen Lai, Huangyufei Feng, et al. (+2)
1002 [GO] 2021―Feb―24 Building the global vaccine manufacturing capacity needed to respond to pandemics Tara Kirk Sell, Daniel Gastfriend, Matthew Watson, Crystal Watson, Lauren Richardson, Anita Cicero, et al. (+2)
1003 [GO] 2021―Feb―21 The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region Justin R. Ortiz, Joanie Robertson, Jui-Shan Hsu, Stephen L. Yu, Amanda J. Driscoll, Sarah R. Williams, et al. (+5)
1004 [GO] 2021―Feb―17 Perspectives on the Receipt of a COVID-19 Vaccine: A Survey of Employees in Two Large Hospitals in Philadelphia Barbara J. Kuter, Safa Browne, Florence M. Momplaisir, Kristen A. Feemster, Angela K. Shen, Judith Green-McKenzie, et al. (+2)
1005 [GO] 2021―Feb―10 Improving COVID-19 Vaccine Acceptance: Including Insights from Human Decision-Making Under Conditions of Uncertainty and Human-Centered Design Caroline M. Poland, Allison Matthews, Gregory A. Poland
1006 [GO] 2021―Feb―09 A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine Laurence Chu, Roderick McPhee, Wenmei Huang, Hamilton Bennett, Rolando Pajon, Biliana Nestorova, Brett Leav
1007 [GO] 2021―Feb―07 International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples Eric Robinson, Andrew Jones, India Lesser, Michael Daly
1008 [GO] 2021―Feb―03 Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries David Gurwitz
1009 [GO] 2021―Jan―31 Vaccines, masks, distancing and credibility: An urgent warning for pandemic management Paul H. Axelsen, Gregory A. Poland
1010 [GO] 2021―Jan―29 General Determination of Causation Between Covid-19 Vaccines and Possible Adverse Events Lee M. Hampton, Rakesh Aggarwal, Stephen J.W. Evans, Barbara Law
1011 [GO] 2021―Jan―22 The economics of global COVID vaccine administration during a pandemic - Why continue skin alcohol preparation as a costly but ineffective practice? Eric G. Poland, Darren K. McGuire, Tamar Ratishvili, Gregory A. Poland
1012 [GO] 2021―Jan―22 Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studies after the 2009/10 influenza pandemic G.N. Okoli, F. Racovitan, T. Abdulwahid, C.H. Righolt, S.M. Mahmud
1013 [GO] 2021―Jan―20 US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine Rafael Dal-Ré
1014 [GO] 2021―Jan―20 Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response Qiu-dong Su, Ye-ning Zou, Yao Yi, Li-ping Shen, Xiang-zhong Ye, Yang Zhang, et al. (+15)
1015 [GO] 2021―Jan―19 Immunoinformatics prediction of overlapping CD8+ T-cell, IFN-γ and IL-4 inducer CD4+ T-cell and linear B-cell epitopes based vaccines against COVID-19 (SARS-CoV-2) Abiodun J. Fatoba, Leah Maharaj, Victoria T. Adeleke, Moses Okpeku, Adebayo A Adeniyi, Matthew A. Adeleke
1016 [GO] 2021―Jan―13 The need for inclusion of pregnant women in COVID-19 vaccine trials Richard H. Beigi, Carleigh Krubiner, Denise J. Jamieson, Anne D. Lyerly, Brenna Hughes, Laura Riley, et al. (+2)
1017 [GO] 2021―Jan―13 Black-white disparities in 2009 H1N1 vaccination among adults in the United States: A cautionary tale for the COVID-19 pandemic Andrew E. Burger, Eric N. Reither, Svenn-Erik Mamelund, Sojung Lim
1018 [GO] 2021―Jan―11 Development of Vaccines for Influenza Disease: Opportunity Costs of the COVID-19 Pandemic Timothy L. Wiemken, Ana Santos Rutschman
1019 [GO] 2021―Jan―11 Immuno-informatics approach for B-cell and T-cell Epitope based peptide vaccine design against novel COVID-19 virus Jitender Singh, Deepti Malik, Ashvinder Raina
1020 [GO] 2021―Jan―11 Predictors of Intention to Vaccinate Against COVID-19: Results of a Nationwide Survey Jeanette B. Ruiz, Robert A. Bell
1021 [GO] 2021―Jan―08 Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020 Marit Middeldorp, Alies van Lier, Nicoline van der Maas, Irene Veldhuijzen, Wieke Freudenburg, Nina M van Sorge, et al. (+3)
1022 [GO] 2021―Jan―08 Acceptance of the COVID-19 vaccine based on the Health Belief Model: a population-based survey in Hong Kong Martin CS Wong, Eliza LY Wong, Junjie Huang, Annie WL Cheung, Kevin Law, Marc KC Chong, et al. (+6)
1023 [GO] 2021―Jan―08 The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: use of cost-effectiveness modeling to inform vaccination prioritization Michele Kohli, Michael Maschio, Debbie Becker, Milton C. Weinstein
1024 [GO] 2021―Jan―08 Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines John M Kelso
1025 [GO] 2021―Jan―08 How should we conduct pandemic vaccination? Jane Williams, Chris Degeling, Jodie McVernon, Angus Dawson
1026 [GO] 2021―Jan―03 Constructing an ethical framework for priority allocation of pandemic vaccines J Fielding, S.G. Sullivan, F. Beard, K. Macartney, J. Williams, A. Dawson, et al. (+6)
1027 [GO] 2020―Dec―26 Childhood vaccinations: hidden impact of COVID-19 on children in Singapore Youjia Zhong, Hannah Eleanor Clapham, Ramkumar Aishworiya, Ying Xian Chua, Jancy Mathews, Mabel Ong, et al. (+5)
1028 [GO] 2020―Dec―17 Timing of COVID-19 Vaccine Approval and Endorsement by Public Figures Scott E. Bokemper, Gregory A. Huber, Alan S. Gerber, Erin K. James, Saad B. Omer
1029 [GO] 2020―Dec―17 Preferences for a COVID-19 vaccine in Australia Antonio Borriello, Daniel Master, Andrea Pellegrini, John M Rose
1030 [GO] 2020―Dec―17 Global production capacity of seasonal and pandemic influenza vaccines in 2019 Erin Sparrow, James G Wood, Christopher Chadwick, Anthony T. Newall, Siranda Torvaldsen, Ann Moen, Guido Torelli
1031 [GO] 2020―Dec―16 Broad cross-national public support for accelerated COVID-19 vaccine trial designs David Broockman, Joshua Kalla, Alexander Guerrero, Mark Budolfson, Nir Eyal, Nicholas P. Jewell, et al. (+2)
1032 [GO] 2020―Dec―13 BCG vaccine: worrying proposal for COVID-19 Emanuel Sarinho, Ekaterini Goudouris, Dirceu Solé
1033 [GO] 2020―Dec―13 Priority allocation of pandemic influenza vaccines in Australia - Recommendations of 3 community juries C. Degeling, J. Williams, S.M. Carter, R. Moss, P. Massey, G.L. Gilbert, et al. (+5)
1034 [GO] 2020―Dec―11 Maintain and increase vaccination coverage in children, adolescents, adults and elderly people: Let's avoid adding epidemics to the pandemic P. Bonanni, I.F. Angelillo, A. Villani, P. Biasci, S. Scotti, R. Russo, et al. (+12)
1035 [GO] 2020―Dec―10 An Inventory-Location Optimization Model for Equitable Influenza Vaccine Distribution in Developing Countries During the COVID-19 Pandemic Mehdi Rastegar, Madjid Tavana, Afshin Meraj, Hassan Mina
1036 [GO] 2020―Dec―09 Potential impact of COVID-19 pandemic on vaccination coverage in children: A case study of measles-containing vaccine administration in the United States (US) Cristina Carias, Manjiri Pawaskar, Mawuli Nyaku, James H. Conway, Craig Roberts, Lyn Finelli, Ya-Ting Chen
1037 [GO] 2020―Dec―09 Critical Aspects of Packaging, Storage, Preparation, and Administration of mRNA and Adenovirus-vectored COVID-19 Vaccines for Optimal Efficacy Michelle Holm, Gregory Poland
1038 [GO] 2020―Dec―05 Epidemiology of COVID-19 infection in young children under five years: a systematic review and meta-analysis Mejbah Uddin Bhuiyan, Eunice Stiboy, Md. Zakiul Hassan, Mei Chan, Md. Saiful Islam, Najmul Haider, et al. (+2)
1039 [GO] 2020―Dec―05 Individual Preferences for COVID-19 Vaccination in China Anli Leng, Elizabeth Maitland, Siyuan Wang, Stephen Nicholas, Rugang Liu, Jian Wang
1040 [GO] 2020―Dec―05 PIPDeploy: Development and implementation of a gamified table top simulation exercise to strengthen national pandemic vaccine preparedness and readiness Ioana Ghiga, Sol Richardson, Alba Maria Ropero Álvarez, Masaya Kato, Dhamari Naidoo, Satoko Otsu, et al. (+3)
1041 [GO] 2020―Dec―04 Pregnant people deserve the protection offered by SARS-CoV-2 vaccines Melanie M. Maykin, Cara Heuser, Helen Feltovich
1042 [GO] 2020―Nov―24 A model for the incremental burden of invasive Haemophilus influenzae type b due to a decline of childhood vaccination during the COVID-19 outbreak: A dynamic transmission model in Japan Taito Kitano, Hirosato Aoki
1043 [GO] 2020―Nov―24 How to ensure we can track and trace the global use of COVID-19 vaccines? Robert H Vander Stichele, Christian Hay, Malin Fladvad, Miriam CJM Sturkenboom, Robert T Chen
1044 [GO] 2020―Nov―24 New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates Takehiro Ura, Akio Yamashita, Nobuhisa Mizuki, Kenji Okuda, Masaru Shimada
1045 [GO] 2020―Nov―08 Pandemic perspectives - The invisible hurricane Carly Muller
1046 [GO] 2020―Nov―07 The demand for a COVID-19 vaccine in Ecuador Oscar Sarasty, Carlos E. Carpio, Darren Hudson, Patricia A. Guerrero-Ochoa, Ivan Borja
1047 [GO] 2020―Nov―05 Influenza vaccination among infection control teams: A EUCIC survey prior to COVID-19 pandemic Şiran Keske, Nico T. Mutters, Constantinos Tsioutis, Önder Ergönül
1048 [GO] 2020―Nov―05 COVID-19: The Worst Date to the Senior Dance Luke Bothun
1049 [GO] 2020―Oct―30 The public’s role in COVID-19 vaccination: human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States Monica Schoch-Spana, Emily K. Brunson, Rex Long, Alexandra Ruth, Sanjana J. Ravi, Marc Trotochaud, et al. (+17)
1050 [GO] 2020―Oct―28 Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group Euzebiusz Jamrozik, Katherine Littler, Susan Bull, Claudia Emerson, Gagandeep Kang, Melissa Kapulu, et al. (+7)
1051 [GO] 2020―Oct―26 “Cultivating” acceptance of a COVID-19 vaccination program: Lessons from Italy Guendalina Graffigna, Lorenzo Palamenghi, Serena Barello, Boccia Stefania
1052 [GO] 2020―Oct―26 Acceptance of a COVID-19 vaccine: A multifactorial consideration Leidy Y. García, Arcadio A. Cerda
1053 [GO] 2020―Oct―23 NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge Mimi Guebre-Xabier, Nita Patel, Jing-Hui Tian, Bin Zhou, Sonia Maciejewski, Kristal Lam, et al. (+7)
1054 [GO] 2020―Oct―21 “Expanding Global and National Influenza Vaccine Systems to match the COVID-19 Pandemic Response” Bruce A. Ruscio, Peter Hotez
1055 [GO] 2020―Oct―20 India’s cost-effective COVID-19 vaccine development initiatives Chiranjib Chakraborty, Govindasamy Agoramoorthy
1056 [GO] 2020―Oct―19 Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: a multi-methods study in England Sadie Bell, Richard Clarke, Sandra Mounier-Jack, Jemma L Walker, Pauline Paterson
1057 [GO] 2020―Oct―19 Identification of a dominant CD8+ CTL epitope in the SARS-associated coronavirus 2 spike protein Daisuke Muraoka, Deng Situo, Sawada Shin-ichi, Akiyoshi Kazunari, Naozumi Harada, Hiroaki Ikeda
1058 [GO] 2020―Oct―13 Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry L. Coudeville, G.B. Gomez, O. Jollivet, R.C. Harris, E. Thommes, S. Druelles, et al. (+3)
1059 [GO] 2020―Oct―10 Caregiver willingness to vaccinate their children against COVID-19: cross sectional survey Ran D. Goldman, Tyler D. Yan, Michelle Seiler, Cristina Parra Cotanda, Julie C. Brown, Eileen J. Klein, et al. (+17)
1060 [GO] 2020―Oct―09 COVID-19 in Africa and collateral effects on health systems and their immunization programs Azucena Bardají, Quique Bassat, Graça Matsinhe, Teresa Aguado
1061 [GO] 2020―Oct―09 COVID-19 vaccine and boosted immunity: nothing ad interim to do? Luca Roncati, Maria Vadalà, Veronica Corazzari, Beniamino Palmieri
1062 [GO] 2020―Oct―09 COVID-19 vaccine trials: duty of care and standard of prevention considerations Jerome Amir Singh
1063 [GO] 2020―Oct―09 Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches Ashkan Safavi, Amirhosein Kefayat, Elham Mahdevar, Ardavan Abiri, Fatemeh Ghahremani
1064 [GO] 2020―Sep―22 Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1) Formulated with Aluminum Hydroxide Induces Protective Immunity and Reduces Immune Enhancement Wen-Hsiang Chen, Xinrong Tao, Anurodh Agrawal, Abdullah Algaissi, Bi-Hung Peng, Jeroen Pollet, et al. (+7)
1065 [GO] 2020―Sep―22 Enhanced Elicitation of Potent Neutralizing Antibodies by the SARS-CoV-2 Spike Receptor Binding Domain Fc Fusion Protein in Mice Xianglei Liu, Aleksandra Drelich, Wei Li, Chuan Chen, Zehua Sun, Megan Shi, et al. (+4)
1066 [GO] 2020―Sep―17 Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic Maëlle Detoc, Sébastien Bruel, Paul Frappe, Bernard Tardy, Elisabeth Botelho-Nevers, Amandine Gagneux-Brunon
1067 [GO] 2020―Sep―15 Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials Natalie E. Dean, Ana Pastore y Piontti, Zachary J. Madewell, Derek A.T Cummings, Matthew D.T. Hitchings, Keya Joshi, et al. (+4)
1068 [GO] 2020―Sep―10 Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: a cross-sectional survey Kailu WANG, Eliza Lai Yi WONG, Kin Fai HO, Annie Wai Ling CHEUNG, Emily Ying-yang CHAN, Eng Kiong YEOH, Samuel Yeung-shan WONG
1069 [GO] 2020―Aug―20 Acceptability of a COVID-19 Vaccine among Adults in the United States: How Many People Would Get Vaccinated? Paul L. Reiter, Michael L. Pennell, Mira L. Katz
1070 [GO] 2020―Aug―20 BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: in silico analyses and a hypothesis Yusuke Tomita, Ryo Sato, Tokunori Ikeda, Takuro Sakagami
1071 [GO] 2020―Aug―19 The impact of influenza vaccination on the COVID-19 pandemic? Evidence and lessons for public health policies John Paget, Saverio Caini, Ben Cowling, Susanna Esposito, Ann R. Falsey, Angela Gentile, et al. (+4)
1072 [GO] 2020―Aug―19 Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes Uri Galili
1073 [GO] 2020―Aug―15 Impact of COVID-19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: an analysis of provincial electronic immunization registry Subhash Chandir, Danya Arif Siddiqi, Mariam Mehmood, Hamidreza Setayesh, Muhammad Siddique, Amna Mirza, et al. (+7)
1074 [GO] 2020―Aug―10 The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing sever infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic Kiddus Yitbarek, Gelila Abraham, Tsinuel Girma, Tizta Tilahun, Mirkuzie Woldie
1075 [GO] 2020―Jul―31 Ensuring access and affordability through COVID-19 vaccine research and development investments: a proposal for the Options Market for Vaccines Rebecca Forman, Michael Anderson, Mark Jit, Elias Mossialos
1076 [GO] 2020―Jul―29 Influenza immunization and COVID-19 Helena C. Maltezou, Kalliopi Theodoridou, Gregory Poland
1077 [GO] 2020―Jul―12 Vaccines based on Virus-Like nano-Particles for use against Middle East Respiratory Syndrome (MERS) coronavirus Alireza Hashemzadeh, Amir Avan, Gordon A Ferns, Majid Khazaei
1078 [GO] 2020―Jul―10 Planning for COVID-19 Vaccines Safety surveillance Sonali Kochhar, Daniel A. Salmon
1079 [GO] 2020―Jul―03 A global agenda for older adult immunization in the COVID-19 era: A roadmap for action Lois A. Privor-Dumm, Gregory A. Poland, Jane Barratt, David N. Durrheim, Maria Deloria Knoll, Prarthana Vasudevan, et al. (+3)
1080 [GO] 2020―Jul―03 Bacillus Calmette-Guérin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality Ahmed Osama El-Gendy, Haitham Saeed, Ahmed M.A. Ali, Hossam M. Zawbaa, Dina Gomaa, Hadeer S. Harb, et al. (+4)
1081 [GO] 2020―Jun―25 Contingent assessment of the COVID-19 vaccine Leidy Y. García, Arcadio A. Cerda
1082 [GO] 2020―Jun―25 Silver Lining of COVID-19: heightened global interest in pneumococcal and influenza vaccines, an infodemiology study Joseph Alexander Paguio, Jasper Seth Yao, Edward Christopher Dee
1083 [GO] 2020―Jun―24 Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates Wenlin Ren, Hunter Sun, George F. Gao, Jianxin Chen, Sean Sun, Rongqing Zhao, et al. (+18)
1084 [GO] 2020―Jun―23 Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers Umit H. Kartoglu, Kelly L. Moore, John S. Lloyd
1085 [GO] 2020―Jun―23 Allocation criteria for an initial shortage of a future SARS-CoV-2 vaccine and necessary measures for global immunity Wolfram Henn
1086 [GO] 2020―Jun―20 Exploring the role of mass immunisation in influenza pandemic preparedness: A modelling study for the UK context Luca Grieco, Jasmina Panovska-Griffiths, Edwin van Leeuwen, Peter Grove, Martin Utley
1087 [GO] 2020―Jun―19 Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality Deus Thindwa, Maria Garcia Quesada, Yang Liu, Julia Bennett, Cheryl Cohen, Maria Deloria Knoll, et al. (+3)
1088 [GO] 2020―Jun―10 Vaccination Against Coronaviruses In Domestic Animals Ian R Tizard
1089 [GO] 2020―Jun―04 COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies? G. Owen Schaefer, Clarence C. Tam, Julian Savulescu, Teck Chuan Voo
1090 [GO] 2020―May―25 Consensus Summary Report for CEPI/BC March 12-13, 2020 Meeting: Assessment of Risk of Disease Enhancement with COVID-19 Vaccines Paul-Henri Lambert, Donna M. Ambrosino, Svein R. Andersen, Ralph S. Baric, Steven B. Black, Robert T. Chen, et al. (+11)
1091 [GO] 2020―May―01 Tortoises, Hares, and Vaccines: A Cautionary Note for SARS-CoV-2 Vaccine Development Gregory A. Poland
1092 [GO] 2020―Apr―30 The biological characteristics of SARS-CoV-2 Spike protein Pro330-Leu650 Qiu-dong Su, Yao Yi, Ye-ning Zou, Zhi-yuan Jia, Feng Qiu, Feng Wang, et al. (+7)
1093 [GO] 2020―Apr―28 An Effective CTL Peptide Vaccine for Ebola Zaire Based on Survivors’ CD8+ Targeting of a Particular Nucleocapsid Protein Epitope with Potential Implications for COVID-19 Vaccine Design C.V. Herst, S. Burkholz, J. Sidney, A. Sette, P.E. Harris, S. Massey, et al. (+10)
1094 [GO] 2020―Apr―20 Enabling Emergency Mass Vaccination: Innovations in Manufacturing and Administration During a Pandemic Divya Hosangadi, Kelsey Lane Warmbrod, Elena K Martin, Amesh Adalja, Anita Cicero, Thomas Inglesby, et al. (+3)
1095 [GO] 2020―Mar―12 Shaping meeting to explore the value of a coordinated work plan for epidemic and pandemic influenza vaccine preparedness Bruce Ruscio, Amanda Bolster, Joseph Bresee, Atika Abelin, Philippe Boutet, Hans Christiansen, et al. (+23)
1096 [GO] 2020―Feb―21 Another coronavirus, another epidemic, another warning Gregory A. Poland
1097 [GO] 2020―Feb―11 Recombinant infectious bronchitis coronavirus H120 with the spike protein S1 gene of the nephropathogenic IBYZ strain remains attenuated but induces protective immunity Yi Jiang, Xu Cheng, Xiumei Zhao, Yan Yu, Mingyan Gao, Sheng Zhou
1098 [GO] 2020―Jan―24 Pandemic influenza A(H1N1pdm09) vaccine induced high levels of influenza-specific IgG and IgM antibodies as analyzed by enzyme immunoassay and dual-mode multiplex microarray immunoassay methods Anna Kazakova, Laura Kakkola, Thedi Ziegler, Ritva Syrjänen, Henna Päkkilä, Matti Waris, et al. (+2)
1099 [GO] 2019―Dec―12 Does having a seasonal influenza program facilitate pandemic preparedness? An analysis of vaccine deployment during the 2009 pandemic Rachael M. Porter, Shoshanna Goldin, Kathryn E. Lafond, Lisa Hedman, Mellissa Ungkuldee, Jordan Kurzum, et al. (+4)

1099 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.227 sec